| 1 |
Ranucci M, Baryshnikova E, Anguissola M, Pugliese S, Falco M, Menicanti L. The Long Term Residual Effects of COVID-Associated Coagulopathy. IJMS 2023;24:5514. [DOI: 10.3390/ijms24065514] [Reference Citation Analysis]
|
| 2 |
Sahin ME, Sahin E, Kirlangic MM, Ak M, Daglıtuncezdi Cam S, Cundubey CR, Col Madendag I, Madendag Y. Fetal Diaphragmatic Excursion Is Decreased in Hospitalized Pregnant Women Infected with COVID-19 during the Second and Third Trimesters. Am J Perinatol 2023. [PMID: 36724872 DOI: 10.1055/a-2024-0907] [Reference Citation Analysis]
|
| 3 |
Shirai K, Ishikawa M, Kobayashi T, Sato K, Murakami H, Kohama K, Manbo N, Hasegawa K, Hirata J. High Plasma tPAPAI-1C Levels May Be Related to a Poor Prognosis in Patients with Severe or Critical COVID-19: A Single-Center Retrospective Study. J Clin Med 2023;12. [PMID: 36902805 DOI: 10.3390/jcm12052019] [Reference Citation Analysis]
|
| 4 |
Jonmarker S, Alarcón F, Litorell J, Granholm A, Alm EJ, Chew M, Russell L, Weihe S, Madsen EK, Meier N, Leistner JW, Mårtensson J, Hollenberg J, Perner A, Kjær MN, Munch MW, Dahlberg M, Cronhjort M, Wahlin RR. Effects of 12 mg vs. 6 mg dexamethasone on thromboembolism and bleeding in patients with critical COVID-19 - a post hoc analysis of the randomized, blinded COVID STEROID 2 trial. Ann Intensive Care 2023;13:12. [PMID: 36862239 DOI: 10.1186/s13613-023-01115-y] [Reference Citation Analysis]
|
| 5 |
Li NY, Murthy NK, Franz CK, Spinner RJ, Bishop AT, Murray PM, Shin AY. Upper Extremity Neuropathies Following Severe COVID-19 Infection: A Multicenter Case Series. World Neurosurg 2023;171:e391-7. [PMID: 36513302 DOI: 10.1016/j.wneu.2022.12.027] [Reference Citation Analysis]
|
| 6 |
Quintal Martínez JP, Segura Campos MR. Flavonoids as a therapeutical option for the treatment of thrombotic complications associated with COVID-19. Phytother Res 2023;37:1092-114. [PMID: 36480428 DOI: 10.1002/ptr.7700] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 7 |
Peck J, Wishon MJ, Wittels H, Hasty F, Hendricks S, Lee SJ, Wittels SH. COVID-19-Induced Changes in Photoplethysmography. Mil Med 2023:usad025. [PMID: 36852874 DOI: 10.1093/milmed/usad025] [Reference Citation Analysis]
|
| 8 |
Forlenza EM, Serino J 3rd, Weintraub MT, Burnett RA 3rd, Karas V, Della Valle CJ. Elective Joint Arthroplasty Should be Delayed by One Month After COVID-19 Infection to Prevent Postoperative Complications. J Arthroplasty 2023:S0883-5403(23)00140-7. [PMID: 36813216 DOI: 10.1016/j.arth.2023.02.032] [Reference Citation Analysis]
|
| 9 |
Belen Apak FB, Yuce G, Topcu DI, Gultekingil A, Felek YE, Sencelikel T. Coagulopathy is Initiated with Endothelial Dysfunction and Disrupted Fibrinolysis in Patients with COVID-19 Disease. Indian J Clin Biochem 2023;:1-11. [PMID: 36816717 DOI: 10.1007/s12291-023-01118-3] [Reference Citation Analysis]
|
| 10 |
Batenova G, Pivina L, Dedov E, Dyussupov A, Zhumanbayeva Z, Smail Y, Belikhina T, Pak L, Ygiyeva D. Restenosis of Coronary Arteries in Patients with Coronavirus Infection: Case Series. Case Rep Med 2023;2023:3000420. [PMID: 36818597 DOI: 10.1155/2023/3000420] [Reference Citation Analysis]
|
| 11 |
Zerangian N, Erabi G, Poudineh M, Monajjem K, Diyanati M, Khanlari M, Khalaji A, Allafi D, Faridzadeh A, Amali A, Alizadeh N, Salimi Y, Ghane Ezabadi S, Abdi A, Hasanabadi Z, ShojaeiBaghini M, Deravi N. Venous thromboembolism in viral diseases: A comprehensive literature review. Health Sci Rep 2023;6:e1085. [PMID: 36778773 DOI: 10.1002/hsr2.1085] [Reference Citation Analysis]
|
| 12 |
Mykhalchuk DI, Pavlovskyi SA, Pavlovska MO, Drozdov VO, Blagaia AV. FEATURES OF COAGULOPATHY AND SYSTEMIC INFLAMMATION IN PATIENTS AFTER COVID-19 INFECTION. Wiad Lek 2022;75:2907-14. [PMID: 36723302 DOI: 10.36740/WLek202212103] [Reference Citation Analysis]
|
| 13 |
Levy DA, Boey HP, Leff PD. Modified Negative Pressure Enclosure During Tracheostomy in Patients With COVID-19. Ear Nose Throat J 2023;102:NP84-8. [PMID: 33530740 DOI: 10.1177/0145561321991319] [Reference Citation Analysis]
|
| 14 |
Uematsu H, Shinoda K, Saito A, Sakai K. Deep venous thrombosis in a kidney transplant recipient with COVID-19: a case report. CEN Case Rep 2023;12:98-103. [PMID: 35972687 DOI: 10.1007/s13730-022-00724-z] [Reference Citation Analysis]
|
| 15 |
Sanjay S, Bhakti Mistra S, Patro SK, Kawali A, Shetty R, Mahendradas P. Systemic Markers in Ophthalmic Manifestations of Post Corona Virus Disease-19 (COVID-19). Ocul Immunol Inflamm 2023;31:410-5. [PMID: 35138993 DOI: 10.1080/09273948.2021.2025253] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 16 |
Rajsic S, Breitkopf R, Rugg C, Bukumiric Z, Reitbauer J, Treml B. Thrombotic Events Develop in 1 Out of 5 Patients Receiving ECMO Support: An 11-Year Referral Centre Experience. J Clin Med 2023;12. [PMID: 36769730 DOI: 10.3390/jcm12031082] [Reference Citation Analysis]
|
| 17 |
Lopez A, Matusov Y, Pedraza I, Tapson V, Falk J, Chen P. COVID‐19: Inpatient Management. Coronavirus Disease 2019 (COVID‐19) 2023. [DOI: 10.1002/9781119789741.ch10] [Reference Citation Analysis]
|
| 18 |
Rivera-Torres J, Girón N, San José E. COVID-19: A Comprehensive Review on Cardiovascular Alterations, Immunity, and Therapeutics in Older Adults. J Clin Med 2023;12. [PMID: 36675416 DOI: 10.3390/jcm12020488] [Reference Citation Analysis]
|
| 19 |
Land WG. The Pathogenetic Role of DAMPs in Severe Infectious Diseases. Damage-Associated Molecular Patterns in Human Diseases 2023. [DOI: 10.1007/978-3-031-21776-0_5] [Reference Citation Analysis]
|
| 20 |
Özdede M, Güven AT, Karadeniz Güven D, Uyaroğlu OA, Durusu Tanriover M. The Collateral Benefit of COVID Pandemic: Improved Pharmacological Venous Thromboembolism Prophylaxis Practices in Non-COVID Patients. Int J Gen Med 2023;16:1069-79. [PMID: 36992696 DOI: 10.2147/IJGM.S404827] [Reference Citation Analysis]
|
| 21 |
Musunuri T, Muehlberger PM. Ischemic Stroke Secondary to Myocarditis in the Setting of COVID-19. Cureus 2023;15:e34446. [PMID: 36874760 DOI: 10.7759/cureus.34446] [Reference Citation Analysis]
|
| 22 |
Sebbar EH, Choukri M. Interleukin 6: A biomarker for COVID-19 progression. Mater Today Proc 2023;72:3351-5. [PMID: 35937954 DOI: 10.1016/j.matpr.2022.07.387] [Reference Citation Analysis]
|
| 23 |
Vlemincx E, Arcoleo KJ, Babb TG, Davenport PW, Feldman JM, Marshall GD, Ramirez JM, Ritz T, Troosters T, Van den Bergh O, von Leupoldt A; Participants of the 2020 Annual Meeting of the International Society for the Advancement of Respiratory Psychophysiology (ISARP). Respiratory psychophysiology and COVID-19: A research agenda. Biol Psychol 2023;176:108473. [PMID: 36535514 DOI: 10.1016/j.biopsycho.2022.108473] [Reference Citation Analysis]
|
| 24 |
Akay C, Orhan Ö, Şen V. Evaluation of Clinical, Biochemical, and Demographic Characteristics of Paediatric COVID-19 Patients Admitted to Dicle University Hospital. Cureus 2023;15:e34171. [PMID: 36843786 DOI: 10.7759/cureus.34171] [Reference Citation Analysis]
|
| 25 |
Reimer R, Zopfs D, Celik E, Reimer P. [Status and recommendations for interventional radiological procedures in COVID-19 patients]. Radiologie (Heidelb) 2023;63:38-42. [PMID: 36380208 DOI: 10.1007/s00117-022-01082-8] [Reference Citation Analysis]
|
| 26 |
Saifman J, Colverson A, Prem A, Chomiak J, Doré S. Therapeutic Potential of Music-Based Interventions on the Stress Response and Neuroinflammatory Biomarkers in COVID-19: A Review. Music & Science 2023;6:205920432211358. [DOI: 10.1177/20592043221135808] [Reference Citation Analysis]
|
| 27 |
Gabarre P, Urbina T, Cunat S, Merdji H, Bonny V, Lavillegrand JR, Raia L, Bige N, Baudel JL, Maury E, Guidet B, Helms J, Ait-Oufella H. Impact of corticosteroids on the procoagulant profile of critically ill COVID-19 patients: a before-after study. Minerva Anestesiol 2023;89:48-55. [PMID: 36282222 DOI: 10.23736/S0375-9393.22.16640-X] [Reference Citation Analysis]
|
| 28 |
Altay N, Karahan MA, Atlas A. The Effectiveness of Platelet and D-Dimer Levels in Predicting Prognosis in Intensive Care Patients Diagnosed With COVID-19. Harran Üniversitesi Tıp Fakültesi Dergisi 2022. [DOI: 10.35440/hutfd.1185729] [Reference Citation Analysis]
|
| 29 |
Aston D, Besser M, Goddard B, Maggs N, Ahmed H, Falter F. Whole-blood Point-of-Care Activated Partial Thromboplastin Time Ratio (APR) is not Accurate Enough to Monitor Heparin Therapy in Patients with Severe Respiratory Failure Secondary to SARS-Cov-2 Infection Supported with Veno-Venous Extracorporeal Membrane Oxygenation (VV-ECMO). Clin Appl Thromb Hemost 2022;28:10760296221148162. [PMID: 36572963 DOI: 10.1177/10760296221148162] [Reference Citation Analysis]
|
| 30 |
Vuimo TS, Tsarenko SV, Filimonova EV, Seregina EA, Karamzin SS. Correction of Anticoagulant Therapy in Patients with Severe COVID-19 Virus Infection Using a Thrombodynamics Coagulation Assay. Clin Appl Thromb Hemost 2022;28:10760296221142862. [PMID: 36560917 DOI: 10.1177/10760296221142862] [Reference Citation Analysis]
|
| 31 |
Chen-Goodspeed A, Dronavalli G, Zhang X, Podbielski J, Patel B, Modis K, Cotton B, Wade C, Cardenas JC. Antithrombin Activity is Associated with Persistent Thromboinflammation and Mortality in Patients with Severe COVID-19 Illness. Acta Haematol 2022;:1-8. [PMID: 36538905 DOI: 10.1159/000528584] [Reference Citation Analysis]
|
| 32 |
Rayyan WA, Hazzaa WA, Seder N, Al-fawares O, Fararjeh AFS. The Implications of COVID-19 Infection on Hematologic Parameters and Coagulation Activity: A Review. Biomed Pharmacol J 2022;15:1837-1851. [DOI: 10.13005/bpj/2522] [Reference Citation Analysis]
|
| 33 |
Carey M, Alser O, Leist J, Sorrells K, Bankhead BK, Li W. Delayed onset phlegmasia cerulea dolens post-SARS-CoV-2 infection treated with minimally invasive clot retrieval technology. J Vasc Surg Cases Innov Tech 2023;9:101082. [PMID: 36568022 DOI: 10.1016/j.jvscit.2022.11.019] [Reference Citation Analysis]
|
| 34 |
Giner-soriano M, Gomez-lumbreras A, Vedia C, Ouchi D, Morros R. Risk of thrombotic events and other complications in anticoagulant users infected with SARS-CoV-2: an observational cohort study in primary health care in SIDIAP (Catalonia, Spain). BMC Prim Care 2022;23:147. [DOI: 10.1186/s12875-022-01752-5] [Reference Citation Analysis]
|
| 35 |
Rajsic S, Breitkopf R, Oezpeker UC, Treml B. ECMO in Cardiogenic Shock: Time Course of Blood Biomarkers and Associated Mortality. Diagnostics (Basel) 2022;12. [PMID: 36552970 DOI: 10.3390/diagnostics12122963] [Reference Citation Analysis]
|
| 36 |
Calvet L, Thouy F, Mascle O, Sapin AF, Grapin K, Liteaudon JM, Evrard B, Bonnet B, Adda M, Souweine B, Dupuis C. Hypercoagulability in critically ill patients with COVID 19, an observational prospective study. PLoS One 2022;17:e0277544. [PMID: 36417476 DOI: 10.1371/journal.pone.0277544] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 37 |
Pechkurov DV, Romanova AA, Tyazheva AA, Poreckova GY. COVID in children and the digestive system: clinical and pathogenetic correlation. jour 2022. [DOI: 10.31146/1682-8658-ecg-202-6-41-49] [Reference Citation Analysis]
|
| 38 |
Muradov AM, Ibragimova AA, Nazirova NZ, Valieva US, Shumilina MV. Features of the hemostasis system in COVID-19. jour 2022. [DOI: 10.52888/0514-2515-2022-354-3-102-108] [Reference Citation Analysis]
|
| 39 |
Mureșan AV, Hălmaciu I, Arbănași EM, Kaller R, Arbănași EM, Budișcă OA, Melinte RM, Vunvulea V, Filep RC, Mărginean L, Suciu BA, Brinzaniuc K, Niculescu R, Russu E. Prognostic Nutritional Index, Controlling Nutritional Status (CONUT) Score, and Inflammatory Biomarkers as Predictors of Deep Vein Thrombosis, Acute Pulmonary Embolism, and Mortality in COVID-19 Patients. Diagnostics (Basel) 2022;12. [PMID: 36428817 DOI: 10.3390/diagnostics12112757] [Cited by in Crossref: 13] [Cited by in F6Publishing: 1] [Article Influence: 13.0] [Reference Citation Analysis]
|
| 40 |
Zebardast A, Latifi T, Shabani M, Hasanzadeh A, Danesh M, Babazadeh S, Sadeghi F. Thrombotic storm in coronavirus disease 2019: from underlying mechanisms to its management. Journal of Medical Microbiology 2022;71. [DOI: 10.1099/jmm.0.001591] [Reference Citation Analysis]
|
| 41 |
Chen S, Malas J, Latson LA Jr, Narula N, Rapkiewicz AV, Williams DM, Pass HI, Galloway AC, Smith DE. COVID-19-Associated Large- and Medium-Sized-Vessel Pathology: A Case Series. Aorta (Stamford) 2022;10:104-13. [PMID: 36318931 DOI: 10.1055/s-0042-1748960] [Reference Citation Analysis]
|
| 42 |
Kanapeckaitė A, Mažeikienė A, Geris L, Burokienė N, Cottrell GS, Widera D. Computational pharmacology: New avenues for COVID-19 therapeutics search and better preparedness for future pandemic crises. Biophys Chem 2022;290:106891. [PMID: 36137310 DOI: 10.1016/j.bpc.2022.106891] [Reference Citation Analysis]
|
| 43 |
Yaghoobpoor S, Fathi M, Vakili K, Tutunchian Z, Dehghani M, Bahrami A, Hajibeygi R, Eslami S, Yaghoobpour T, Hajiesmaeili M. Cardiovascular Complications of COVID-19 among Pregnant Women and Their Fetuses: A Systematic Review. JCM 2022;11:6194. [DOI: 10.3390/jcm11206194] [Reference Citation Analysis]
|
| 44 |
Gollamudi J, Sartain SE, Navaei AH, Aneja S, Kaur Dhawan P, Tran D, Joshi J, Gidudu J, Gollamudi J, Chiappini E, Varricchio F, Law B, Munoz FM. Thrombosis and thromboembolism: Brighton collaboration case definition and guidelines for data collection, analysis, and presentation of immunization safety data. Vaccine 2022;40:6431-44. [PMID: 36150973 DOI: 10.1016/j.vaccine.2022.09.001] [Reference Citation Analysis]
|
| 45 |
Benramdane H, Nasri S, Ouahabi N, Belharti A, Chehita K, Yassine M, Housni B, Skiker I. Multiple ischemic stroke with pulmonary embolism revealing severe COVID-19 infection in a young healthy patient. Radiol Case Rep 2022;17:4879-84. [PMID: 36247700 DOI: 10.1016/j.radcr.2022.08.017] [Reference Citation Analysis]
|
| 46 |
Prokhorova MV, Yakovlev AI, Voznyuk IA, Morozova EM, Gogoleva EA, Pivovarova LP. Inflammation and endothelial toxicity: pathogenetic aspects of central nervous system damage due to novel coronavirus disease. Annals of Clinical and Experimental Neurology 2022;16:15-24. [DOI: 10.54101/acen.2022.3.2] [Reference Citation Analysis]
|
| 47 |
Ali GK, Omer KM. Nanozyme and Stimulated Fluorescent Cu-Based Metal–Organic Frameworks (Cu-MOFs) Functionalized with Engineered Aptamers as a Molecular Recognition Element for Thrombin Detection in the Plasma of COVID-19 Patients. ACS Omega. [DOI: 10.1021/acsomega.2c05232] [Reference Citation Analysis]
|
| 48 |
Brizawasi A, Ahirwar AK, Prabhat, Kaim K, Ahirwar P, Kumawat R, Prasad J. COVID-19: a viewpoint from hepatic perspective. Horm Mol Biol Clin Investig 2022. [PMID: 36190156 DOI: 10.1515/hmbci-2022-0026] [Reference Citation Analysis]
|
| 49 |
Aktürk İF, Yıldız C, Karabulut D, Oflar E, Şahin A, Ertuğrul AS, Koyuncu A, Polat V, Karahan A, Koşar F, Alp İB, Keskin K, Çağlar FNT. Is the revascularisation strategy and outcome different in patients with acute coronary syndrome in COVID-19 pandemic era: a tertiary centre experience. Acta Cardiol 2022;77:720-8. [PMID: 34427169 DOI: 10.1080/00015385.2021.1967614] [Reference Citation Analysis]
|
| 50 |
da Silveira WC, Ramos LEF, Silva RT, de Paiva BBM, Pereira PD, Schwarzbold AV, Garbini AF, Barreira BSM, de Castro BM, Ramos CM, Gomes CD, Cimini CCR, Pereira EC, Roesch EW, Kroger EMS, Aranha FFMG, Anschau F, Botoni FA, Aranha FG, Crestani GP, Vietta GG, Bastos GAN, Costa JHSM, da Fonseca JRCS, Ruschel KB, de Oliveira LS, Pinheiro LS, Pacheco LS, Segala LB, Couto LSF, Kopittke L, Floriani MA, Silva MM, Carneiro M, Ferreira MAP, Martins MAP, de Faria MNZ, Nogueira MCA, Guimarães Júnior MH, Sampaio NDCS, de Oliveira NR, Pertile NM, Andrade PGS, Assaf PL, Valacio RA, Menezes RM, Francisco SC, Guimarães SMM, Araújo SF, Rezende SM, Pereira SA, Kurtz T, Fereguetti TO, Polanczyk CA, Pires MC, Gonçalves MA, Marcolino MS. Predictors of venous thromboembolism in COVID-19 patients: results of the COVID-19 Brazilian Registry. Intern Emerg Med 2022;17:1863-78. [PMID: 35648280 DOI: 10.1007/s11739-022-03002-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 51 |
Arbănași EM, Halmaciu I, Kaller R, Mureșan AV, Arbănași EM, Suciu BA, Coșarcă CM, Cojocaru II, Melinte RM, Russu E. Systemic Inflammatory Biomarkers and Chest CT Findings as Predictors of Acute Limb Ischemia Risk, Intensive Care Unit Admission, and Mortality in COVID-19 Patients. Diagnostics (Basel) 2022;12. [PMID: 36292068 DOI: 10.3390/diagnostics12102379] [Cited by in Crossref: 12] [Cited by in F6Publishing: 1] [Article Influence: 12.0] [Reference Citation Analysis]
|
| 52 |
Bepouka B, Odio O, Mayasi N, Longokolo M, Mangala D, Mandina M, Mbula M, Kayembe JM, Situakibanza H. Prevalence and Outcomes of COVID -19 Patients with Happy Hypoxia: A Systematic Review. Infect Drug Resist 2022;15:5619-28. [PMID: 36172621 DOI: 10.2147/IDR.S378060] [Reference Citation Analysis]
|
| 53 |
Gaur K, Natarajan S, Gupta M. Covid-19: Consumption coagulopathy with increased severity and mortality - A retrospective study. JDPO 2022;7:165-168. [DOI: 10.18231/j.jdpo.2022.039] [Reference Citation Analysis]
|
| 54 |
Metin S, Eraybar S, Aygün H, Demir C. The importance of biomarkers in determining the prognosis of patients requiring intensive care hospitalization due to COVID-19 infection. Med Sci Discov 2022;9:537-547. [DOI: 10.36472/msd.v9i9.817] [Reference Citation Analysis]
|
| 55 |
Mera Martínez PF, Tobar Marcillo MA, Guerrero Montero AG, Benavides Recalde J, Burbano Andrade GA, Portillo JD. Isquemia arterial bilateral espontánea de extremidades inferiores por COVID-19 leve. Repert Med Cir 2022;31:81-86. [DOI: 10.31260/repertmedcir.01217372.1402] [Reference Citation Analysis]
|
| 56 |
Wifi MN, Morad MA, El Sheemy R, Abdeen N, Afify S, Abdalgaber M, Abdellatef A, Zaghloul M, Alboraie M, El-Kassas M. Hemostatic system and COVID-19 crosstalk: A review of the available evidence. World J Methodol 2022; 12(5): 331-349 [DOI: 10.5662/wjm.v12.i5.331] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 57 |
Фролов ВГ, Петросян М, Нагапетян Н. К вопросу о характере изменений гематологических параметров у беременных и небеременных женщин, пораженных COVID-19. Medical Science of Armenia 2022. [DOI: 10.54503/0514-7484-2022-62.3-3] [Reference Citation Analysis]
|
| 58 |
Leung HHL, Perdomo J, Ahmadi Z, Zheng SS, Rashid FN, Enjeti A, Ting SB, Chong JJH, Chong BH. NETosis and thrombosis in vaccine-induced immune thrombotic thrombocytopenia. Nat Commun 2022;13:5206. [PMID: 36064843 DOI: 10.1038/s41467-022-32946-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 59 |
García-boyano F, Castro Ávila CM, Arguello-tomás M, Moreno Cuervo Á, Ligero Ramos JM, Pascual-izquierdo C. Acute limb ischemia secondary to vaccine-induced inmune thrombotic thrombocytopenia (VITT) after ChAdOx1 nCoV-19. Annals of Vascular Surgery - Brief Reports and Innovations 2022;2:100102. [DOI: 10.1016/j.avsurg.2022.100102] [Reference Citation Analysis]
|
| 60 |
Rajsic S, Breitkopf R, Jadzic D, Popovic Krneta M, Tauber H, Treml B. Anticoagulation Strategies during Extracorporeal Membrane Oxygenation: A Narrative Review. JCM 2022;11:5147. [DOI: 10.3390/jcm11175147] [Reference Citation Analysis]
|
| 61 |
Kasinadhuni G, Chikkam V, Singh P, Vijayvergiya R. COVID-19 and Cardiovascular Manifestations. COVID-19: Effects in Comorbidities and Special Populations 2022. [DOI: 10.2174/9789815036367122010007] [Reference Citation Analysis]
|
| 62 |
Choi S, Mazzeffi MA, Henderson R, Mondal S, Morita Y, Deshpande S, Tanaka KA. The FIBTEM paradox: Do coronary artery bypass grafting patients with high baseline FIBTEM clot firmness need more allogeneic blood transfusion? Transfusion. [DOI: 10.1111/trf.17065] [Reference Citation Analysis]
|
| 63 |
Xu X, Feng Y, Jia Y, Zhang X, Li L, Bai X, Jiao L. Prognostic value of von Willebrand factor and ADAMTS13 in patients with COVID-19: A systematic review and meta-analysis. Thromb Res 2022;218:83-98. [PMID: 36027630 DOI: 10.1016/j.thromres.2022.08.017] [Reference Citation Analysis]
|
| 64 |
Altunok İ, Özkan A. Complications of SARS-CoV-2 Infection in geriatrics. Eurasian Journal of Critical Care 2022. [DOI: 10.55994/ejcc.1158838] [Reference Citation Analysis]
|
| 65 |
Dutt N, Shishir S, Chauhan NK, Jalandra R, kuwal A, Garg P, Kumar D, Vishwajeet V, Chakraborti A, Deokar K, Asfahan S, Babu A, bajad P, Gupta N, Khurana A, Garg MK. Mortality and Its Predictors in COVID-19 Patients With Pre-existing Interstitial Lung Disease. Cureus 2022. [DOI: 10.7759/cureus.27759] [Reference Citation Analysis]
|
| 66 |
Seo J, Kim D, Yun N, Kim D. Coronavirus Disease 2019-Associated Coagulopathy. Microorganisms 2022;10:1556. [DOI: 10.3390/microorganisms10081556] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 67 |
Kerolos MM, Ruge M, Gill A, Planek MI, Volgman AS, Du-fay-de-lavallaz JM, Gomez JMD, Suboc TM, Williams KA, Abusin S. Clinical outcomes of COVID-19 infection in patients with pre-existing cardiovascular disease. American Heart Journal Plus: Cardiology Research and Practice 2022;20:100189. [DOI: 10.1016/j.ahjo.2022.100189] [Reference Citation Analysis]
|
| 68 |
Vahdat S. A review of pathophysiological mechanism, diagnosis, and treatment of thrombosis risk associated with COVID-19 infection. Int J Cardiol Heart Vasc 2022;41:101068. [PMID: 35677840 DOI: 10.1016/j.ijcha.2022.101068] [Cited by in Crossref: 5] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 69 |
Sakcak B, Alkan M, Denizli R, Farisoğullari N, Kara Ö, Ayhan ŞG, Tanacan A, Şahin D. Point shear wave velocity(pSWV) evaluation of the placenta of pregnant women who had recovered from COVID-19: A prospective cohort study from a tertiary pandemic center. Placenta 2022. [DOI: 10.1016/j.placenta.2022.08.003] [Reference Citation Analysis]
|
| 70 |
Dujardin RWG, Garcia Rosenbaum G, Klercq TCJ, Thachil J, Nielsen ND, Juffermans NP. Rotational thromboelastometry in critically ill COVID-19 patients does not predict thrombosis. Res Pract Thromb Haemost 2022;6:e12798. [PMID: 36090158 DOI: 10.1002/rth2.12798] [Reference Citation Analysis]
|
| 71 |
Hasan A, Arefanian H, Channanath AM, AlKhairi I, Cherian P, Devarajan S, Thanaraj TA, Abu-Farha M, Abubaker J, Al-Mulla F. Association of COVID-19 Vaccines ChAdOx1-S and BNT162b2 with Circulating Levels of Coagulation Factors and Antithrombin. Vaccines (Basel) 2022;10:1226. [PMID: 36016114 DOI: 10.3390/vaccines10081226] [Reference Citation Analysis]
|
| 72 |
Bonaventura A, Potere N. Blood Hyperviscosity: A Novel Link Between Hyperinflammation and Hypercoagulability in COVID-19. J Am Coll Cardiol 2022;80:329-31. [PMID: 35863849 DOI: 10.1016/j.jacc.2022.04.061] [Reference Citation Analysis]
|
| 73 |
Jafari A, Esmaeilzadeh Z, Khezri MR, Ghasemnejad-Berenji H, Pashapour S, Sadeghpour S, Ghasemnejad-Berenji M. An overview of possible pivotal mechanisms of Genistein as a potential phytochemical against SARS-CoV-2 infection: A hypothesis. J Food Biochem 2022;:e14345. [PMID: 35866873 DOI: 10.1111/jfbc.14345] [Reference Citation Analysis]
|
| 74 |
Antonopoulou S, Petsini F, Detopoulou M, Theoharides TC, Demopoulos CA. Is there an interplay between the SARS-CoV-2 spike protein and Platelet-Activating factor? Biofactors 2022;48:1271-83. [PMID: 35852257 DOI: 10.1002/biof.1877] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 75 |
Rani M, Uniyal A, Akhilesh, Tiwari V. Decrypting the cellular and molecular intricacies associated with COVID-19-induced chronic pain. Metab Brain Dis 2022. [PMID: 35849300 DOI: 10.1007/s11011-022-01048-8] [Reference Citation Analysis]
|
| 76 |
Forcina L, Franceschi C, Musarò A. The hormetic and hermetic role of IL-6. Ageing Res Rev 2022;80:101697. [PMID: 35850167 DOI: 10.1016/j.arr.2022.101697] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 77 |
Ferdiana KA, Ramlan AAW, Soenarto RF, Alatas A. Thromboelastographic method for early decision on anticoagulant therapy in moderate to severe COVID-19 patients. Med J Indones 2022;31:96-101. [DOI: 10.13181/mji.oa.225890] [Reference Citation Analysis]
|
| 78 |
Ferreira de Sousa G, Antonio de Souza Silva G, Rafaela da Silva Barros B, Cesar Abreu de Aquino R, Fonseca de Lima MRC, de Oliveira Cruz LC, Galdino de Oliveira E, Assunção de Sá IW, Augusto da Cunha Rodrigues F, Oliveira FH, Carlos de Freitas A, de Barros Campelo Júnior E, Lagos de Melo CM. COVID-19: Clinical, Immunological, and Image Findings from Infection to Post-COVID Syndrome. Intelligent Diagnosis of Lung Cancer and Respiratory Diseases 2022. [DOI: 10.2174/9789815050509122010007] [Reference Citation Analysis]
|
| 79 |
Snegovskikh D, Kendall MC, Levinson A, Sarpatwari R, Pisano D, Görlinger K, De Oliveira G. Thromboelastometry Predicts Thromboembolic Events, Hospital Length of Stay, and Mortality in Patients with COVID-19 Infection and Mild Hypoxemia: A Prospective Observational Study. J Blood Med 2022;13:363-72. [PMID: 35789896 DOI: 10.2147/JBM.S363999] [Reference Citation Analysis]
|
| 80 |
Johnson JN, Loriaux DB, Jenista E, Kim HW, Baritussio A, De Garate Iparraguirre E, Bucciarelli-Ducci C, Denny V, O'Connor B, Siddiqui S, Fujikura K, Benton CW, Weinsaft JW, Kochav J, Kim J, Madamanchi C, Steigner M, Kwong R, Chango-Azanza D, Chapa M, Rosales-Uvera S, Sitwala P, Filev P, Sahu A, Craft J, Punnakudiyil GJ, Jayam V, Shams F, Hughes SG, Lee JCY, Hulten EA, Steel KE, Chen SSM. Society for Cardiovascular Magnetic Resonance 2021 cases of SCMR and COVID-19 case collection series. J Cardiovasc Magn Reson 2022;24:42. [PMID: 35787291 DOI: 10.1186/s12968-022-00872-2] [Reference Citation Analysis]
|
| 81 |
Cook MR, Dykes K, White K, Desale S, Agrawal R, Fernandez S, Huang X, Cobb NK, Lai C. Thrombotic and Clinical Outcomes in Patients with Hematologic Malignancy and COVID-19. Clinical Lymphoma Myeloma and Leukemia 2022;22:e452-e458. [DOI: 10.1016/j.clml.2021.12.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 82 |
King A, Doyle KM. Implications of COVID-19 to Stroke Medicine: An Epidemiological and Pathophysiological Perspective. Curr Vasc Pharmacol 2022;20:333-40. [PMID: 36324222 DOI: 10.2174/1570161120666220428101337] [Reference Citation Analysis]
|
| 83 |
Shah S, Yadav R, Yadav S, Khanal R, Poudel CM. A rare case of atrial and biventricular thrombi with dilated cardiomyopathy as a delayed presentation in a patient with COVID-19. Annals of Medicine and Surgery 2022;79:104057. [DOI: 10.1016/j.amsu.2022.104057] [Reference Citation Analysis]
|
| 84 |
Lim S, Murphy S, Murphy S, Coughlan T, O'neill D, Tierney S, Egan B, Collins D, Mccarthy A, Lim S, Smith D, Cox D, Mccabe D. Assessment of on-treatment platelet reactivity at high and low shear stress and platelet activation status after the addition of dipyridamole to aspirin in the early and late phases after TIA and ischaemic stroke. Journal of the Neurological Sciences 2022. [DOI: 10.1016/j.jns.2022.120334] [Reference Citation Analysis]
|
| 85 |
Leiva O, Campia U, Snyder J, Barns BM, Rizzo S, Khairani CD, Brunner A, Al-Samkari H, Leaf RK, Rosovsky R, Goodarzi K, Bornikova L, Fathi A, Goldhaber SZ, Hobbs G, Piazza G. Patients with myeloproliferative neoplasms and COVID-19 have increased rates of arterial thrombosis. Res Pract Thromb Haemost 2022;6:e12752. [PMID: 35979196 DOI: 10.1002/rth2.12752] [Reference Citation Analysis]
|
| 86 |
Stefanile A, Cellerino M, Koudriavtseva T. Elevated risk of thrombotic manifestations of SARS-CoV-2 infection in cancer patients: A literature review. EXCLI J 2022;21:906-20. [PMID: 36172074 DOI: 10.17179/excli2022-5073] [Reference Citation Analysis]
|
| 87 |
Biasucci DG, Bocci MG, Buonsenso D, Pisapia L, Consalvo LM, Vargas J, Grieco DL, De Pascale G, Antonelli M. Thromboelastography Profile Is Associated with Lung Aeration Assessed by Point-of-Care Ultrasound in COVID-19 Critically Ill Patients: An Observational Retrospective Study. Healthcare (Basel) 2022;10. [PMID: 35885695 DOI: 10.3390/healthcare10071168] [Reference Citation Analysis]
|
| 88 |
Soma P, Bester J. Pathophysiological Changes in Erythrocytes Contributing to Complications of Inflammation and Coagulation in COVID-19. Front Physiol 2022;13:899629. [DOI: 10.3389/fphys.2022.899629] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 89 |
Block H, Rossaint J, Zarbock A. The Fatal Circle of NETs and NET-Associated DAMPs Contributing to Organ Dysfunction. Cells 2022;11:1919. [PMID: 35741047 DOI: 10.3390/cells11121919] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 90 |
Duhailib ZA, Oczkowski S, Polok K, Fronczek J, Szczeklik W, Piticaru J, Mammen MJ, Alshamsi F, Eikelboom J, Belley-Cote E, Alhazzani W. Venous and arterial thrombosis in COVID-19: An updated narrative review. J Infect Public Health 2022;15:689-702. [PMID: 35643053 DOI: 10.1016/j.jiph.2022.05.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 91 |
Arslan FD, Başok BI, Terzioğlu M, Altan TK, Karaca Y, Senger SS, Çolak A. Evaluation of D-dimer levels measured by different analytical methods in COVID-19 patients. Blood Coagul Fibrinolysis 2022;33:209-15. [PMID: 35239616 DOI: 10.1097/MBC.0000000000001129] [Reference Citation Analysis]
|
| 92 |
Bang SA, Kim H, Jeong YM, Lee J, Lee J, Lee E. Prophylactic Anticoagulant Use and Adverse Events with Bleeding in Critically Ill COVID-19 Patients. J Korean Soc Health-Syst Pharm 2022;39:146-157. [DOI: 10.32429/jkshp.2022.39.2.001] [Reference Citation Analysis]
|
| 93 |
Fragkou PC, Palaiodimou L, Stefanou MI, Katsanos AH, Lambadiari V, Paraskevis D, Andreadou E, Dimopoulou D, Zompola C, Ferentinos P, Vassilakopoulos TI, Kotanidou A, Sfikakis PP, Tsiodras S, Tsivgoulis G. Effects of low molecular weight heparin and fondaparinux on mortality, hemorrhagic and thrombotic complications in COVID-19 patients. Ther Adv Neurol Disord 2022;15:175628642210994. [DOI: 10.1177/17562864221099472] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 94 |
Mang S, Danziger G, Metz C, Rixecker T, Becker A, Omlor AJ, Jentgen C, Schmoll C, Seiler F, Reyher C, Muellenbach RM, Bals R, Lepper PM. Injection of Recombinant Tissue Plasminogen Activator into Extracorporeal Membrane Oxygenators Postpones Oxygenator Exchange in COVID-19. ASAIO J 2022. [PMID: 35617687 DOI: 10.1097/MAT.0000000000001733] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 95 |
Baygozina EА. Combination of arterial and venous thrombosis in a patient with the novel coronavirus infection (a clinical case). Tuberk bolezni lëgk 2022;100:22-25. [DOI: 10.21292/2075-1230-2022-100-4-22-25] [Reference Citation Analysis]
|
| 96 |
Abowali H, Pacifico A, Erdinc B, Elkholy K, Burkhanova U, Aroriode T, Watson A, Ahmed MF, Uwagbale E, Visweshwar N, Jaglal M. Assessment of Bleeding Risk in Hospitalized COVID-19 Patients: A Tertiary Hospital Experience during the Pandemic in a Predominant Minority Population-Bleeding Risk Factors in COVID-19 Patients. J Clin Med 2022;11. [PMID: 35628881 DOI: 10.3390/jcm11102754] [Reference Citation Analysis]
|
| 97 |
Landsman A, Pellegrini JR, Tiwana MS, Berry S, Singh J. Double Trouble: A Case of Two Simultaneous Thrombotic Events in a Patient With COVID-19. Cureus 2022. [DOI: 10.7759/cureus.24912] [Reference Citation Analysis]
|
| 98 |
Goncu Ayhan S, Turgut E, Ozden Tokalioglu E, Oluklu D, Sakcak B, Uyan Hendem D, Tanacan A, Moraloglu Tekin O, Sahin D. Post-COVID-19 fetal cardiac evaluation in moderate infection group of pregnant women. J Clin Ultrasound 2022. [PMID: 35524502 DOI: 10.1002/jcu.23220] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 99 |
Levi M, van Es N. COVID-19 associated coagulopathy and thrombosis in cancer. Thromb Res 2022;213 Suppl 1:S72-6. [PMID: 36210564 DOI: 10.1016/j.thromres.2021.12.006] [Reference Citation Analysis]
|
| 100 |
Akella R, Raj R, Kannan L, Jacob A. Coexisting portal vein thrombosis and aortic thrombosis in a patient with COVID-19: A case report and literature review. IDCases 2022;28:e01509. [DOI: 10.1016/j.idcr.2022.e01509] [Reference Citation Analysis]
|
| 101 |
Mañón VA, Balandran S, Young S, Wong M, Melville JC. COVID-Associated Avascular Necrosis of the Maxilla - A Rare, New Side Effect of COVID-19. Journal of Oral and Maxillofacial Surgery 2022. [DOI: 10.1016/j.joms.2022.04.015] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 102 |
Ngu S, Smith JK, Goldin M. Use of Anticoagulants in COVID-19: A Review. Am J Ther 2022. [PMID: 35476050 DOI: 10.1097/MJT.0000000000001515] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 103 |
Saha SA, Russo AM, Chung MK, Deering TF, Lakkireddy D, Gopinathannair R. COVID-19 and Cardiac Arrhythmias: a Contemporary Review. Curr Treat Options Cardiovasc Med 2022;24:87-107. [PMID: 35462637 DOI: 10.1007/s11936-022-00964-3] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
|
| 104 |
Simonetto M, Wechsler PM, Merkler AE. Stroke Treatment in the Era of COVID-19: a Review. Curr Treat Options Neurol. [DOI: 10.1007/s11940-022-00713-8] [Reference Citation Analysis]
|
| 105 |
Rajsic S, Breitkopf R, Oezpeker UC, Bukumirić Z, Dobesberger M, Treml B. The Role of Excessive Anticoagulation and Missing Hyperinflammation in ECMO-Associated Bleeding. J Clin Med 2022;11:2314. [PMID: 35566439 DOI: 10.3390/jcm11092314] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 106 |
Drapkina OM, Kontsevaya AV, Kalinina AM, Avdeev SM, Agaltsov MV, Alexandrova LM, Antsiferova AA, Aronov DM, Akhmedzhanov NM, Balanova YA, Balakhonova TV, Berns SA, Bochkarev MV, Bochkareva EV, Bubnova MV, Budnevsky AV, Gambaryan MG, Gorbunov VM, Gorny BE, Gorshkov AY, Gumanova NG, Dadaeva VA, Drozdova LY, Egorov VA, Eliashevich SO, Ershova AI, Ivanova ES, Imaeva AE, Ipatov PV, Kaprin AD, Karamnova NS, Kobalava ZD, Konradi AO, Kopylova OV, Korostovtseva LS, Kotova MB, Kulikova MS, Lavrenova EA, Lischenko OV, Lopatina MV, Lukina YV, Lukyanov MM, Mayev IV, Mamedov MN, Markelova SV, Martsevich SY, Metelskaya VA, Meshkov AN, Milushkina OY, Mukaneeva DK, Myrzamatova AO, Nebieridze DV, Orlov DO, Poddubskaya EA, Popovich MV, Popovkina OE, Potievskaya VI, Prozorova GG, Rakovskaya YS, Rotar OP, Rybakov IA, Sviryaev YV, Skripnikova IA, Skoblina NA, Smirnova MI, Starinsky VV, Tolpygina SN, Usova EV, Khailova ZV, Shalnova SA, Shepel RN, Shishkova VN, Yavelov IS. 2022 Prevention of chronic non-communicable diseases in Of the Russian Federation. National guidelines. Cardiovasc Ther Prev 2022;21:3235. [DOI: 10.15829/1728-8800-2022-3235] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 107 |
Fayyad D, Kelts JL, Nielson TH, Epelle IL, Monear NC, Strawn MTG, Woerner BN, Xhabija B. COVID-19: A Systematic Review of the Transmissibility, Pathogenesis, Entry Factors, and Signature Immune Response. BioChem 2022;2:115-144. [DOI: 10.3390/biochem2020009] [Reference Citation Analysis]
|
| 108 |
Abd El-lateef AE, Alghamdi S, Ebid G, Khalil K, Kabrah S, Abdel Ghafar MT. Coagulation Profile in COVID-19 Patients and its Relation to Disease Severity and Overall Survival: A Single-Center Study. Br J Biomed Sci 2022;79:10098. [DOI: 10.3389/bjbs.2022.10098] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 109 |
Belarbi Z, Brem FL, El Ouafi N. Upper-extremity deep venous thrombosis and bilateral pulmonary embolism in a patient with COVID-19 under prophylactic anticoagulation: A case report. Ann Med Surg (Lond) 2022;:103485. [PMID: 35401976 DOI: 10.1016/j.amsu.2022.103485] [Reference Citation Analysis]
|
| 110 |
Sastry S, Cuomo F, Muthusamy J. COVID-19 and thrombosis: The role of hemodynamics. Thromb Res 2022;212:51-7. [PMID: 35219932 DOI: 10.1016/j.thromres.2022.02.016] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 111 |
Poletto F, Spiezia L, Simion C, Campello E, Dalla Valle F, Tormene D, Camporese G, Simioni P. Risk Factors of Venous Thromboembolism in Noncritically Ill Patients Hospitalized for Acute COVID-19 Pneumonia Receiving Prophylactic-Dose Anticoagulation. Viruses 2022;14. [PMID: 35458467 DOI: 10.3390/v14040737] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 112 |
Dwivedi S, Choudhary P, Gupta A, Singh S. The cross-talk between mucormycosis, steroids and diabetes mellitus amidst the global contagion of COVID-19. Crit Rev Microbiol 2022;:1-16. [PMID: 35324372 DOI: 10.1080/1040841X.2022.2052795] [Reference Citation Analysis]
|
| 113 |
de Mello Mendes Filho SP, Martins FS, Giroldi PJ, Melo RHE, de Oliveira EL, dos Santos AB, Medeiros DCO, de Almeida Basano S, Lopes JA, Chaves YO, Pinheiro RS, Camargo LMA, Zuliani JP, Nogueira PA. Home Care Follow up determine the point of inversion of IL-6 levels in relation to C-Reactive Protein as the cytokine storm marker in COVID-19.. [DOI: 10.1101/2022.03.21.22270828] [Reference Citation Analysis]
|
| 114 |
Bashardoust P, Fano BJ. Incidence of COVID-19-Associated Venous Thromboembolism Among Hospitalized Patients in McAllen, Texas, USA, in Late 2021. Cureus 2022. [DOI: 10.7759/cureus.23270] [Reference Citation Analysis]
|
| 115 |
Rauch-Kröhnert U, Riess H. [Anticoagulation in coronavirus disease 2019 (COVID-19): confirmed and controversial aspects]. Internist (Berl) 2022. [PMID: 35290499 DOI: 10.1007/s00108-022-01296-x] [Reference Citation Analysis]
|
| 116 |
Len P, Iskakova G, Sautbayeva Z, Kussanova A, Tauekelova AT, Sugralimova MM, Dautbaeva AS, Abdieva MM, Ponomarev ED, Tikhonov A, Bekbossynova MS, Barteneva NS. Meta-Analysis and Systematic Review of Coagulation Disbalances in COVID-19: 41 Studies and 17,601 Patients. Front Cardiovasc Med 2022;9:794092. [DOI: 10.3389/fcvm.2022.794092] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 117 |
Sharma S, Mishra A, Ashraf Z. COVID-19 Induced Coagulopathy (CIC): Thrombotic Manifestations of Viral Infection. TH Open 2022;6:e70-9. [PMID: 35280973 DOI: 10.1055/s-0042-1744185] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 118 |
Shousha HI, Ramadan A, Lithy R, El-Kassas M. Patterns of liver profile disturbance in patients with COVID-19 . World J Clin Cases 2022; 10(7): 2063-2071 [DOI: 10.12998/wjcc.v10.i7.2063] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 119 |
Billoir P, Leprêtre P, Thill C, Bellien J, Le Cam Duchez V, Selim J, Tamion F, Clavier T, Besnier E. Routine and Advanced Laboratory Tests for Hemostasis Disorders in COVID-19 Patients: A Prospective Cohort Study. JCM 2022;11:1383. [DOI: 10.3390/jcm11051383] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 120 |
Centurión OA. Cardiac injury and COVID-19 associated coagulopathy assessed by rotational thromboelastometry tests: Keep on searching for the right path. Adv Med Sci 2022;67:139-41. [PMID: 35227984 DOI: 10.1016/j.advms.2022.02.001] [Reference Citation Analysis]
|
| 121 |
Atıcı SD, Akpınar G. Splenic infarct in a COVID-19 patient under anticoagulant therapy with normal D-dimer levels. Int J Surg Case Rep 2022;92:106847. [PMID: 35194547 DOI: 10.1016/j.ijscr.2022.106847] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 122 |
Özhan A, Bastopcu M. Factors Associated with Positive Thrombus Findings at Ultrasonography in Covid-19 Ward Patients who Underwent Imaging for Suspected DVT Under Prophylactic Anticoagulation. J Vasc Surg Venous Lymphat Disord 2022:S2213-333X(22)00093-2. [PMID: 35218956 DOI: 10.1016/j.jvsv.2022.02.012] [Reference Citation Analysis]
|
| 123 |
Di Dedda U, Ascari A, Fantinato A, Fina D, Baryshnikova E, Ranucci M. Microcirculatory Alterations in Critically Ill Patients with COVID-19-Associated Acute Respiratory Distress Syndrome. J Clin Med 2022;11:1032. [PMID: 35207303 DOI: 10.3390/jcm11041032] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 124 |
Abrignani MG, Murrone A, De Luca L, Roncon L, Di Lenarda A, Valente S, Caldarola P, Riccio C, Oliva F, Gulizia MM, Gabrielli D, Colivicchi F, On Behalf Of The Working Group On Anti-Covid-Vaccination Of The Associazione Nazionale Medici Cardiologi Ospedalieri Anmco. COVID-19, Vaccines, and Thrombotic Events: A Narrative Review. J Clin Med 2022;11:948. [PMID: 35207220 DOI: 10.3390/jcm11040948] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
|
| 125 |
El-qutob D, Alvarez L, García-sidro P, Barreda I, Nieto M, Pin M, Poveda-andrés JL, Carrera-hueso F. High incidence of pulmonary thromboembolism in hospitalized SARS-CoV-2 infected patients despite thrombo-prophylaxis. Heart & Lung 2022. [DOI: 10.1016/j.hrtlng.2022.02.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 126 |
Turgut E, Ayhan SG, Tokalioglu EO, Oluklu D, Tanacan A, Tekin OM, Sahin D. Evaluation of Foetal Doppler After Maternal Covid-19 Disease: How Does Foetal Aortic Isthmus Doppler Change? Med Sci Discov 2022;9:39-43. [DOI: 10.36472/msd.v9i1.653] [Reference Citation Analysis]
|
| 127 |
Cryer MJ, Farhan S, Kaufmann CC, Jäger B, Garg A, Krishnan P, Mehran R, Huber K. Prothrombotic Milieu, Thrombotic Events and Prophylactic Anticoagulation in Hospitalized COVID-19 Positive Patients: A Review. Clin Appl Thromb Hemost 2022;28:107602962210743. [DOI: 10.1177/10760296221074353] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 128 |
Zhuravel SV, Vladimirov VV, Gavrilov PV, Ivanov IV, Petrikov SS, Popugayev KA, Talyzin AM. Antithrombin-III for New Coronavirus Infection (COVID-19) Under Conditions of Extracorporeal Membrane Oxygenation (Clinical Observation). Neotložnaâ med pomoŝʹ 2022;10:642-648. [DOI: 10.23934/2223-9022-2021-10-4-642-648] [Reference Citation Analysis]
|
| 129 |
Cani E, Dwivedi DJ, Liaw KL, Fraser DD, Yeh CH, Martin C, Slessarev M, Cerroni SE, Fox-Robichaud AA, Weitz JI, Kim PY, Liaw PC. Immunothrombosis Biomarkers for Distinguishing Coronavirus Disease 2019 Patients From Noncoronavirus Disease Septic Patients With Pneumonia and for Predicting ICU Mortality. Crit Care Explor 2021;3:e0588. [PMID: 34984340 DOI: 10.1097/CCE.0000000000000588] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 130 |
Lim W, Tin S, Breitling M, Grodman R, Diaz K. A Case of Intracardiac Thrombus in a Recovery Coronavirus Disease 2019 (COVID-19) Patient. Cureus 2022. [DOI: 10.7759/cureus.20972] [Reference Citation Analysis]
|
| 131 |
Asrani R, Bahou WF, Department of Medicine/Hematology, Stony Brook University, Stony Brook, NY, USA, Department of Medicine/Hematology, Stony Brook University, Stony Brook, NY, USA. COVID Coagulopathy and Thrombosis: A Systematic Review. Oncology & Haematology 2022;18:78. [DOI: 10.17925/ohr.2022.18.1.78] [Reference Citation Analysis]
|
| 132 |
Panigada M, Meli A, Grasselli G. Clinical Manifestation of COVID-19-Associated Coagulopathy. The Coagulation Labyrinth of Covid-19 2022. [DOI: 10.1007/978-3-030-82938-4_9] [Reference Citation Analysis]
|
| 133 |
El Menshawy N, Elsaid G, Zeid TA, Farag NA. Down Protein C and S Antigen Could Be Predictor of Mortality Outcome in Critical Egyptian COVID-19 Illness. JBM 2022;10:190-202. [DOI: 10.4236/jbm.2022.103018] [Reference Citation Analysis]
|
| 134 |
Jawish M, Şeyhibrahim A, Ahmed S, Bazie E, Alabdulqader A, Awad MA, Goraini YA. COVID-19 Related Multisystem Inflammatory Syndrome in Children: A Case Series from a Tertiary Hospital in Riyadh, Saudi Arabia. OJPed 2022;12:802-814. [DOI: 10.4236/ojped.2022.125081] [Reference Citation Analysis]
|
| 135 |
Sonkar G, Singh S, Sonkar S. A systematic review approach in understanding the COVID-19 mechanism in diabetes and its progression to diabetic microvascular complications. J Diabetol 2022;13:322. [DOI: 10.4103/jod.jod_87_22] [Reference Citation Analysis]
|
| 136 |
Bisso IC, Huespe I, Prado E, Garbarini M, López MS, Barrera L, Las Heras M, Sinner J, Martinuzzo M. Rotational Thromboelastometry Profile among Critically ill COVID-19 Patients. Clin Appl Thromb Hemost 2022;28:10760296221091213. [PMID: 35345901 DOI: 10.1177/10760296221091213] [Reference Citation Analysis]
|
| 137 |
Silişteanu S. Impact of the COVID-19 pandemic on the physical and mental health of the elderly. Biomedical Engineering Applications for People with Disabilities and the Elderly in the COVID-19 Pandemic and Beyond 2022. [DOI: 10.1016/b978-0-323-85174-9.00012-1] [Reference Citation Analysis]
|
| 138 |
Ascari A, Meani P, Cotza M. ECMO in COVID-19: Bleeding and Thrombosis. The Coagulation Labyrinth of Covid-19 2022. [DOI: 10.1007/978-3-030-82938-4_12] [Reference Citation Analysis]
|
| 139 |
Panigada M, Meli A, Dalton HJ. Coagulation Disorders and Management. COVID-19 Critical and Intensive Care Medicine Essentials 2022. [DOI: 10.1007/978-3-030-94992-1_20] [Reference Citation Analysis]
|
| 140 |
Ranucci M, Niro D. The Overall Scenario of COVID-19-Associated Coagulopathy. The Coagulation Labyrinth of Covid-19 2022. [DOI: 10.1007/978-3-030-82938-4_7] [Reference Citation Analysis]
|
| 141 |
Castro P, Palomo M, Moreno-Castaño AB, Fernández S, Torramadé-Moix S, Pascual G, Martinez-Sanchez J, Richardson E, Téllez A, Nicolas JM, Carreras E, Richardson PG, Badimon JJ, Escolar G, Diaz-Ricart M. Is the Endothelium the Missing Link in the Pathophysiology and Treatment of COVID-19 Complications? Cardiovasc Drugs Ther 2022;36:547-60. [PMID: 34097193 DOI: 10.1007/s10557-021-07207-w] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 18.0] [Reference Citation Analysis]
|
| 142 |
Ranucci M, Aloisio T. Standard Coagulation Tests in COVID-19. The Coagulation Labyrinth of Covid-19 2022. [DOI: 10.1007/978-3-030-82938-4_2] [Reference Citation Analysis]
|
| 143 |
Racca F, Zanza C, Longhitano Y. Coagulation Abnormalities in Patients with COVID-19. Practical Trends in Anesthesia and Intensive Care 2020-2021 2022. [DOI: 10.1007/978-3-031-14612-1_8] [Reference Citation Analysis]
|
| 144 |
López-Jaime FJ, Fernández-Bello I, Martín-Téllez S, Doblas-Márquez A, Tesfay Y, Márquez-Gómez I, Reguera-Iglesias JM, Muñoz-Pérez MI, Montaño A. Clot Stiffness Measured By Seer Sonorheometry As a Marker Of Poor Prognosis In Hospitalized COVID-19 Patients. Clin Appl Thromb Hemost 2022;28:10760296221112085. [PMID: 35903939 DOI: 10.1177/10760296221112085] [Reference Citation Analysis]
|
| 145 |
Bhat RA, Maqbool S, Rathi A, Ali SM, Hussenbocus YAAM, Wentao X, Qu Y, Zhang Y, Sun Y, Fu HX, Wang LY, Dwivedi A, Bhat JA, Iqbal RS, Islam MM, Tibrewal A, Gao C. The Effects of the SARS-CoV-2 Virus on the Cardiovascular System and Coagulation State Leading to Cardiovascular Diseases: A Narrative Review. Inquiry 2022;59:469580221093442. [PMID: 35613600 DOI: 10.1177/00469580221093442] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 146 |
Scala MR, Spennato P, Cicala D, Piccolo V, Varone A, Cinalli G. Malignant cerebral infarction associated with COVID-19 in a child. Childs Nerv Syst 2022;38:441-5. [PMID: 34175976 DOI: 10.1007/s00381-021-05273-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 147 |
Baryshnikova E. Point-of-Care Coagulation Tests in COVID-19. The Coagulation Labyrinth of Covid-19 2022. [DOI: 10.1007/978-3-030-82938-4_3] [Reference Citation Analysis]
|
| 148 |
Ranucci M, Aloisio T. COVID-19 Associated Coagulopathy: The Thrombin Burst. The Coagulation Labyrinth of Covid-19 2022. [DOI: 10.1007/978-3-030-82938-4_4] [Reference Citation Analysis]
|
| 149 |
Tersakyan S, Chappidi M, Patel A, Hainsworth K, Alshoubi A. The potential effect of iopamidol contrast on renal function in patients infected with SARS-CoV-2 virus: A retrospective cohort study. Int J Crit Illn Inj Sci 2022;12:155-9. [PMID: 36506924 DOI: 10.4103/ijciis.ijciis_92_21] [Reference Citation Analysis]
|
| 150 |
Fistera D, Pabst D, Falk M, Anastasiou OE, Goer S, Dolff S, Konik M, Herbstreit F, Taube C, Kill C, Risse J. [Wave riding - 12 months of COVID-19 in a German tertiary care center]. Dtsch Med Wochenschr 2021. [PMID: 34965591 DOI: 10.1055/a-1522-1502] [Reference Citation Analysis]
|
| 151 |
Takeshita Y, Terada J, Hirasawa Y, Kinoshita T, Tajima H, Koshikawa K, Kinouchi T, Isaka Y, Shionoya Y, Fujikawa A, Tada Y, Nakaseko C, Tsushima K. Elevated TAT in COVID-19 Patients with Normal D-Dimer as a Predictor of Severe Respiratory Failure: A Retrospective Analysis of 797 Patients. J Clin Med 2021;11:134. [PMID: 35011875 DOI: 10.3390/jcm11010134] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 152 |
Gauchel N, Krauel K, Hamad MA, Bode C, Duerschmied D. Thromboinflammation as a Driver of Venous Thromboembolism. Hamostaseologie 2021;41:428-32. [PMID: 34942655 DOI: 10.1055/a-1661-0257] [Reference Citation Analysis]
|
| 153 |
Stanevich OV, Fomina DS, Bakulin IG, Galeev SI, Bakin EA, Belash VA, Kulikov AN, Lebedeva AA, Lioznov DA, Polushin YS, Shlyk IV, Vorobyev EA, Vorobyeva SV, Surovceva TV, Bakulina NV, Lysenko MA, Moiseev IS. Ruxolitinib versus dexamethasone in hospitalized adults with COVID-19: multicenter matched cohort study. BMC Infect Dis 2021;21:1277. [PMID: 34937556 DOI: 10.1186/s12879-021-06982-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 154 |
Poveda-Jaramillo R. Coronavirus disease 2019-induced hypercoagulability and its clinical implications. Asian Cardiovasc Thorac Ann 2021;:2184923211069185. [PMID: 34930050 DOI: 10.1177/02184923211069185] [Reference Citation Analysis]
|
| 155 |
Connors JM, Iba T, Gandhi RT. Thrombosis and Coronavirus Disease 2019: Controversies and (Tentative) Conclusions. Clin Infect Dis 2021;73:2294-7. [PMID: 33539504 DOI: 10.1093/cid/ciab096] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 156 |
Laouan Brem F, Asmae B, Amane Y, Bouazzaoui MA, Chaymae M, Rasras H, Nasri S, Abda N, Skiker I, Kouismi H, Zakaria B, Ismaili N, El Ouafi N. Diagnostic Accuracy of D-Dimers for Predicting Pulmonary Embolism in COVID-19-Patients. Clin Appl Thromb Hemost 2021;27:10760296211057901. [PMID: 34905979 DOI: 10.1177/10760296211057901] [Reference Citation Analysis]
|
| 157 |
Haslbauer JD, Zinner C, Stalder AK, Schneeberger J, Menter T, Bassetti S, Mertz KD, Went P, Matter MS, Tzankov A. Vascular Damage, Thromboinflammation, Plasmablast Activation, T-Cell Dysregulation and Pathological Histiocytic Response in Pulmonary Draining Lymph Nodes of COVID-19. Front Immunol 2021;12:763098. [DOI: 10.3389/fimmu.2021.763098] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 158 |
Zhang Y, Wang M, Zhang X, Liu T, Libby P, Shi GP. COVID-19, the Pandemic of the Century and Its Impact on Cardiovascular Diseases. Cardiol Discov 2021;1:233-58. [PMID: 34888547 DOI: 10.1097/CD9.0000000000000038] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 159 |
Thilagar B, Beidoun M, Rhoades R, Kaatz S. COVID-19 and thrombosis: searching for evidence. Hematology Am Soc Hematol Educ Program 2021;2021:621-7. [PMID: 34889411 DOI: 10.1182/hematology.2021000298] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 160 |
Gerber GF, Chaturvedi S. How to recognize and manage COVID-19-associated coagulopathy. Hematology Am Soc Hematol Educ Program 2021;2021:614-20. [PMID: 34889412 DOI: 10.1182/hematology.2021000297] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 161 |
Infanger L, Dibiasi C, Schaden E, Ulbing S, Wiegele M, Lacom C, Gratz J. Comparison of the New Viscoelastic Coagulation Analyzer ClotPro® With ROTEM® Delta and Conventional Coagulation Tests in Critically Ill Patients With COVID-19. Front Med (Lausanne) 2021;8:777145. [PMID: 34869496 DOI: 10.3389/fmed.2021.777145] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 162 |
Zhang H, Shao B, Dang Q, Chen Z, Zhou Q, Luo H, Yuan W, Sun Z. Pathogenesis and Mechanism of Gastrointestinal Infection With COVID-19. Front Immunol 2021;12:674074. [PMID: 34858386 DOI: 10.3389/fimmu.2021.674074] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 163 |
Kalita B, Saviola AJ, Samuel SP, Mukherjee AK. State-of-the-art review - A review on snake venom-derived antithrombotics: Potential therapeutics for COVID-19-associated thrombosis? Int J Biol Macromol 2021;192:1040-57. [PMID: 34656540 DOI: 10.1016/j.ijbiomac.2021.10.015] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 164 |
Gold DD, Kurd R, Einav S. Don't forget arterial thrombosis in patients with COVID-19: A case series. Thrombosis Update 2021;5:100065. [DOI: 10.1016/j.tru.2021.100065] [Reference Citation Analysis]
|
| 165 |
Ge J, Ma Y, Wu Z, Jin J, Sun X. Anticoagulation treatment for patients with coronavirus disease 2019 (COVID-19) and its clinical effectiveness in 2020: A meta-analysis study. Medicine (Baltimore) 2021;100:e27861. [PMID: 34964754 DOI: 10.1097/MD.0000000000027861] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 166 |
Zarkesh K, Entezar-Almahdi E, Ghasemiyeh P, Akbarian M, Bahmani M, Roudaki S, Fazlinejad R, Mohammadi-Samani S, Firouzabadi N, Hosseini M, Farjadian F. Drug-based therapeutic strategies for COVID-19-infected patients and their challenges. Future Microbiol 2021;16:1415-51. [PMID: 34812049 DOI: 10.2217/fmb-2021-0116] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 167 |
Önal H, Arslan B, Üçüncü Ergun N, Topuz Ş, Yilmaz Semerci S, Kurnaz ME, Molu YM, Bozkurt MA, Süner N, Kocataş A. Treatment of COVID-19 patients with quercetin: a prospective, single center, randomized, controlled trial. Turk J Biol 2021;45:518-29. [PMID: 34803451 DOI: 10.3906/biy-2104-16] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 168 |
Narasimhan B, Lorente-Ros M, Aguilar-Gallardo JS, Lizardo CP, Narasimhan H, Morton C, Donahue KR, Aronow WS. Anticoagulation in COVID-19: a review of current literature and guidelines. Hosp Pract (1995) 2021;49:307-24. [PMID: 34807786 DOI: 10.1080/21548331.2021.2007648] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 169 |
Shareef RH, Zwain ZD, Mahbuba WA. Superiority of lymphocyte ratio over total leukocyte count in detecting the severity of COVID- 19 pneumonia. Heliyon 2021;7:e08412. [PMID: 34805573 DOI: 10.1016/j.heliyon.2021.e08412] [Reference Citation Analysis]
|
| 170 |
Lim MS, Mcrae S. COVID-19 and immunothrombosis: Pathophysiology and therapeutic implications. Crit Rev Oncol Hematol 2021;168:103529. [PMID: 34800652 DOI: 10.1016/j.critrevonc.2021.103529] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 171 |
Belikina DV, Malysheva ES, Petrov AV, Nekrasova TA, Nekaeva ES, Lavrova AE, Zarubina DG, Atduev KA, Magomedova DM, Strongin LG. COVID-19 in Patients with Diabetes: Clinical Course, Metabolic Status, Inflammation, and Coagulation Disorder. Sovrem Tekhnologii Med 2021;12:6-16. [PMID: 34796000 DOI: 10.17691/stm2020.12.5.01] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 172 |
Jeyalan V, Storrar J, Wu HHL, Ponnusamy A, Sinha S, Kalra PA, Chinnadurai R. Native and transplant kidney histopathological manifestations in association with COVID-19 infection: A systematic review. World J Transplant 2021; 11(11): 480-502 [PMID: 34868898 DOI: 10.5500/wjt.v11.i11.480] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 173 |
Worth H, Helmlinger K, Raj R, Heidel E, Lands R. Thromboembolic Rates Are Similar Between Intensive Care Unit and Nonintensive Care Unit Hospitalized Patients With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): A Retrospective Cohort Study. Clin Appl Thromb Hemost 2021;27:10760296211053315. [PMID: 34786969 DOI: 10.1177/10760296211053315] [Reference Citation Analysis]
|
| 174 |
Evtugina NG, Sannikova SS, Peshkova AD, Safiullina SI, Andrianova IA, Tarasova GR, Khabirova AI, Rumyantsev AG, Ataullakhanov FI, Litvinov RI. Peculiarities of blood coagulation disorders in patients with COVID-19. Terapevticheskii arkhiv 2021;93:1255-63. [DOI: 10.26442/00403660.2021.11.201185] [Reference Citation Analysis]
|
| 175 |
Barzegar M, Stokes KY, Chernyshev O, Kelley RE, Alexander JS. The Role of the ACE2/MasR Axis in Ischemic Stroke: New Insights for Therapy. Biomedicines 2021;9. [PMID: 34829896 DOI: 10.3390/biomedicines9111667] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 176 |
Sengupta S, Handoo A, Pande R, Kapoor RK. Retrospective Analysis of Clinical Laboratory Parameters, Therapeutics and Outcome in Patients Infected with SARS-CoV2. Indian J Clin Biochem 2021;:1-7. [PMID: 34785872 DOI: 10.1007/s12291-021-01009-5] [Reference Citation Analysis]
|
| 177 |
Wang IE, Cooper G, Mousa SA. Diagnostic Approaches for COVID-19 and Its Associated Complications. Diagnostics (Basel) 2021;11:2071. [PMID: 34829418 DOI: 10.3390/diagnostics11112071] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 178 |
Neethling C, Calligaro G, Miller M, Opie JJS. The evolution of clot strength in critically-ill COVID-19 patients: a prospective observational thromboelastography study. Thromb J 2021;19:83. [PMID: 34742307 DOI: 10.1186/s12959-021-00331-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 179 |
Lichter Y, Badelbayov T, Shalev I, Schvartz R, Szekely Y, Benisty D, Goldiner I, Kagarlyk M, Asraf K, Doolman R, Luttwak E, Kirgner I, Avivi I, Adi N, Katz BZ. Low FXIII activity levels in intensive care unit hospitalized COVID-19 patients. Thromb J 2021;19:79. [PMID: 34736472 DOI: 10.1186/s12959-021-00333-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 180 |
Makatsariya AD, Slukhanchuk EV, Bitsadze VO, Khizroeva JK, Tretyakova MV, Shkoda AS, Akinshina SV, Makatsariya NA, Tsibizova VI, Gris J, Elalamy I, Ay С, Grandone E. Thrombotic storm, hemostasis disorders and thromboinflammation in COVID-19. Akušerstvo, ginekologiâ i reprodukciâ 2021;15:499-514. [DOI: 10.17749/2313-7347/ob.gyn.rep.2021.247] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 181 |
Anipindi M, Scott A, Joyce L, Wali S, Morginstin M. Case Report: Cerebral Venous Sinus Thrombosis and COVID-19 Infection. Front Med (Lausanne) 2021;8:741594. [PMID: 34722579 DOI: 10.3389/fmed.2021.741594] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 182 |
Schimmel L, Chew KY, Stocks CJ, Yordanov TE, Essebier P, Kulasinghe A, Monkman J, Dos Santos Miggiolaro AFR, Cooper C, de Noronha L, Schroder K, Lagendijk AK, Labzin LI, Short KR, Gordon EJ. Endothelial cells are not productively infected by SARS-CoV-2. Clin Transl Immunology 2021;10:e1350. [PMID: 34721846 DOI: 10.1002/cti2.1350] [Cited by in Crossref: 23] [Cited by in F6Publishing: 27] [Article Influence: 11.5] [Reference Citation Analysis]
|
| 183 |
Mackman N, Grover SP, Antoniak S. Tissue factor expression, extracellular vesicles, and thrombosis after infection with the respiratory viruses influenza A virus and coronavirus. J Thromb Haemost 2021;19:2652-8. [PMID: 34418279 DOI: 10.1111/jth.15509] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 8.5] [Reference Citation Analysis]
|
| 184 |
Chow JH, Yin Y, Yamane DP, Davison D, Keneally RJ, Hawkins K, Parr KG, Al-Mashat M, Berger JS, Bushardt RL, Mazzeffi MA, Nelson SJ. Association of prehospital antiplatelet therapy with survival in patients hospitalized with COVID-19: A propensity score-matched analysis. J Thromb Haemost 2021;19:2814-24. [PMID: 34455688 DOI: 10.1111/jth.15517] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 7.5] [Reference Citation Analysis]
|
| 185 |
Acharya Y, Alameer A, Calpin G, Alkhattab M, Sultan S. A comprehensive review of vascular complications in COVID-19. J Thromb Thrombolysis 2021. [PMID: 34724155 DOI: 10.1007/s11239-021-02593-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 186 |
Bahraini M, Dorgalaleh A. The Impact of SARS-CoV-2 Infection on Blood Coagulation and Fibrinolytic Pathways: A Review of Prothrombotic Changes Caused by COVID-19. Semin Thromb Hemost 2021. [PMID: 34695858 DOI: 10.1055/s-0041-1736166] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 187 |
Tufano A, Rendina D, Abate V, Casoria A, Marra A, Buonanno P, Galletti F, Di Minno G, Servillo G, Vargas M. Venous Thromboembolism in COVID-19 Compared to Non-COVID-19 Cohorts: A Systematic Review with Meta-Analysis. J Clin Med 2021;10:4925. [PMID: 34768445 DOI: 10.3390/jcm10214925] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 188 |
Ahmad F, Kannan M, Ansari AW. Role of SARS-CoV-2 -induced cytokines and growth factors in coagulopathy and thromboembolism. Cytokine Growth Factor Rev 2021:S1359-6101(21)00079-4. [PMID: 34750061 DOI: 10.1016/j.cytogfr.2021.10.007] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 189 |
Satta S, Lai A, Cavallero S, Williamson C, Chen J, Blázquez-Medela AM, Roustaei M, Dillon BJ, Ashammakhi N, Carlo DD, Li Z, Sun R, Hsiai TK. Rapid Detection and Inhibition of SARS-CoV-2-Spike Mutation-Mediated Microthrombosis. Adv Sci (Weinh) 2021;8:e2103266. [PMID: 34687279 DOI: 10.1002/advs.202103266] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 190 |
Cacciola R, Gentilini Cacciola E, Vecchio V, Cacciola E. Cellular and molecular mechanisms in COVID-19 coagulopathy: role of inflammation and endotheliopathy. J Thromb Thrombolysis 2021. [PMID: 34687400 DOI: 10.1007/s11239-021-02583-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 191 |
Tang X, Zheng F. A review of ischemic stroke in COVID-19: currently known pathophysiological mechanisms. Neurol Sci 2021. [PMID: 34671854 DOI: 10.1007/s10072-021-05679-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 192 |
Len P, Iskakova G, Sautbayeva Z, Kussanova A, Tauekelova AT, Sugralimova MM, Dautbaeva AS, Abdieva MM, Ponomarev ED, Tikhonov A, Bekbossynova MS, Barteneva NS. Meta-analysis of coagulation disbalances in COVID-19: 41 studies and 17601 patients.. [DOI: 10.1101/2021.10.17.21265108] [Reference Citation Analysis]
|
| 193 |
Raj K, Chandna S, Doukas SG, Watts A, Jyotheeswara Pillai K, Anandam A, Singh D, Nagarakanti R, Sankaramangalam K. Combined Use of Wells Scores and D-dimer Levels for the Diagnosis of Deep Vein Thrombosis and Pulmonary Embolism in COVID-19: A Retrospective Cohort Study. Cureus 2021;13:e17687. [PMID: 34650862 DOI: 10.7759/cureus.17687] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 194 |
Wang J, Hajizadeh N, Shore-Lesserson L. The Value of Thromboelastography (TEG) in COVID-19 Critical Illness as Illustrated by a Case Series. J Cardiothorac Vasc Anesth 2021:S1053-0770(21)00934-4. [PMID: 34802831 DOI: 10.1053/j.jvca.2021.10.015] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 195 |
Nehme R, Fleifel M, Abou Khalil M, Al Dailaty A. A case of massive saddle pulmonary embolism and benign tracheal stenosis in a patient with COVID-19 infection. Respirol Case Rep 2021;9:e0861. [PMID: 34631107 DOI: 10.1002/rcr2.861] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 196 |
Seregina EA, Koltsova EM, Ataullakhanov FI, Rumyantsev AG. Laboratory parameters of hemostasis in patients with COVID-19. Voprosy gematologii/onkologii i immunopatologii v pediatrii 2021;20:147-155. [DOI: 10.24287/1726-1708-2021-20-3-147-155] [Reference Citation Analysis]
|
| 197 |
Tang JS, Lai JK, McCusker MW, Irving L, Pascoe DM, Heinze SB. Chest imaging findings in COVID-19-positive patients in an Australian tertiary hospital. J Med Imaging Radiat Oncol 2021. [PMID: 34612025 DOI: 10.1111/1754-9485.13339] [Reference Citation Analysis]
|
| 198 |
Swan D, Carrier M, Lisman T, Thachil J. Heparin - Messias or Verschlimmbesserung? J Thromb Haemost 2021;19:2373-82. [PMID: 34272818 DOI: 10.1111/jth.15464] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 199 |
Massaro G, Lecis D, Martuscelli E, Chiricolo G, Sangiorgi GM. Clinical Features and Management of COVID-19–Associated Hypercoagulability. Cardiac Electrophysiology Clinics 2021. [DOI: 10.1016/j.ccep.2021.10.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 200 |
Trichel AM. Overview of Nonhuman Primate Models of SARS-CoV-2 Infection. Comp Med 2021;71:411-32. [PMID: 34548126 DOI: 10.30802/AALAS-CM-20-000119] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 201 |
Oliynyk O, Barg W, Slifirczyk A, Oliynyk Y, Dubrov S, Gurianov V, Rorat M. Comparison of the Effect of Unfractionated Heparin and Enoxaparin Sodium at Different Doses on the Course of COVID-19-Associated Coagulopathy. Life (Basel) 2021;11:1032. [PMID: 34685403 DOI: 10.3390/life11101032] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 202 |
Razi M, Gu J, He X, Kong J, Ahmed MJ. Venous thromboembolism in patients with COVID-19. A prevalent and a preventable complication of the pandemic. J Interv Med 2021;4:62-5. [PMID: 34557323 DOI: 10.1016/j.jimed.2021.02.006] [Reference Citation Analysis]
|
| 203 |
Sharma R, Chaudhary D, Goel P, Khandelwal S, Singh V, Kapoor R. COVID-19 Masquerading as Postoperative Surgical Complications after Cancer Surgery. Indian J Surg Oncol 2021;:1-4. [PMID: 34584368 DOI: 10.1007/s13193-021-01452-z] [Reference Citation Analysis]
|
| 204 |
Swenson KE, Swenson ER. Pathophysiology of Acute Respiratory Distress Syndrome and COVID-19 Lung Injury. Crit Care Clin 2021;37:749-76. [PMID: 34548132 DOI: 10.1016/j.ccc.2021.05.003] [Cited by in Crossref: 14] [Cited by in F6Publishing: 19] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 205 |
Vasile MC, Arbune AA, Lupasteanu G, Vlase CM, Popovici GC, Arbune M. Epidemiologic and Clinic Characteristics of the First Wave of the COVID-19 Pandemic in Hospitalized Patients from Galați County. J Clin Med 2021;10:4210. [PMID: 34575321 DOI: 10.3390/jcm10184210] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 206 |
Bobescu E, Marceanu LG, Covaciu A, Vladau LA. Thrombosis, an important piece in the COVID-19 puzzle: From pathophysiology to therapy. Anatol J Cardiol 2021;25:601-8. [PMID: 34498590 DOI: 10.5152/AnatolJCardiol.2021.475] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 207 |
Singh AK, Bansal S, Singhania N, Singhania G. Recurrent arteriovenous graft thrombosis in COVID-19 positive patient. Clin Case Rep 2021;9:e04732. [PMID: 34484766 DOI: 10.1002/ccr3.4732] [Reference Citation Analysis]
|
| 208 |
Ma Y, Deutsch G, Van Tassel D, Shub M, Schroeder S, Krauss J, Davenport K, Carpentieri D. SARS-CoV-2 Related Ischemic Colitis in an Adolescent With Trisomy 21: Diagnostic Pitfalls and Considerations. Pediatr Dev Pathol 2021;24:445-9. [PMID: 34048305 DOI: 10.1177/10935266211015666] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 209 |
Gaddh M, Maier CL. Interdisciplinary Approach to Thrombosis Management in COVID-19 at a Large Academic Center. JCO Oncol Pract 2021;17:517-21. [PMID: 34019440 DOI: 10.1200/OP.20.01056] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 210 |
Kazemi S, Pourgholaminejad A, Saberi A. Stroke Associated with SARS-CoV-2 Infection and its Pathogenesis: A Systematic Review. Basic Clin Neurosci 2021;12:569-86. [PMID: 35173912 DOI: 10.32598/bcn.2021.3277.1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 211 |
Zengin M, Baldemir R. INVESTIGATION OF THE GLOBAL OUTCOMES OF ACUTE RESPIRATORY DISTRESS SYNDROME WITH THE EFFECT OF COVID-19 IN PUBLICATIONS: A BIBLIOMETRIC ANALYSIS BETWEEN 1980 AND 2020. Kırıkkale Üniversitesi Tıp Fakültesi Dergisi. [DOI: 10.24938/kutfd.916560] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 212 |
Kaidashev I, Shlykova O, Izmailova O, Torubara O, Yushchenko Y, Tyshkovska T, Kyslyi V, Belyaeva A, Maryniak D. Host gene variability and SARS-CoV-2 infection: A review article. Heliyon 2021;7:e07863. [PMID: 34458641 DOI: 10.1016/j.heliyon.2021.e07863] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 213 |
Ladozhskaya-gapeenko EE, Khrapov KN, Polushin YS, Shlyk IV, Petrishchev NN, Vartanova IV. Microcirculation Disorders in Patients with Severe COVID-19. Vestn anesteziol reanimatol 2021;18:7-19. [DOI: 10.21292/2078-5658-2021-18-4-7-19] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 214 |
Sui J, Noubouossie DF, Gandotra S, Cao L. Elevated Plasma Fibrinogen Is Associated With Excessive Inflammation and Disease Severity in COVID-19 Patients. Front Cell Infect Microbiol 2021;11:734005. [PMID: 34414135 DOI: 10.3389/fcimb.2021.734005] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 215 |
Raychaudhuri S, Pujani M, Menia R, Verma N, Singh M, Chauhan V, Jain M, Chandoke RK, Kaur H, Agrawal S, Singh A. COVID-19 Associated Coagulopathy in an Indian Scenario: A Correlation with Disease Severity and Survival Status. Indian J Hematol Blood Transfus 2021;:1-11. [PMID: 34426721 DOI: 10.1007/s12288-021-01465-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 216 |
Swenson KE, Ruoss SJ, Swenson ER. The Pathophysiology and Dangers of Silent Hypoxemia in COVID-19 Lung Injury. Ann Am Thorac Soc 2021;18:1098-105. [PMID: 33621159 DOI: 10.1513/AnnalsATS.202011-1376CME] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 9.5] [Reference Citation Analysis]
|
| 217 |
Gomellya MV, Tatarinova AV, Krupskaya TS, Rychkova LV. COVID-19-associated coagulopathy in children and adolescents. Acta biomedica scientifica 2021;6:142-153. [DOI: 10.29413/abs.2021-6.3.15] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 218 |
Baltrūnas T, Račytė A, Pikturnaitė G, Skrebūnas A, Vaišnytė B. Aortic thrombosis after DVT and PE in a young COVID-19 patient. Ann Vasc Surg 2021:S0890-5096(21)00498-2. [PMID: 34411673 DOI: 10.1016/j.avsg.2021.07.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 219 |
Zhang J, Gao XL, Yang LH. [Research progress in coagulation dysfunction and its relationship with cytokine storm syndrome in patients with severe/critical COVID-19]. Zhonghua Xue Ye Xue Za Zhi 2021;42:700-4. [PMID: 34547883 DOI: 10.3760/cma.j.issn.0253-2727.2021.08.019] [Reference Citation Analysis]
|
| 220 |
Speybroeck J, Marsee M, Shariff F, Zackariya N, Grisoli A, Lune SV, Larson EE, Hatch J, McCauley R, Shariff F, Aversa JG, Son M, Agostini V, Campello E, Simioni P, Scărlătescu E, Kwaan H, Hartmann J, Fries D, Walsh M. Viscoelastic testing in benign hematologic disorders: Clinical perspectives and future implications of point-of-care testing to assess hemostatic competence. Transfusion 2020;60 Suppl 6:S101-21. [PMID: 33089936 DOI: 10.1111/trf.16088] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 221 |
Litvinov RI, Evtugina NG, Peshkova AD, Safiullina SI, Andrianova IA, Khabirova AI, Nagaswami C, Khismatullin RR, Sannikova SS, Weisel JW. Altered platelet and coagulation function in moderate-to-severe COVID-19. Sci Rep 2021;11:16290. [PMID: 34381066 DOI: 10.1038/s41598-021-95397-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 222 |
Sen S, Kannan NB, Kumar J, Rajan RP, Kumar K, Baliga G, Reddy H, Upadhyay A, Ramasamy K. Retinal manifestations in patients with SARS-CoV-2 infection and pathogenetic implications: a systematic review. Int Ophthalmol 2021. [PMID: 34379290 DOI: 10.1007/s10792-021-01996-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 223 |
Dabholkar N, Gorantla S, Dubey SK, Alexander A, Taliyan R, Singhvi G. Repurposing methylene blue in the management of COVID-19: Mechanistic aspects and clinical investigations. Biomed Pharmacother 2021;142:112023. [PMID: 34399199 DOI: 10.1016/j.biopha.2021.112023] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 224 |
Morris G, Bortolasci CC, Puri BK, Marx W, O'Neil A, Athan E, Walder K, Berk M, Olive L, Carvalho AF, Maes M. The cytokine storms of COVID-19, H1N1 influenza, CRS and MAS compared. Can one sized treatment fit all? Cytokine 2021;144:155593. [PMID: 34074585 DOI: 10.1016/j.cyto.2021.155593] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 17.5] [Reference Citation Analysis]
|
| 225 |
Levy JH, Iba T, Olson LB, Corey KM, Ghadimi K, Connors JM. COVID-19: Thrombosis, thromboinflammation, and anticoagulation considerations. Int J Lab Hematol 2021;43 Suppl 1:29-35. [PMID: 34288441 DOI: 10.1111/ijlh.13500] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 226 |
Devreese KMJ. COVID-19-related laboratory coagulation findings. Int J Lab Hematol 2021;43 Suppl 1:36-42. [PMID: 34288440 DOI: 10.1111/ijlh.13547] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 227 |
Logette E, Lorin C, Favreau C, Oshurko E, Coggan JS, Casalegno F, Sy MF, Monney C, Bertschy M, Delattre E, Fonta PA, Krepl J, Schmidt S, Keller D, Kerrien S, Scantamburlo E, Kaufmann AK, Markram H. A Machine-Generated View of the Role of Blood Glucose Levels in the Severity of COVID-19. Front Public Health 2021;9:695139. [PMID: 34395368 DOI: 10.3389/fpubh.2021.695139] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 8.5] [Reference Citation Analysis]
|
| 228 |
Ayhan SG, Tanacan A, Atalay A, Sinaci S, Tokalioglu EO, Sahin D, Tekin OM. Assessment of fetal Doppler parameters in pregnant women with COVID-19 infection: a prospective case-control study. J Perinat Med 2021;49:697-701. [PMID: 33660492 DOI: 10.1515/jpm-2020-0512] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 229 |
Delshad M, Safaroghli-Azar A, Pourbagheri-Sigaroodi A, Poopak B, Shokouhi S, Bashash D. Platelets in the perspective of COVID-19; pathophysiology of thrombocytopenia and its implication as prognostic and therapeutic opportunity. Int Immunopharmacol 2021;99:107995. [PMID: 34304001 DOI: 10.1016/j.intimp.2021.107995] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 230 |
Huang YK, Li YJ, Li B, Wang P, Wang QH. Dysregulated liver function in SARS-CoV-2 infection: Current understanding and perspectives. World J Gastroenterol 2021; 27(27): 4358-4370 [PMID: 34366609 DOI: 10.3748/wjg.v27.i27.4358] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 231 |
Albasheer OB, Almutairi HA, Almalki FM, Malaka HM. Massive Arterial Cerebral Thrombosis in a 59-year old Female Patient With Severe COVID-19. Cureus 2021;13:e15553. [PMID: 34277178 DOI: 10.7759/cureus.15553] [Reference Citation Analysis]
|
| 232 |
López-jaime FJ, Martín-téllez S, Doblas-márquez A, Márquez-gómez I, Reguera-iglesias JM, Muñoz-pérez MI, Fernández-bello I, Montaño A. CLOT STIFFNESS MEASURED BY SEER SONORHEOMETRY AS A MARKER OF POOR PROGNOSIS IN HOSPITALIZED COVID-19 PATIENTS.. [DOI: 10.1101/2021.07.13.21260256] [Reference Citation Analysis]
|
| 233 |
Pavoni V, Gianesello L, Pazzi M, Dattolo P, Prisco D. Questions about COVID-19 associated coagulopathy: possible answers from the viscoelastic tests. J Clin Monit Comput 2021. [PMID: 34264472 DOI: 10.1007/s10877-021-00744-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 234 |
Viurcos-Sanabria R, Escobedo G. Immunometabolic bases of type 2 diabetes in the severity of COVID-19. World J Diabetes 2021; 12(7): 1026-1041 [PMID: 34326952 DOI: 10.4239/wjd.v12.i7.1026] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 235 |
Kang S, Kishimoto T. Interplay between interleukin-6 signaling and the vascular endothelium in cytokine storms. Exp Mol Med 2021;53:1116-23. [PMID: 34253862 DOI: 10.1038/s12276-021-00649-0] [Cited by in Crossref: 46] [Cited by in F6Publishing: 45] [Article Influence: 23.0] [Reference Citation Analysis]
|
| 236 |
Badimon L, Robinson EL, Jusic A, Carpusca I, deWindt LJ, Emanueli C, Ferdinandy P, Gu W, Gyöngyösi M, Hackl M, Karaduzovic-Hadziabdic K, Lustrek M, Martelli F, Nham E, Potočnjak I, Satagopam V, Schneider R, Thum T, Devaux Y. Cardiovascular RNA markers and artificial intelligence may improve COVID-19 outcome: a position paper from the EU-CardioRNA COST Action CA17129. Cardiovasc Res 2021;117:1823-40. [PMID: 33839767 DOI: 10.1093/cvr/cvab094] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 237 |
Shatohin YV, Snezhko IV, Ryabikina EV. Violation of hemostasis in coronavirus infection. jour 2021;2:6-15. [DOI: 10.21886/2712-8156-2021-2-2-6-15] [Reference Citation Analysis]
|
| 238 |
Gönenli MG, Komesli Z, İncir S, Yalçın Ö, Akay OM. Rotational Thromboelastometry Reveals Distinct Coagulation Profiles for Patients With COVID-19 Depending on Disease Severity. Clin Appl Thromb Hemost 2021;27:10760296211027653. [PMID: 34184563 DOI: 10.1177/10760296211027653] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 239 |
Al-Ghafry M, Vagrecha A, Malik M, Levine C, Uster E, Aygun B, Appiah-Kubi A, Vlachos A, Capone CA, Rajan S, Palumbo N, Misra N, Mitchell EC, Wolfe LC, Lipton JM, Shore-Lesserson L, Acharya SS. Multisystem inflammatory syndrome in children (MIS-C) and the prothrombotic state: Coagulation profiles and rotational thromboelastometry in a MIS-C cohort. J Thromb Haemost 2021;19:1764-70. [PMID: 33872443 DOI: 10.1111/jth.15340] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 240 |
Semeraro N, Colucci M. The Prothrombotic State Associated with SARS-CoV-2 Infection: Pathophysiological Aspects. Mediterr J Hematol Infect Dis 2021;13:e2021045. [PMID: 34276914 DOI: 10.4084/MJHID.2021.045] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 241 |
Taştemur Ş, Ataseven H. Quercetin in the treatment and prevention of COVID-19. Cumhuriyet Medical Journal 2021;43:100-116. [DOI: 10.7197/cmj.939856] [Reference Citation Analysis]
|
| 242 |
Sule GA, Aysegul A, Selcan S, Atakan T, Eda OT, Deniz O, Filiz HO, Ozlem MT, Dilek S. Effects of SARS-COV-2 infection on fetal pulmonary artery Doppler parameters. Echocardiography 2021;38:1314-8. [PMID: 34184313 DOI: 10.1111/echo.15146] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 243 |
Lanza E, Mancuso ME, Messana G, Ferrazzi P, Lisi C, Di Micco P, Barco S, Balzarini L, Lodigiani C. Compromised Lung Volume and Hemostatic Abnormalities in COVID-19 Pneumonia: Results from an Observational Study on 510 Consecutive Patients. J Clin Med 2021;10:2894. [PMID: 34209720 DOI: 10.3390/jcm10132894] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 244 |
Smadja DM, Mentzer SJ, Fontenay M, Laffan MA, Ackermann M, Helms J, Jonigk D, Chocron R, Pier GB, Gendron N, Pons S, Diehl JL, Margadant C, Guerin C, Huijbers EJM, Philippe A, Chapuis N, Nowak-Sliwinska P, Karagiannidis C, Sanchez O, Kümpers P, Skurnik D, Randi AM, Griffioen AW. COVID-19 is a systemic vascular hemopathy: insight for mechanistic and clinical aspects. Angiogenesis 2021. [PMID: 34184164 DOI: 10.1007/s10456-021-09805-6] [Cited by in Crossref: 49] [Cited by in F6Publishing: 35] [Article Influence: 24.5] [Reference Citation Analysis]
|
| 245 |
Kerawala AA, Das B, Solangi A. Mesenteric ischemia in COVID-19 patients: A review of current literature. World J Clin Cases 2021; 9(18): 4700-4708 [PMID: 34222436 DOI: 10.12998/wjcc.v9.i18.4700] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 246 |
Fattorutto M, Bouckaert Y, Brauner J, Franck S, Bouton F, Heuse D, Bouckaert C, Bruyneel A. Pragmatic study of a thromboprophylaxis algorithm in critically ill patients with SARS-COV-2 infection. J Thromb Thrombolysis 2021. [PMID: 34173169 DOI: 10.1007/s11239-021-02514-3] [Reference Citation Analysis]
|
| 247 |
Magomedov A, Zickler D, Karaivanov S, Kurreck A, Münch FH, Kamhieh-Milz J, Ferse C, Kahl A, Piper SK, Eckardt KU, Dörner T, Kruse JM. Viscoelastic testing reveals normalization of the coagulation profile 12 weeks after severe COVID-19. Sci Rep 2021;11:13325. [PMID: 34172793 DOI: 10.1038/s41598-021-92683-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 248 |
Matli K, Farah R, Maalouf M, Chamoun N, Costanian C, Ghanem G. Role of combining anticoagulant and antiplatelet agents in COVID-19 treatment: a rapid review. Open Heart 2021;8:e001628. [PMID: 34099529 DOI: 10.1136/openhrt-2021-001628] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 249 |
Bilge A, Karasoy İ, Neziroğlu E, Güner Y. Upper extremity arterial thromboembolism in a patient with severe COVID-19 pneumonia: A case report. Jt Dis Relat Surg 2021;32:551-5. [PMID: 34145839 DOI: 10.52312/jdrs.2021.82766] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 250 |
Hasan MR, Al Zubaidi K, Diab K, Hejazi Y, Bout-Tabaku S, Al-Adba B, Al Maslamani E, Janahi M, Roscoe D, Lopez AP, Tang P. COVID-19 related multisystem inflammatory syndrome in children (MIS-C): a case series from a tertiary care pediatric hospital in Qatar. BMC Pediatr 2021;21:267. [PMID: 34103044 DOI: 10.1186/s12887-021-02743-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 251 |
Zhan XY, Li L, Hu Y, Li Q, Kong H, Ng MHL, Chen C, He Y, Huang B, Yang M. Elderly Male With Cardiovascular-Related Comorbidities Has a Higher Rate of Fatal Outcomes: A Retrospective Study in 602 Patients With Coronavirus Disease 2019. Front Cardiovasc Med 2021;8:680604. [PMID: 34164443 DOI: 10.3389/fcvm.2021.680604] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 252 |
Savastano MC, Culiersi C, Savastano A, Gambini G, Caporossi T, Rizzo S. Focal superior quadrant haemorrhages in post COVID-19 patient: A target for personalized medicine. Eur J Ophthalmol 2021;:11206721211021296. [PMID: 34088221 DOI: 10.1177/11206721211021296] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 253 |
Dandu H, Yadav G, Malhotra HS, Pandey S, Sachu R, Dubey K. Hemophagocytic histiocytosis in severe SARS-CoV-2 infection: A bone marrow study. Int J Lab Hematol 2021. [PMID: 34086418 DOI: 10.1111/ijlh.13619] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 254 |
Levi M. Pathophysiology of Coagulopathy in Hematological Malignancies and in COVID-19. Hemasphere 2021;5:e571. [PMID: 34095755 DOI: 10.1097/HS9.0000000000000571] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 255 |
Gabbai-Armelin PR, de Oliveira AB, Ferrisse TM, Sales LS, Barbosa ERO, Miranda ML, Salomão KB, Brighenti FL. COVID-19 (SARS-CoV-2) infection and thrombotic conditions: A systematic review and meta-analysis. Eur J Clin Invest 2021;51:e13559. [PMID: 33772772 DOI: 10.1111/eci.13559] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 256 |
FitzGerald ES, Chen Y, Fitzgerald KA, Jamieson AM. Lung Epithelial Cell Transcriptional Regulation as a Factor in COVID-19-associated Coagulopathies. Am J Respir Cell Mol Biol 2021;64:687-97. [PMID: 33740387 DOI: 10.1165/rcmb.2020-0453OC] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 9.0] [Reference Citation Analysis]
|
| 257 |
Ambrosino P, Molino A, Calcaterra I, Formisano R, Stufano S, Spedicato GA, Motta A, Papa A, Di Minno MND, Maniscalco M. Clinical Assessment of Endothelial Function in Convalescent COVID-19 Patients Undergoing Multidisciplinary Pulmonary Rehabilitation. Biomedicines 2021;9:614. [PMID: 34071308 DOI: 10.3390/biomedicines9060614] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 258 |
Testori A, Giudici VM, Alloisio M, Cioffi U. Case Report: COVID-19 Pneumonia Following Left Pneumonectomy for Lung Cancer Complicated by Empyema and Bronchopleural Fistula. Front Surg 2021;8:679757. [PMID: 34095211 DOI: 10.3389/fsurg.2021.679757] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 259 |
Weeks LD, Sylvester KW, Connors JM, Connell NT. Management of therapeutic unfractionated heparin in COVID-19 patients: A retrospective cohort study. Res Pract Thromb Haemost 2021;5:e12521. [PMID: 34013153 DOI: 10.1002/rth2.12521] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 260 |
Ghosh R, Roy D, Mandal A, Pal SK, Chandra Swaika B, Naga D, Pandit A, Ray BK, Benito-León J. Cerebral venous thrombosis in COVID-19. Diabetes Metab Syndr 2021;15:1039-45. [PMID: 34015627 DOI: 10.1016/j.dsx.2021.04.026] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 9.0] [Reference Citation Analysis]
|
| 261 |
Iba T, Levy JH, Levi M, Connors JM, Thachil J. The authors reply. Crit Care Med 2020;48:e1160-1. [PMID: 32932349 DOI: 10.1097/CCM.0000000000004616] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 262 |
Budimir Mršić D, Perković-Tabak L, Ćavar M, Luetić A, Petričević M, Dolić K. Pulmonary Embolism Associated with COVID-19 Occurs in Predominantly Elderly Patients with Comorbidities: A Single Center Retrospective Study. Gerontol Geriatr Med 2021;7:23337214211017398. [PMID: 34046516 DOI: 10.1177/23337214211017398] [Reference Citation Analysis]
|
| 263 |
Voulalas G, Tsui J, Candilio L, Baker D. SARS-CoV-2 and Pre-existing Vascular Diseases: Guilt by Association? Clin Med Insights Cardiol 2021;15:11795468211010705. [PMID: 34035654 DOI: 10.1177/11795468211010705] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 264 |
Englert H, Rangaswamy C, Deppermann C, Sperhake JP, Krisp C, Schreier D, Gordon E, Konrath S, Haddad M, Pula G, Mailer RK, Schlüter H, Kluge S, Langer F, Püschel K, Panousis K, Stavrou EX, Maas C, Renné T, Frye M. Defective NET clearance contributes to sustained FXII activation in COVID-19-associated pulmonary thrombo-inflammation. EBioMedicine 2021;67:103382. [PMID: 34000623 DOI: 10.1016/j.ebiom.2021.103382] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 17.0] [Reference Citation Analysis]
|
| 265 |
Duque P, Chasco-Ganuza M, Burgos-Santamaria A, Terradillos E. Increased resistance to fibrinolysis activation in patients with coronavirus disease 2019: a case series. Blood Coagul Fibrinolysis 2021;32:298-301. [PMID: 33491994 DOI: 10.1097/MBC.0000000000001017] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 266 |
Raheman FJ, Rojoa DM, Nayan Parekh J, Berber R, Ashford R. Meta-analysis and metaregression of risk factors associated with mortality in hip fracture patients during the COVID-19 pandemic. Sci Rep 2021;11:10157. [PMID: 33980936 DOI: 10.1038/s41598-021-89617-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 267 |
Strauss SA, Seo C, Carrier M, Jetty P. From cellular function to global impact: the vascular perspective on COVID-19. Can J Surg 2021;64:E289-97. [PMID: 33978563 DOI: 10.1503/cjs.023820] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 268 |
Kaur S, Hussain S, Kolhe K, Kumar G, Tripathi DM, Tomar A, Kale P, Narayanan A, Bihari C, Bajpai M, Maiwall R, Gupta E, Sarin SK. Elevated plasma ICAM1 levels predict 28-day mortality in cirrhotic patients with COVID-19 or bacterial sepsis. JHEP Rep 2021;3:100303. [PMID: 33997748 DOI: 10.1016/j.jhepr.2021.100303] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 269 |
Zhao R, Su Z, Komissarov AA, Liu SL, Yi G, Idell S, Matthay MA, Ji HL. Associations of D-Dimer on Admission and Clinical Features of COVID-19 Patients: A Systematic Review, Meta-Analysis, and Meta-Regression. Front Immunol 2021;12:691249. [PMID: 34025688 DOI: 10.3389/fimmu.2021.691249] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 270 |
Lu Y, Zhao JJ, Ye MF, Li HM, Yao FR, Kong Y, Xu Z. The relationship between COVID-19's severity and ischemic stroke: a systematic review and meta-analysis. Neurol Sci 2021;42:2645-51. [PMID: 33954827 DOI: 10.1007/s10072-021-05299-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 271 |
Kohansal Vajari M, Shirin M, Pourbagheri-Sigaroodi A, Akbari ME, Abolghasemi H, Bashash D. COVID-19-related coagulopathy: A review of pathophysiology and pharmaceutical management. Cell Biol Int 2021. [PMID: 33945651 DOI: 10.1002/cbin.11623] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 272 |
Lio D, Scola L, Giarratana RM, Candore G, Colonna-Romano G, Caruso C, Balistreri CR. SARS CoV2 infection _The longevity study perspectives. Ageing Res Rev 2021;67:101299. [PMID: 33607290 DOI: 10.1016/j.arr.2021.101299] [Cited by in Crossref: 21] [Cited by in F6Publishing: 10] [Article Influence: 10.5] [Reference Citation Analysis]
|
| 273 |
Logette E, Lorin C, Favreau C, Oshurko E, Coggan JS, Casalegno F, Sy MF, Monney C, Bertschy M, Delattre E, Fonta P, Krepl J, Schmidt S, Keller D, Kerrien S, Scantamburlo E, Kaufmann A, Markram H. Elevated Blood Glucose Levels as a Primary Risk Factor for the Severity of COVID-19.. [DOI: 10.1101/2021.04.29.21256294] [Reference Citation Analysis]
|
| 274 |
Tzaneva S. Thrombose und COVID-19. hautnah 2021;20:92-97. [DOI: 10.1007/s12326-021-00438-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 275 |
Ippolito D, Giandola T, Maino C, Pecorelli A, Capodaglio C, Ragusi M, Porta M, Gandola D, Masetto A, Drago S, Allegranza P, Corso R, Talei Franzesi C, Sironi S. Acute pulmonary embolism in hospitalized patients with SARS-CoV-2-related pneumonia: multicentric experience from Italian endemic area. Radiol Med 2021;126:669-78. [PMID: 33417194 DOI: 10.1007/s11547-020-01328-2] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 11.0] [Reference Citation Analysis]
|
| 276 |
Chan KH, Lim SL, Shaaban H, Guron G, Slim J. Persistent Hypercoagulable State in COVID-19: A Case Series of COVID-19 Associated Pulmonary Embolism. J Glob Infect Dis 2021;13:38-41. [PMID: 33911452 DOI: 10.4103/jgid.jgid_180_20] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 277 |
Shahani P, Datta I. Mesenchymal stromal cell therapy for coronavirus disease 2019: which? when? and how much? Cytotherapy 2021:S1465-3249(21)00234-6. [PMID: 34053857 DOI: 10.1016/j.jcyt.2021.04.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 278 |
Koyuncu K, Alan Y, Sakin Ö, Karamustafaoğlu Balci B, Denizli R, Anğin AD. COVID 19 IN PREGNANT WOMEN - A RETROSPECTIVE COHORT STUDY. Samsun Sağlık Bilimleri Dergisi 2021;6:181-186. [DOI: 10.47115/jshs.793218] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 279 |
Kuznetsova TA, Andryukov BG, Makarenkova ID, Zaporozhets TS, Besednova NN, Fedyanina LN, Kryzhanovsky SP, Shchelkanov MY. The Potency of Seaweed Sulfated Polysaccharides for the Correction of Hemostasis Disorders in COVID-19. Molecules 2021;26:2618. [PMID: 33947107 DOI: 10.3390/molecules26092618] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 280 |
Doevelaar AAN, Bachmann M, Hölzer B, Seibert FS, Rohn BJ, Bauer F, Witzke O, Dittmer U, Bachmann M, Yilmaz S, Dittmer R, Schneppenheim S, Babel N, Budde U, Westhoff TH. von Willebrand Factor Multimer Formation Contributes to Immunothrombosis in Coronavirus Disease 2019. Crit Care Med 2021;49:e512-20. [PMID: 33591004 DOI: 10.1097/CCM.0000000000004918] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 18.5] [Reference Citation Analysis]
|
| 281 |
Palazzuoli A, Giustozzi M, Ruocco G, Tramonte F, Gronda E, Agnelli G. Thromboembolic Complications in Covid-19: From Clinical Scenario to Laboratory Evidence. Life (Basel) 2021;11:395. [PMID: 33925334 DOI: 10.3390/life11050395] [Reference Citation Analysis]
|
| 282 |
Mazzeffi MA, Chow JH, Tanaka K. COVID-19 Associated Hypercoagulability: Manifestations, Mechanisms, and Management. Shock 2021;55:465-71. [PMID: 32890309 DOI: 10.1097/SHK.0000000000001660] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 10.0] [Reference Citation Analysis]
|
| 283 |
Hulshof AM, Brüggemann RAG, Mulder MMG, van de Berg TW, Sels JEM, Olie RH, Spaetgens B, Streng AS, Verhezen P, van der Horst ICC, Ten Cate H, Spronk HMH, van Bussel BCT, Henskens YMC. Serial EXTEM, FIBTEM, and tPA Rotational Thromboelastometry Observations in the Maastricht Intensive Care COVID Cohort-Persistence of Hypercoagulability and Hypofibrinolysis Despite Anticoagulation. Front Cardiovasc Med 2021;8:654174. [PMID: 33981736 DOI: 10.3389/fcvm.2021.654174] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 8.5] [Reference Citation Analysis]
|
| 284 |
Moonla C, Sosothikul D, Chiasakul T, Rojnuckarin P, Uaprasert N. Anticoagulation and In-Hospital Mortality From Coronavirus Disease 2019: A Systematic Review and Meta-Analysis. Clin Appl Thromb Hemost 2021;27:10760296211008999. [PMID: 33874753 DOI: 10.1177/10760296211008999] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 285 |
Gergi M, Goodwin A, Freeman K, Colovos C, Volod O. Viscoelastic hemostasis assays in septic, critically ill coronavirus disease 2019 patients: a practical guide for clinicians. Blood Coagul Fibrinolysis 2021;32:225-8. [PMID: 33443923 DOI: 10.1097/MBC.0000000000000999] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 286 |
Stanevich O, Fomina D, Bakulin I, Galeev SI, Bakin E, Belash V, Kulikov A, Lebedeva A, Lioznov D, Polushin YS, Shlyk I, Vorobyev E, Vorobyeva S, Surovceva T, Bakulina N, Lysenko M, Moiseev I. Ruxolitinib versus Dexamethasone in Hospitalized Adults with Covid-19: multicenter matched-controlled study.. [DOI: 10.1101/2021.04.20.21255662] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 287 |
Savla SR, Prabhavalkar KS, Bhatt LK. Cytokine storm associated coagulation complications in COVID-19 patients: Pathogenesis and Management. Expert Rev Anti Infect Ther 2021;:1-17. [PMID: 33832398 DOI: 10.1080/14787210.2021.1915129] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 288 |
Marco A, Marco P. Von Willebrand factor and ADAMTS13 activity as clinical severity markers in patients with COVID-19. J Thromb Thrombolysis 2021. [PMID: 33866481 DOI: 10.1007/s11239-021-02457-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 289 |
Loforte A, Di Mauro M, Pellegrini C, Monterosso C, Pelenghi S, Degani A, Rinaldi M, Cura Stura E, Sales G, Montrucchio G, Mangino D, Terrini A, Pacini D, Affronti A, Tarzia V, Bottio T, Pantaleo A, Donatelli F, Miceli A, Santini F, Salsano A, Colli A, Ravenni G, Montalto A, Musumeci F, Salvador L, Gerosa G, Parolari A, Picichè M; endorsed by the Italian Society for Cardiac Surgery (SICCH). Extracorporeal Membrane Oxygenation for COVID-19 Respiratory Distress Syndrome: An Italian Society for Cardiac Surgery Report. ASAIO J 2021;67:385-91. [PMID: 33470643 DOI: 10.1097/MAT.0000000000001399] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 290 |
Manzoor D, Bui C, Makhoul E, Luthringer D, Marchevsky A, Volod O. Improvement in plasma D-dimer level in severe SARS-CoV-2 infection can be an indicator of fibrinolysis suppression: Case reports. Medicine (Baltimore) 2021;100:e25255. [PMID: 33847623 DOI: 10.1097/MD.0000000000025255] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 291 |
Bareille M, Hardy M, Douxfils J, Roullet S, Lasne D, Levy JH, Stépanian A, Susen S, Frère C, Lecompte T, Mullier F. Viscoelastometric Testing to Assess Hemostasis of COVID-19: A Systematic Review. J Clin Med 2021;10:1740. [PMID: 33923851 DOI: 10.3390/jcm10081740] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 10.0] [Reference Citation Analysis]
|
| 292 |
Shehata GA, Lord KC, Grudzinski MC, Elsayed M, Abdelnaby R, Elshabrawy HA. Neurological Complications of COVID-19: Underlying Mechanisms and Management. Int J Mol Sci 2021;22:4081. [PMID: 33920904 DOI: 10.3390/ijms22084081] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 10.5] [Reference Citation Analysis]
|
| 293 |
Ozer KB, Sakin O, Koyuncu K, Cimenoglu B, Demirhan R. Comparison of Laboratory and Radiological Findings of Pregnant and Non-Pregnant Women with Covid-19. Rev Bras Ginecol Obstet 2021;43:200-6. [PMID: 33860503 DOI: 10.1055/s-0041-1726054] [Reference Citation Analysis]
|
| 294 |
Rodríguez C, Luque N, Blanco I, Sebastian L, Barberà JA, Peinado VI, Tura-Ceide O. Pulmonary Endothelial Dysfunction and Thrombotic Complications in Patients with COVID-19. Am J Respir Cell Mol Biol 2021;64:407-15. [PMID: 33180562 DOI: 10.1165/rcmb.2020-0359PS] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 13.0] [Reference Citation Analysis]
|
| 295 |
de la Morena-Barrio ME, Bravo-Pérez C, Miñano A, de la Morena-Barrio B, Fernandez-Perez MP, Bernal E, Gómez-Verdu JM, Herranz MT, Vicente V, Corral J, Lozano ML. Prognostic value of thrombin generation parameters in hospitalized COVID-19 patients. Sci Rep 2021;11:7792. [PMID: 33833254 DOI: 10.1038/s41598-021-85906-y] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]
|
| 296 |
Bonaventura A, Vecchié A, Dagna L, Martinod K, Dixon DL, Van Tassell BW, Dentali F, Montecucco F, Massberg S, Levi M, Abbate A. Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19. Nat Rev Immunol 2021;21:319-29. [PMID: 33824483 DOI: 10.1038/s41577-021-00536-9] [Cited by in Crossref: 272] [Cited by in F6Publishing: 284] [Article Influence: 136.0] [Reference Citation Analysis]
|
| 297 |
Ferrari F, Martins VM, Teixeira M, Santos RD, Stein R. COVID-19 and Thromboinflammation: Is There a Role for Statins? Clinics (Sao Paulo) 2021;76:e2518. [PMID: 33787678 DOI: 10.6061/clinics/2021/e2518] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 298 |
Wang Z, Du Z, Zhao X, Guo F, Wang T, Zhu F. Determinants of Increased Fibrinogen in COVID-19 Patients With and Without Diabetes and Impaired Fasting Glucose.Clin Appl Thromb Hemost. 2021;27:1076029621996445. [PMID: 33760664 DOI: 10.1177/1076029621996445] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 299 |
Moin ASM, Al-Qaissi A, Sathyapalan T, Atkin SL, Butler AE. Platelet Protein-Related Abnormalities in Response to Acute Hypoglycemia in Type 2 Diabetes. Front Endocrinol (Lausanne) 2021;12:651009. [PMID: 33859620 DOI: 10.3389/fendo.2021.651009] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 300 |
Coopersmith CM, Antonelli M, Bauer SR, Deutschman CS, Evans LE, Ferrer R, Hellman J, Jog S, Kesecioglu J, Kissoon N, Martin-Loeches I, Nunnally ME, Prescott HC, Rhodes A, Talmor D, Tissieres P, De Backer D. The Surviving Sepsis Campaign: Research Priorities for Coronavirus Disease 2019 in Critical Illness. Crit Care Med 2021;49:598-622. [PMID: 33591008 DOI: 10.1097/CCM.0000000000004895] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 11.5] [Reference Citation Analysis]
|
| 301 |
Engin AB, Engin ED, Engin A. Current opinion in neurological manifestations of SARS-CoV-2 infection. Curr Opin Toxicol 2021;25:49-56. [PMID: 33817451 DOI: 10.1016/j.cotox.2021.03.004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 302 |
Mang S, Kalenka A, Broman LM, Supady A, Swol J, Danziger G, Becker A, Hörsch SI, Mertke T, Kaiser R, Bracht H, Zotzmann V, Seiler F, Bals R, Taccone FS, Moerer O, Lorusso R, Bělohlávek J, Muellenbach RM, Lepper PM; COVEC-Study Group. Extracorporeal life support in COVID-19-related acute respiratory distress syndrome: A EuroELSO international survey. Artif Organs 2021;45:495-505. [PMID: 33590542 DOI: 10.1111/aor.13940] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 303 |
Han CY, Tarr AM, Gewirtz AN, Kaunzner UW, Roy-Burman P, Cutler TS, MacGowan DJ. Brachial plexopathy as a complication of COVID-19. BMJ Case Rep 2021;14:e237459. [PMID: 33766961 DOI: 10.1136/bcr-2020-237459] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 304 |
Chow JH, Khanna AK, Kethireddy S, Yamane D, Levine A, Jackson AM, McCurdy MT, Tabatabai A, Kumar G, Park P, Benjenk I, Menaker J, Ahmed N, Glidewell E, Presutto E, Cain S, Haridasa N, Field W, Fowler JG, Trinh D, Johnson KN, Kaur A, Lee A, Sebastian K, Ulrich A, Peña S, Carpenter R, Sudhakar S, Uppal P, Fedeles BT, Sachs A, Dahbour L, Teeter W, Tanaka K, Galvagno SM, Herr DL, Scalea TM, Mazzeffi MA. Aspirin Use Is Associated With Decreased Mechanical Ventilation, Intensive Care Unit Admission, and In-Hospital Mortality in Hospitalized Patients With Coronavirus Disease 2019. Anesth Analg 2021;132:930-41. [PMID: 33093359 DOI: 10.1213/ANE.0000000000005292] [Cited by in Crossref: 173] [Cited by in F6Publishing: 195] [Article Influence: 86.5] [Reference Citation Analysis]
|
| 305 |
El-qutob D, Alvarez L, García-sidro P, Robustillo M, Barreda I, Nieto M, Pin M, Carrera-hueso F. High incidence of pulmonary thromboembolism in hospitalized SARS-CoV-2 infected patients.. [DOI: 10.1101/2021.03.23.21253258] [Reference Citation Analysis]
|
| 306 |
Malone RW, Tisdall P, Fremont-Smith P, Liu Y, Huang XP, White KM, Miorin L, Moreno E, Alon A, Delaforge E, Hennecker CD, Wang G, Pottel J, Blair RV, Roy CJ, Smith N, Hall JM, Tomera KM, Shapiro G, Mittermaier A, Kruse AC, García-Sastre A, Roth BL, Glasspool-Malone J, Ricke DO. COVID-19: Famotidine, Histamine, Mast Cells, and Mechanisms. Front Pharmacol 2021;12:633680. [PMID: 33833683 DOI: 10.3389/fphar.2021.633680] [Cited by in Crossref: 25] [Cited by in F6Publishing: 30] [Article Influence: 12.5] [Reference Citation Analysis]
|
| 307 |
Matli K, Farah R, Maalouf M, Costanian C, Chamoun N, Ghanem G. Role of Combining Anticoagulant and Antiplatelet Agents in COVID-19 Treatment: A Rapid Review.. [DOI: 10.1101/2021.03.21.21253754] [Reference Citation Analysis]
|
| 308 |
von Meijenfeldt FA, Havervall S, Adelmeijer J, Lundström A, Magnusson M, Mackman N, Thalin C, Lisman T. COVID-19 is Associated with an Acquired Factor XIII Deficiency. Thromb Haemost 2021. [PMID: 33742434 DOI: 10.1055/a-1450-8414] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 309 |
Yu MD, Desai N, Sanagala T, Darki A. Paradoxical Embolism Causing Myocardial Infarction in a COVID-19 Patient Presenting With Pulmonary Embolism. Cureus 2021;13:e13975. [PMID: 33880303 DOI: 10.7759/cureus.13975] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 310 |
Bumiller-Bini V, de Freitas Oliveira-Toré C, Carvalho TM, Kretzschmar GC, Gonçalves LB, Alencar NM, Gasparetto Filho MA, Beltrame MH, Winter Boldt AB. MASPs at the crossroad between the complement and the coagulation cascades - the case for COVID-19. Genet Mol Biol 2021;44:e20200199. [PMID: 33729332 DOI: 10.1590/1678-4685-GMB-2020-0199] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 311 |
Brem FL, Abu-Al-Tayef T, Rasras H, Mir ZE, Mahi OE, Ouafi NE. Concomitant acute limb ischemia and multiple acute ischemic strokes complicating COVID-19: a case report. Pan Afr Med J 2021;38:275. [PMID: 34122702 DOI: 10.11604/pamj.2021.38.275.28712] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 312 |
Moosavi M, Wooten M, Goodman A, Nahab FB, Duncan A, Maier C, Guarner J. Retrospective Analyses Associate Hemostasis Activation Biomarkers With Poor Outcomes in Patients With COVID-19. Am J Clin Pathol 2021;155:498-505. [PMID: 33300981 DOI: 10.1093/ajcp/aqaa266] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 313 |
de Macedo VSO, Moreira GB, de Albuquerque ACF, Oliveira SCS, Esmeraldo MA, Barbosa FCB. Late mesenteric ischemia after Sars-Cov-2 infection: case report. J Vasc Bras 2021;20:e20200105. [PMID: 34093678 DOI: 10.1590/1677-5449.200105] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 314 |
Iba T, Levy JH, Connors JM, Warkentin TE, Thachil J, Levi M. Managing thrombosis and cardiovascular complications of COVID-19: answering the questions in COVID-19-associated coagulopathy. Expert Rev Respir Med 2021;15:1003-11. [PMID: 33667146 DOI: 10.1080/17476348.2021.1899815] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 315 |
Gratz J, Wiegele M, Maleczek M, Herkner H, Schöchl H, Chwala E, Knöbl P, Schaden E. Risk of Clinically Relevant Venous Thromboembolism in Critically Ill Patients With COVID-19: A Systematic Review and Meta-Analysis. Front Med (Lausanne) 2021;8:647917. [PMID: 33768106 DOI: 10.3389/fmed.2021.647917] [Cited by in Crossref: 13] [Cited by in F6Publishing: 17] [Article Influence: 6.5] [Reference Citation Analysis]
|
| 316 |
Gonzalez-Ochoa AJ, Raffetto JD, Hernández AG, Zavala N, Gutiérrez O, Vargas A, Loustaunau J. Sulodexide in the Treatment of Patients with Early Stages of COVID-19: A Randomized Controlled Trial. Thromb Haemost 2021;121:944-54. [PMID: 33677827 DOI: 10.1055/a-1414-5216] [Cited by in Crossref: 29] [Cited by in F6Publishing: 20] [Article Influence: 14.5] [Reference Citation Analysis]
|
| 317 |
García-Posada M, Aruachan-Vesga S, Mestra D, Humánez K, Serrano-Coll H, Cabrales H, Faccini Á, Mattar S. Clinical outcomes of patients hospitalized for COVID-19 and evidence-based on the pharmacological management reduce mortality in a region of the Colombian Caribbean. J Infect Public Health 2021;14:696-701. [PMID: 34020208 DOI: 10.1016/j.jiph.2021.02.013] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 318 |
Panigada M, Meli A, Scotti E, Properzi P, Brioni M, Kamel S, Ghirardello S, Scudeller L, Dalton HJ, Grasselli G. Viscoelastic Coagulation Monitor as a Novel Device to Assess Coagulation at the Bedside. A Single-Center Experience During the COVID-19 Pandemic. ASAIO J 2021;67:254-62. [PMID: 33627598 DOI: 10.1097/MAT.0000000000001380] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 319 |
Pradhan F, Alishahi Y. Gastrointestinal Bleeding and Endoscopic Outcomes in Patients with SARS-CoV-2. Clin Endosc 2021;54:428-31. [PMID: 33652519 DOI: 10.5946/ce.2020.244] [Reference Citation Analysis]
|
| 320 |
Patel PA, Henderson RA Jr, Bolliger D, Erdoes G, Mazzeffi MA. The Year in Coagulation: Selected Highlights from 2020. J Cardiothorac Vasc Anesth 2021;35:2260-72. [PMID: 33781668 DOI: 10.1053/j.jvca.2021.02.057] [Reference Citation Analysis]
|
| 321 |
Motta NAV, Autran LJ, Brazão SC, Lopes RO, Scaramello CBV, Lima GF, Brito FCF. Could cilostazol be beneficial in COVID-19 treatment? Thinking about phosphodiesterase-3 as a therapeutic target. Int Immunopharmacol 2021;92:107336. [PMID: 33418248 DOI: 10.1016/j.intimp.2020.107336] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 322 |
Valle C, Bonaffini PA, Dal Corso M, Mercanzin E, Franco PN, Sonzogni A, Vacca G, Gianatti A, Sironi S. Association between pulmonary embolism and COVID-19 severe pneumonia: Experience from two centers in the core of the infection Italian peak. Eur J Radiol 2021;137:109613. [PMID: 33657476 DOI: 10.1016/j.ejrad.2021.109613] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 323 |
Pellegrini JAS, Rech TH, Schwarz P, de Oliveira ACT, Vieceli T, Moraes RB, Sekine L, Viana MV. Incidence of venous thromboembolism among patients with severe COVID-19 requiring mechanical ventilation compared to other causes of respiratory failure: a prospective cohort study. J Thromb Thrombolysis 2021. [PMID: 33599858 DOI: 10.1007/s11239-021-02395-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 324 |
Creel-Bulos C, Auld SC, Caridi-Scheible M, Barker NA, Friend S, Gaddh M, Kempton CL, Maier CL, Nahab F, Sniecinski R. Fibrinolysis Shutdown and Thrombosis in a COVID-19 ICU. Shock 2021;55:316-20. [PMID: 32769822 DOI: 10.1097/SHK.0000000000001635] [Cited by in Crossref: 44] [Cited by in F6Publishing: 51] [Article Influence: 22.0] [Reference Citation Analysis]
|
| 325 |
Baker SA, Kwok S, Berry GJ, Montine TJ. Angiotensin-converting enzyme 2 (ACE2) expression increases with age in patients requiring mechanical ventilation. PLoS One 2021;16:e0247060. [PMID: 33592054 DOI: 10.1371/journal.pone.0247060] [Cited by in Crossref: 39] [Cited by in F6Publishing: 52] [Article Influence: 19.5] [Reference Citation Analysis]
|
| 326 |
Schimmel L, Chew KY, Stocks C, Yordanov T, Essebier P, Kulasinghe A, Monkman J, Miggiolaro AFRDS, Cooper C, de Noronha L, Lagendijk AK, Schroder K, Labzin LI, Gordon EJ, Short KR. Endothelial cells elicit a pro-inflammatory response to SARS-CoV-2 without productive viral infection.. [DOI: 10.1101/2021.02.14.431177] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 327 |
Marchiano S, Hsiang TY, Khanna A, Higashi T, Whitmore LS, Bargehr J, Davaapil H, Chang J, Smith E, Ong LP, Colzani M, Reinecke H, Yang X, Pabon L, Sinha S, Najafian B, Sniadecki NJ, Bertero A, Gale M Jr, Murry CE. SARS-CoV-2 Infects Human Pluripotent Stem Cell-Derived Cardiomyocytes, Impairing Electrical and Mechanical Function. Stem Cell Reports 2021;16:478-92. [PMID: 33657418 DOI: 10.1016/j.stemcr.2021.02.008] [Cited by in Crossref: 44] [Cited by in F6Publishing: 45] [Article Influence: 22.0] [Reference Citation Analysis]
|
| 328 |
Dennison JJ, Carlson S, Faehling S, Phelan H, Tariq M, Mubarik A. Splenic infarction and spontaneous rectus sheath hematomas in COVID-19 patient. Radiol Case Rep 2021;16:999-1004. [PMID: 33619439 DOI: 10.1016/j.radcr.2021.02.016] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 329 |
Heinz C, Miesbach W, Herrmann E, Sonntagbauer M, Raimann FJ, Zacharowski K, Weber CF, Adam EH. Greater Fibrinolysis Resistance but No Greater Platelet Aggregation in Critically Ill COVID-19 Patients. Anesthesiology 2021;134:457-67. [PMID: 33417674 DOI: 10.1097/ALN.0000000000003685] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 14.5] [Reference Citation Analysis]
|
| 330 |
Banno A, Hifumi T, Okamoto H, Masaki M, Seki K, Isokawa S, Otani N, Hayashi K, Ishimatsu S. Clinical characteristics and outcomes of critically ill COVID-19 patients in Tokyo: a single-center observational study from the first wave. BMC Infect Dis 2021;21:163. [PMID: 33563218 DOI: 10.1186/s12879-021-05840-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 331 |
Mitrovic M, Sabljic N, Cvetkovic Z, Pantic N, Zivkovic Dakic A, Bukumiric Z, Libek V, Savic N, Milenkovic B, Virijevic M, Vucinic V, Milosevic I, Pravdic Z, Suvajdzic N, Fareed J, Antic D. Rotational thromboelastometry (ROTEM) profiling of COVID-19 patients. Platelets 2021;32:690-6. [PMID: 33561381 DOI: 10.1080/09537104.2021.1881949] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 332 |
Ng WH, Tipih T, Makoah NA, Vermeulen JG, Goedhals D, Sempa JB, Burt FJ, Taylor A, Mahalingam S. Comorbidities in SARS-CoV-2 Patients: a Systematic Review and Meta-Analysis. mBio 2021;12:e03647-20. [PMID: 33563817 DOI: 10.1128/mBio.03647-20] [Cited by in Crossref: 93] [Cited by in F6Publishing: 113] [Article Influence: 46.5] [Reference Citation Analysis]
|
| 333 |
Falter T, Rossmann H, Menge P, Goetje J, Groenwoldt S, Weinmann A, Sivanathan V, Schulz A, Lemmermann NAW, Danckwardt S, Lackner KJ, Galle PR, Scharrer I, Lämmle B, Sprinzl MF. No Evidence for Classic Thrombotic Microangiopathy in COVID-19. J Clin Med 2021;10:671. [PMID: 33572417 DOI: 10.3390/jcm10040671] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 334 |
Fedorov SA, Medvedev AP, Maksimov AL, Borovkova NY, Sukhanova MB, Pichugin VV, Zhurko SA, Tselousova LM, Brichkin YD. The first experience of treatment applied to patients with pulmonary embolism that developed on the COVID-19 background. jour 2021;98:612-618. [DOI: 10.30629/0023-2149-2020-98-8-612-618] [Reference Citation Analysis]
|
| 335 |
Bauer W, Galtung N, Neuwinger N, Kaufner L, Langer E, Somasundaram R, Tauber R, Kappert K. A Matter of Caution: Coagulation Parameters in COVID-19 Do Not Differ from Patients with Ruled-Out SARS-CoV-2 Infection in the Emergency Department. TH Open 2021;5:e43-55. [PMID: 33564744 DOI: 10.1055/s-0040-1722612] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 336 |
Ölmez H, Tosun M, Ünver E, Doğan M, Arslan Işik N. COVID-19 and hypercoagulability. The European Research Journal 2021. [DOI: 10.18621/eurj.830973] [Reference Citation Analysis]
|
| 337 |
Campello E, Bulato C, Spiezia L, Boscolo A, Poletto F, Cola M, Gavasso S, Simion C, Radu CM, Cattelan A, Tiberio I, Vettor R, Navalesi P, Simioni P. Thrombin generation in patients with COVID-19 with and without thromboprophylaxis. Clin Chem Lab Med 2021;59:1323-30. [PMID: 33544518 DOI: 10.1515/cclm-2021-0108] [Cited by in Crossref: 20] [Cited by in F6Publishing: 26] [Article Influence: 10.0] [Reference Citation Analysis]
|
| 338 |
García-Ortega A, de la Rosa D, Oscullo G, Castillo-Villegas D, López-Reyes R, Martínez-García MÁ. Coagulation disorders and thromboembolic disease in COVID-19: review of current evidence in search of a better approach. J Thorac Dis 2021;13:1239-55. [PMID: 33717596 DOI: 10.21037/jtd-20-3062] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 339 |
Zanza C, Racca F, Longhitano Y, Piccioni A, Franceschi F, Artico M, Abenavoli L, Maiese A, Passaro G, Volonnino G, La Russa R. Risk Management and Treatment of Coagulation Disorders Related to COVID-19 Infection. Int J Environ Res Public Health 2021;18:1268. [PMID: 33572570 DOI: 10.3390/ijerph18031268] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 12.5] [Reference Citation Analysis]
|
| 340 |
Liu Y, Cai J, Wang C, Jin J, Qu L. A systematic review and meta-analysis of incidence, prognosis, and laboratory indicators of venous thromboembolism in hospitalized patients with coronavirus disease 2019. J Vasc Surg Venous Lymphat Disord 2021;9:1099-1111.e6. [PMID: 33529719 DOI: 10.1016/j.jvsv.2021.01.012] [Cited by in Crossref: 19] [Cited by in F6Publishing: 26] [Article Influence: 9.5] [Reference Citation Analysis]
|
| 341 |
Tazi Mezalek Z. [COVID-19: Coagulopathy and thrombosis]. Rev Med Interne 2021;42:93-100. [PMID: 33509669 DOI: 10.1016/j.revmed.2020.12.014] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 342 |
Kounis NG, Koniari I, Gogos C, Assimakopoulos SF. Ηypercoagulation and myocardial injury as risk factors for mortality in patients with COVID-19 pneumonia. Am J Emerg Med 2021;47:313-4. [PMID: 33494959 DOI: 10.1016/j.ajem.2021.01.035] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 343 |
VasanthiDharmalingam P, Karuppagounder V, Watanabe K, Karmouty-Quintana H, Palaniyandi SS, Guha A, Thandavarayan RA. SARS-CoV-2 Mediated Hyperferritinemia and Cardiac Arrest: Preliminary Insights. Drug Discov Today 2021;26:1265-74. [PMID: 33493677 DOI: 10.1016/j.drudis.2021.01.014] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 344 |
Anaklı İ, Ergin Özcan P, Polat Ö, Orhun G, Alay GH, Tuna V, Çeliksoy E, Kılıç M, Mercan M, Ali A, Beşışık S, Esen F. Prognostic Value of Antithrombin Levels in COVID-19 Patients and Impact of Fresh Frozen Plasma Treatment: A Retrospective Study. Turk J Haematol 2021;38:15-21. [PMID: 33486940 DOI: 10.4274/tjh.galenos.2021.2020.0695] [Cited by in Crossref: 4] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 345 |
Siddiqui SN, Jayasekhar R, Tshering S, Jugjali R, Shanmugavadivel D, Jawed A, Rahman MM. A unique tale of COVID-19 induced concomitant overt disseminated intravascular coagulation and acute bilateral pulmonary embolism. Int J Infect Dis 2021;104:568-71. [PMID: 33486013 DOI: 10.1016/j.ijid.2021.01.040] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 346 |
Poulakou G, Dimakakos E, Kollias A, Kyriakoulis KG, Rapti V, Trontzas I, Thanos C, Abdelrasoul M, Vantana T, Leontis K, Kakalou E, Argyraki K, Baraboutis I, Michelakis E, Giamarellos-Bourboulis E, Dimakou K, Tsoukalas G, Rapti A, Michelakis ED, Syrigos KN. Beneficial Effects of Intermediate Dosage of Anticoagulation Treatment on the Prognosis of Hospitalized COVID-19 Patients: The ETHRA Study. In Vivo 2021;35:653-61. [PMID: 33402523 DOI: 10.21873/invivo.12305] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 347 |
Tomo S, Kumar KP, Roy D, Sankanagoudar S, Purohit P, Yadav D, Banerjee M, Sharma P, Misra S. Complement activation and coagulopathy - an ominous duo in COVID19. Expert Rev Hematol 2021;14:155-73. [PMID: 33480807 DOI: 10.1080/17474086.2021.1875813] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 348 |
Jamil A, Shyam V, Neupane K. Atypical Presentation of Pulmonary Embolism Several Months After COVID-19 Infection. Cureus 2021;13:e12863. [PMID: 33633893 DOI: 10.7759/cureus.12863] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 349 |
Biancari F, Mariscalco G, Dalén M, Settembre N, Welp H, Perrotti A, Wiebe K, Leo E, Loforte A, Chocron S, Pacini D, Juvonen T, Broman LM, Perna DD, Yusuff H, Harvey C, Mongardon N, Maureira JP, Levy B, Falk L, Ruggieri VG, Zipfel S, Folliguet T, Fiore A. Six-Month Survival After Extracorporeal Membrane Oxygenation for Severe COVID-19. J Cardiothorac Vasc Anesth 2021;35:1999-2006. [PMID: 33573928 DOI: 10.1053/j.jvca.2021.01.027] [Cited by in Crossref: 28] [Cited by in F6Publishing: 31] [Article Influence: 14.0] [Reference Citation Analysis]
|
| 350 |
Cristiano A, Fortunati V, Cherubini F, Bernardini S, Nuccetelli M. Anti-phospholipids antibodies and immune complexes in COVID-19 patients: a putative role in disease course for anti-annexin-V antibodies. Clin Rheumatol 2021;40:2939-45. [PMID: 33464429 DOI: 10.1007/s10067-021-05580-3] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 6.5] [Reference Citation Analysis]
|
| 351 |
Polverino F, Kheradmand F. COVID-19, COPD, and AECOPD: Immunological, Epidemiological, and Clinical Aspects. Front Med (Lausanne) 2020;7:627278. [PMID: 33537336 DOI: 10.3389/fmed.2020.627278] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 352 |
Yeganegi M, Fattahi P. Management and Prevention of Cerebrovascular Accidents in SARS-CoV-2-Positive Patients Recovering from COVID-19: a Case Report and Review of Literature. SN Compr Clin Med 2021;:1-12. [PMID: 33490876 DOI: 10.1007/s42399-021-00744-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 353 |
Lobastov KV, Schastlivtsev IV, Porembskaya OY, Dzenina OV, Bargandzhiya AB, Tsaplin SN. COVID-19-associated coagulopathy: review of current recommendations for diagnosis, treatment and prevention. Ambulatornaya khirurgiya 2021. [DOI: 10.21518/1995-1477-2020-3-4-36-51] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 354 |
Zhang S, Zhang J, Wang C, Chen X, Zhao X, Jing H, Liu H, Li Z, Wang L, Shi J. COVID‑19 and ischemic stroke: Mechanisms of hypercoagulability (Review). Int J Mol Med 2021;47:21. [PMID: 33448315 DOI: 10.3892/ijmm.2021.4854] [Cited by in Crossref: 20] [Cited by in F6Publishing: 25] [Article Influence: 10.0] [Reference Citation Analysis]
|
| 355 |
Görlinger K, Almutawah H, Almutawaa F, Alwabari M, Alsultan Z, Almajed J, Alwabari M, Alsultan M, Shahwar D, Yassen KA. The role of rotational thromboelastometry during the COVID-19 pandemic: a narrative review. Korean J Anesthesiol 2021;74:91-102. [PMID: 33440114 DOI: 10.4097/kja.21006] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 356 |
Umar Shahzad M, Han J, Ramtoola MI, Lamprou V, Gupta U. Spontaneous Tension Pneumothorax as a Complication of COVID-19. Case Rep Med 2021;2021:4126861. [PMID: 33424976 DOI: 10.1155/2021/4126861] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 357 |
Luo J, Zhu X, Jian J, Chen X, Yin K. Cardiovascular disease in patients with COVID-19: evidence from cardiovascular pathology to treatment. Acta Biochim Biophys Sin (Shanghai) 2021;53:273-82. [PMID: 33428706 DOI: 10.1093/abbs/gmaa176] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 6.5] [Reference Citation Analysis]
|
| 358 |
El-Shimy IA, Mohamed MMA, Hasan SS, Hadi MA. Targeting host cell proteases as a potential treatment strategy to limit the spread of SARS-CoV-2 in the respiratory tract. Pharmacol Res Perspect 2021;9:e00698. [PMID: 33369210 DOI: 10.1002/prp2.698] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 359 |
Schiaffino S, Giacomazzi F, Esseridou A, Cozzi A, Carriero S, Mazzaccaro DP, Nano G, Di Leo G, Spagnolo P, Sardanelli F. Pulmonary thromboembolism in coronavirus disease 2019 patients undergoing thromboprophylaxis. Medicine (Baltimore) 2021;100:e24002. [PMID: 33429763 DOI: 10.1097/MD.0000000000024002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 360 |
Iba T, Warkentin TE, Thachil J, Levi M, Levy JH. Proposal of the Definition for COVID-19-Associated Coagulopathy. J Clin Med 2021;10:E191. [PMID: 33430431 DOI: 10.3390/jcm10020191] [Cited by in Crossref: 47] [Cited by in F6Publishing: 54] [Article Influence: 23.5] [Reference Citation Analysis]
|
| 361 |
Muñoz-Rivas N, Abad-Motos A, Mestre-Gómez B, Sierra-Hidalgo F, Cortina-Camarero C, Lorente-Ramos RM, Torres-Rubio P, Arranz-García P, Franco-Moreno AI, Gómez-Mariscal E, Mauleón-Fernández C, Alonso-García S, Rogado J, Saez-Vaquero T, Such-Diaz A, Ryan P, Moya-Mateo E, Martín-Navarro JA, Hernández-Rivas JA, Torres-Macho J, Churruca J; Infanta Leonor Thrombosis Research Group. Systemic thrombosis in a large cohort of COVID-19 patients despite thromboprophylaxis: A retrospective study. Thromb Res 2021;199:132-42. [PMID: 33503547 DOI: 10.1016/j.thromres.2020.12.024] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 7.5] [Reference Citation Analysis]
|
| 362 |
Sh Hassan AA, Alsaleh ME, Alsaleh ME, Al Zaher FA, Almajed FA, Alkhudhair AM, Alali MM, Alzayer HA, Alolayan AJ. Budd-Chiari Syndrome: A Case Report of a Rare Presentation of COVID-19. Cureus 2021;13:e12554. [PMID: 33564546 DOI: 10.7759/cureus.12554] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 363 |
Cai C, Guo Y, You Y, Hu K, Cai F, Xie M, Yang L, Ling K, Ye D, Misra S, Wang W, Li Y. Deep Venous Thrombosis in COVID-19 Patients: A Cohort Analysis. Clin Appl Thromb Hemost 2020;26:1076029620982669. [PMID: 33372807 DOI: 10.1177/1076029620982669] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 364 |
Storti B, Cereda D, Balducci C, Santangelo F, Ferrarese C, Appollonio I. Who is really blind in the time of coronavirus: the patient or the doctor? A rare case of Balint's syndrome. Neurol Sci 2021;42:2079-80. [PMID: 33400067 DOI: 10.1007/s10072-020-04934-0] [Reference Citation Analysis]
|
| 365 |
Cabrera-garcia D, Miltiades A, Parsons S, Elisman K, Mansouri MT, Wagener G, Harrison NL. High levels of plasminogen activator inhibitor-1, tissue plasminogen activator and fibrinogen in patients with severe COVID-19.. [DOI: 10.1101/2020.12.29.20248869] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 366 |
Robba C, Battaglini D, Ball L, Valbusa A, Porto I, Della Bona R, La Malfa G, Patroniti N, Brunetti I, Loconte M, Bassetti M, Giacobbe DR, Vena A, Silva CLM, Rocco PRM, Pelosi P. Coagulative Disorders in Critically Ill COVID-19 Patients with Acute Distress Respiratory Syndrome: A Critical Review. J Clin Med 2021;10:E140. [PMID: 33401632 DOI: 10.3390/jcm10010140] [Cited by in Crossref: 18] [Cited by in F6Publishing: 22] [Article Influence: 9.0] [Reference Citation Analysis]
|
| 367 |
Wu Y, Li Z, Zhao YS, Huang YY, Jiang MY, Luo HB. Therapeutic targets and potential agents for the treatment of COVID-19. Med Res Rev 2021;41:1775-97. [PMID: 33393116 DOI: 10.1002/med.21776] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
|
| 368 |
Iba T, Connors JM, Nagaoka I, Levy JH. Recent advances in the research and management of sepsis-associated DIC. Int J Hematol 2021;113:24-33. [PMID: 33386597 DOI: 10.1007/s12185-020-03053-y] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 10.5] [Reference Citation Analysis]
|
| 369 |
Mir N, D'Amico A, Dasher J, Tolwani A, Valentine V. Understanding the andromeda strain - The role of cytokine release, coagulopathy and antithrombin III in SARS-CoV2 critical illness. Blood Rev 2021;45:100731. [PMID: 32829961 DOI: 10.1016/j.blre.2020.100731] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 370 |
Singh S, Pandey R, Tomar S, Varshney R, Sharma D, Gangenahalli G. A brief molecular insight of COVID-19: epidemiology, clinical manifestation, molecular mechanism, cellular tropism and immuno-pathogenesis. Mol Cell Biochem 2021;476:3987-4002. [PMID: 34195882 DOI: 10.1007/s11010-021-04217-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 371 |
Krenytska D, Rachkovska A, Savchuk O, Karbovskiy V. Blood coagulation parameters in pregnant women with COVID-19. BTSNUKSB 2021;86:34-39. [DOI: 10.17721/1728_2748.2021.86.34-39] [Reference Citation Analysis]
|
| 372 |
Maier CL, Sarker T, Szlam F, Sniecinski RM. COVID-19 patient plasma demonstrates resistance to tPA-induced fibrinolysis as measured by thromboelastography. J Thromb Thrombolysis 2021;52:766-71. [PMID: 33829396 DOI: 10.1007/s11239-021-02438-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 373 |
Marongiu I, Pavlovsky B, Mauri T. Mechanisms of Hypoxemia in the Acute Respiratory Distress Syndrome. Annual Update in Intensive Care and Emergency Medicine 2021 2021. [DOI: 10.1007/978-3-030-73231-8_15] [Reference Citation Analysis]
|
| 374 |
López-Reyes R, Oscullo G, Jiménez D, Cano I, García-Ortega A. [Thrombotic Risk and Covid-19: Review of Current Evidence for a Better Diagnostic and Therapeutic Approach]. Arch Bronconeumol 2021;57:55-64. [PMID: 34629653 DOI: 10.1016/j.arbres.2020.07.033] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 375 |
Yasmin H, Saha S, Butt MT, Modi RK, George AJT, Kishore U. SARS-CoV-2: Pathogenic Mechanisms and Host Immune Response. Adv Exp Med Biol 2021;1313:99-134. [PMID: 34661893 DOI: 10.1007/978-3-030-67452-6_6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 376 |
Kow CS, Hasan SS. The use of antiplatelet agents for arterial thromboprophylaxis in COVID-19. Rev Esp Cardiol (Engl Ed) 2021;74:114-5. [PMID: 32933883 DOI: 10.1016/j.rec.2020.08.009] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 377 |
Sweed D, El Shanshory MR, Elaskary EM, Hassan HA, Sweed E, Sweed E, Abdelsattar S, Abdelgawad A, Mosbeh A, Abdallah H, El-Mashad S, Ehsan N. Trichrome-positive intrahepatic cytoplasmic globules are potential histopathological clue for COVID-19-induced hepatitis: a case report. Egypt Liver J 2021;11:69. [PMID: 34777872 DOI: 10.1186/s43066-021-00140-5] [Reference Citation Analysis]
|
| 378 |
Maarek A. Endothelial and Autonomic Assessments in the Management of COVID-19. OJPM 2021;11:425-438. [DOI: 10.4236/ojpm.2021.1112033] [Reference Citation Analysis]
|
| 379 |
Bobescu E, Marceanu LG, Covaciu A, Vladau LA. Thrombosis, an Important Piece in the COVID-19 Puzzle – From Pathophysiology to Therapy. SSRN Journal. [DOI: 10.2139/ssrn.3796627] [Reference Citation Analysis]
|
| 380 |
Rivera-Caravaca JM, Núñez-Gil IJ, Vivas D, Viana-Llamas MC, Uribarri A, Becerra-Muñoz VM, Trabattoni D, Fernández Rozas I, Feltes G, López-Pais J, El-Battrawy I, Macaya C, Fernandez-Ortiz A, Estrada V, Marín F; HOPE COVID-19 Investigators. Clinical profile and prognosis in patients on oral anticoagulation before admission for COVID-19. Eur J Clin Invest 2021;51:e13436. [PMID: 33080051 DOI: 10.1111/eci.13436] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 13.0] [Reference Citation Analysis]
|
| 381 |
Fedele D, De Francesco A, Riso S, Collo A. Obesity, malnutrition, and trace element deficiency in the coronavirus disease (COVID-19) pandemic: An overview. Nutrition 2021;81:111016. [PMID: 33059127 DOI: 10.1016/j.nut.2020.111016] [Cited by in Crossref: 68] [Cited by in F6Publishing: 37] [Article Influence: 34.0] [Reference Citation Analysis]
|
| 382 |
Gu SX, Tyagi T, Jain K, Gu VW, Lee SH, Hwa JM, Kwan JM, Krause DS, Lee AI, Halene S, Martin KA, Chun HJ, Hwa J. Thrombocytopathy and endotheliopathy: crucial contributors to COVID-19 thromboinflammation. Nat Rev Cardiol 2021;18:194-209. [PMID: 33214651 DOI: 10.1038/s41569-020-00469-1] [Cited by in Crossref: 193] [Cited by in F6Publishing: 204] [Article Influence: 96.5] [Reference Citation Analysis]
|
| 383 |
Salvador Ibarra IJ, Alva Arroyo NV, Ramírez Romero EF, Pizaña Dávila A, Huerta Escobar MG, Gasca Aldama JC. Perfil tromboelastográfico en pacientes con neumonía por SARS-CoV-2**. Medicina Crítica 2021;35:312-318. [DOI: 10.35366/103717] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 384 |
Gil R, Bitar P, Deza C, Dreyse J, Florenzano M, Ibarra C, Jorquera J, Melo J, Olivi H, Parada MT, Rodríguez JC, Undurraga Á. CUADRO CLÍNICO DEL COVID-19. Revista Médica Clínica Las Condes 2021;32:20-9. [DOI: 10.1016/j.rmclc.2020.11.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 385 |
Pivonello R, Auriemma RS, Pivonello C, Isidori AM, Corona G, Colao A, Millar RP. Sex Disparities in COVID-19 Severity and Outcome: Are Men Weaker or Women Stronger? Neuroendocrinology 2021;111:1066-85. [PMID: 33242856 DOI: 10.1159/000513346] [Cited by in Crossref: 48] [Cited by in F6Publishing: 43] [Article Influence: 24.0] [Reference Citation Analysis]
|
| 386 |
Wali AA, Abd-el-fatah SM. Prognosis and Outcomes of COVID-19 infection During Pregnancy. Covid-19 Infections and Pregnancy 2021. [DOI: 10.1016/b978-0-323-90595-4.00003-0] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 387 |
Nooti SK, Rai V, Singh H, Potluri V, Agrawal DK. Strokes, Neurological, and Neuropsychiatric Disorders in COVID-19. Delineating Health and Health System: Mechanistic Insights into Covid 19 Complications 2021. [DOI: 10.1007/978-981-16-5105-2_12] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 388 |
Bartoli A, Gabrielli F, Alicandro T, Nascimbeni F, Andreone P. COVID-19 treatment options: a difficult journey between failed attempts and experimental drugs. Intern Emerg Med 2021;16:281-308. [PMID: 33398609 DOI: 10.1007/s11739-020-02569-9] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 14.5] [Reference Citation Analysis]
|
| 389 |
Mandal AKJ, Kho J, Ioannou A, Van den Abbeele K, Missouris CG. Covid-19 and in situ pulmonary artery thrombosis. Respir Med 2021;176:106176. [PMID: 33092932 DOI: 10.1016/j.rmed.2020.106176] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 390 |
Đenić A. Pulmonary thromboembolism and pericardial effusion as cardiovascular complications of COVID-19 infection. Med gl Spec bol štit Zlatibor 2021;26:34-57. [DOI: 10.5937/medgla2180034q] [Reference Citation Analysis]
|
| 391 |
Lim S, Bae JH, Kwon HS, Nauck MA. COVID-19 and diabetes mellitus: from pathophysiology to clinical management. Nat Rev Endocrinol 2021;17:11-30. [PMID: 33188364 DOI: 10.1038/s41574-020-00435-4] [Cited by in Crossref: 472] [Cited by in F6Publishing: 395] [Article Influence: 236.0] [Reference Citation Analysis]
|
| 392 |
Ağababaoğlu İ, İnci K. Management of COVID-19 in the Intensive Care Unit. Coronavirus Therapeutics – Volume II 2021. [DOI: 10.1007/978-3-030-85113-2_5] [Reference Citation Analysis]
|
| 393 |
Lippi G, Henry BM, Sanchis-Gomar F. Plasma Antithrombin Values Are Significantly Decreased in Coronavirus Disease 2019 (COVID-19) Patients with Severe Illness. Semin Thromb Hemost 2021;47:460-2. [PMID: 33378783 DOI: 10.1055/s-0040-1716873] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 394 |
Englert H, Rangaswamy C, Deppermann C, Sperhake J, Krisp C, Schreier D, Gordon E, Konrath S, Haddad M, Pula G, Mailer RK, Schlüter H, Kluge S, Langer F, Püschel K, Panousis K, Stavrou EX, Maas C, Renné T, Frye M. Defective NET clearance contributes to sustained FXII activation in COVID-19-associated pulmonary thrombo-inflammation.. [DOI: 10.1101/2020.12.29.424644] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 395 |
Formigari R, Marcora S, Luciani GB, Favilli S, Egidy Assenza G, Rinelli G, Meliota G, Castaldi B, Limongelli G, Flocco S, Vairo U; Italian Society of Pediatric Cardiology and Congenital Heart Disease. Resilience and response of the congenital cardiac network in Italy during the COVID-19 pandemic. J Cardiovasc Med (Hagerstown) 2021;22:9-13. [PMID: 32740440 DOI: 10.2459/JCM.0000000000001063] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 396 |
Presnyakova MV, Galova EA, Sosnina LN, Popovicheva AN, Lyubavina NA, Kostina OV, Kuznetsova VL, Karyakin NN. Disturbances of the hemostasis system and expression of inflammatory reaction in patients with new coronaviral pneumonia. Klin Lab Diagn 2020;65:744-9. [PMID: 33373505 DOI: 10.18821/0869-2084-2020-65-12-744-749] [Reference Citation Analysis]
|
| 397 |
Scudiero F, Pitì A, Keim R, Parodi G. Acute pulmonary embolism in COVID-19 patient: a case report of free-floating right heart thrombus successfully treated with fibrinolysis. Eur Heart J Case Rep 2021;5:ytaa388. [PMID: 33542972 DOI: 10.1093/ehjcr/ytaa388] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 398 |
Argañaraz GA, Palmeira JDF, Argañaraz ER. Phosphatidylserine inside out: a possible underlying mechanism in the inflammation and coagulation abnormalities of COVID-19. Cell Commun Signal 2020;18:190. [PMID: 33357215 DOI: 10.1186/s12964-020-00687-7] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 399 |
Vavougios GD, Ntoskas KT, Doskas TK. Impairment in selenocysteine synthesis as a candidate mechanism of inducible coagulopathy in COVID-19 patients. Med Hypotheses 2021;147:110475. [PMID: 33421689 DOI: 10.1016/j.mehy.2020.110475] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 400 |
Jin Y, Ji W, Yang H, Chen S, Zhang W, Duan G. Endothelial activation and dysfunction in COVID-19: from basic mechanisms to potential therapeutic approaches. Signal Transduct Target Ther 2020;5:293. [PMID: 33361764 DOI: 10.1038/s41392-020-00454-7] [Cited by in Crossref: 195] [Cited by in F6Publishing: 204] [Article Influence: 65.0] [Reference Citation Analysis]
|
| 401 |
Levi M, Iba T. COVID-19 coagulopathy: is it disseminated intravascular coagulation? Intern Emerg Med 2021;16:309-12. [PMID: 33368021 DOI: 10.1007/s11739-020-02601-y] [Cited by in Crossref: 42] [Cited by in F6Publishing: 29] [Article Influence: 14.0] [Reference Citation Analysis]
|
| 402 |
Bellos I, Lourida P, Argyraki A, Korompoki E, Zirou C, Kokkinaki I, Pefanis A. Development of a novel risk score for the prediction of critical illness amongst COVID-19 patients. Int J Clin Pract 2021;75:e13915. [PMID: 33969593 DOI: 10.1111/ijcp.13915] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 403 |
Pierpaolo Di Micco, Vincenzo Russo, Novella Carannante, Michele Imparato, Giuseppe Cardillo, Corrado Lodigiani. Prognostic Value of Fibrinogen among COVID-19 Patients Admitted to an Emergency Department: An Italian Cohort Study. J Clin Med 2020;9:4134. [PMID: 33371524 DOI: 10.3390/jcm9124134] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 6.3] [Reference Citation Analysis]
|
| 404 |
Vogrig A, Gigli GL, Bnà C, Morassi M. Stroke in patients with COVID-19: Clinical and neuroimaging characteristics. Neurosci Lett 2021;743:135564. [PMID: 33352277 DOI: 10.1016/j.neulet.2020.135564] [Cited by in Crossref: 54] [Cited by in F6Publishing: 62] [Article Influence: 18.0] [Reference Citation Analysis]
|
| 405 |
Friedrich MS, Studt JD, Braun J, Spahn DR, Kaserer A. Coronavirus-induced coagulopathy during the course of disease. PLoS One 2020;15:e0243409. [PMID: 33332362 DOI: 10.1371/journal.pone.0243409] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 5.7] [Reference Citation Analysis]
|
| 406 |
Kumar S, Mehta S, Sarangdhar N, Ray A, Sinha S, Wig N. Management of COVID-19 from the pulmonologist's perspective: a narrative review. Expert Rev Respir Med 2021;15:519-35. [PMID: 33211553 DOI: 10.1080/17476348.2021.1853529] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 407 |
Corrêa TD, Cordioli RL, Campos Guerra JC, Caldin da Silva B, Dos Reis Rodrigues R, de Souza GM, Midega TD, Campos NS, Carneiro BV, Campos FND, Guimarães HP, de Matos GFJ, de Aranda VF, Rolim Ferraz LJ. Coagulation profile of COVID-19 patients admitted to the ICU: An exploratory study. PLoS One 2020;15:e0243604. [PMID: 33320874 DOI: 10.1371/journal.pone.0243604] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 7.7] [Reference Citation Analysis]
|
| 408 |
Demopoulos C, Antonopoulou S, Theoharides TC. COVID-19, microthromboses, inflammation, and platelet activating factor. Biofactors 2020;46:927-33. [PMID: 33296106 DOI: 10.1002/biof.1696] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 10.0] [Reference Citation Analysis]
|
| 409 |
Khacha A, Bouchal S, Ettabyaoui A, Haloua M, Lamrani YA, Boubbou M, Belahsen F, Maâroufi M, Alami B. Cavernous sinus thrombosis in a COVID-19 patient: A case report. Radiol Case Rep 2021;16:480-2. [PMID: 33318774 DOI: 10.1016/j.radcr.2020.12.013] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 410 |
Truong AD, Auld SC, Barker NA, Friend S, Wynn AT, Cobb J, Sniecinski RM, Tanksley CL, Polly DM, Gaddh M, Connor M, Nakahara H, Sullivan HC, Kempton C, Guarner J, Duncan A, Josephson CD, Roback JD, Stowell SR, Maier CL. Therapeutic plasma exchange for COVID-19-associated hyperviscosity. Transfusion 2021;61:1029-34. [PMID: 33231313 DOI: 10.1111/trf.16218] [Cited by in Crossref: 26] [Cited by in F6Publishing: 30] [Article Influence: 8.7] [Reference Citation Analysis]
|
| 411 |
Xu J, Yang X, Huang C, Zou X, Zhou T, Pan S, Yang L, Wu Y, Ouyang Y, Wang Y, Xu D, Zhao X, Shu H, Jiang Y, Xiong W, Ren L, Liu H, Yuan Y, Qi H, Fu S, Chen D, Zhang D, Yuan S, Shang Y. A Novel Risk-Stratification Models of the High-Flow Nasal Cannula Therapy in COVID-19 Patients With Hypoxemic Respiratory Failure. Front Med (Lausanne) 2020;7:607821. [PMID: 33425951 DOI: 10.3389/fmed.2020.607821] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
|
| 412 |
Hashim HT. The ability of COVID-19 patients' blood to coagulate after withdrawn to EDTA tube: A case report. Cumhuriyet Medical Journal 2020. [DOI: 10.7197/cmj.772643] [Reference Citation Analysis]
|
| 413 |
von Meijenfeldt FA, Havervall S, Adelmeijer J, Lundström A, Rudberg AS, Magnusson M, Mackman N, Thalin C, Lisman T. Prothrombotic changes in patients with COVID-19 are associated with disease severity and mortality. Res Pract Thromb Haemost 2021;5:132-41. [PMID: 33537537 DOI: 10.1002/rth2.12462] [Cited by in Crossref: 42] [Cited by in F6Publishing: 44] [Article Influence: 14.0] [Reference Citation Analysis]
|
| 414 |
Foti G, Giannini A, Bottino N, Castelli GP, Cecconi M, Grasselli G, Guatteri L, Latronico N, Langer T, Monti G, Muttini S, Pesenti A, Radrizzani D, Ranucci M, Russotto V, Fumagalli R; COVID-19 Lombardy ICU Network. Management of critically ill patients with COVID-19: suggestions and instructions from the coordination of intensive care units of Lombardy. Minerva Anestesiol 2020;86:1234-45. [PMID: 33228329 DOI: 10.23736/S0375-9393.20.14762-X] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 6.7] [Reference Citation Analysis]
|
| 415 |
Sharma M, Surani S. Revisiting One of the Dreaded Outcomes of the Current Pandemic: Pulmonary Embolism in COVID-19. Medicina (Kaunas) 2020;56:E670. [PMID: 33287199 DOI: 10.3390/medicina56120670] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 416 |
Al-Horani RA. Potential Therapeutic Roles for Direct Factor Xa Inhibitors in Coronavirus Infections. Am J Cardiovasc Drugs 2020;20:525-33. [PMID: 32918208 DOI: 10.1007/s40256-020-00438-6] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 4.7] [Reference Citation Analysis]
|
| 417 |
Hanff TC, Mohareb AM, Giri J, Cohen JB, Chirinos JA. Thrombosis in COVID-19. Am J Hematol 2020;95:1578-89. [PMID: 32857878 DOI: 10.1002/ajh.25982] [Cited by in Crossref: 125] [Cited by in F6Publishing: 134] [Article Influence: 41.7] [Reference Citation Analysis]
|
| 418 |
Visser C, Sprenger RA, van den Bout HJ, Boer DP, el Moussaoui R, den Hollander JG. Venous thrombotic events in severe and critically COVID-19 patients despite high dose prophylactic low-molecular-weight heparin. Thrombosis Update 2020;1:100006. [DOI: 10.1016/j.tru.2020.100006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 419 |
Sherren PB, Ostermann M, Agarwal S, Meadows CIS, Ioannou N, Camporota L. COVID-19-related organ dysfunction and management strategies on the intensive care unit: a narrative review. Br J Anaesth 2020;125:912-25. [PMID: 32988604 DOI: 10.1016/j.bja.2020.08.050] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 9.7] [Reference Citation Analysis]
|
| 420 |
Yeh CH, de Wit K, Levy JH, Weitz JI, Vaezzadeh N, Liaw PC, Fox-Robichaud A, Soliman K, Kim PY. Hypercoagulability and coronavirus disease 2019-associated hypoxemic respiratory failure: Mechanisms and emerging management paradigms. J Trauma Acute Care Surg 2020;89:e177-81. [PMID: 32890338 DOI: 10.1097/TA.0000000000002938] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 421 |
Thakkar S, Arora S, Kumar A, Jaswaney R, Faisaluddin M, Ammad Ud Din M, Shariff M, Barssoum K, Patel HP, Nirav A, Jani C, Patel K, Savani S, DeSimone C, Mulpuru S, Deshmukh A. A Systematic Review of the Cardiovascular Manifestations and Outcomes in the Setting of Coronavirus-19 Disease. Clin Med Insights Cardiol 2020;14:1179546820977196. [PMID: 33312009 DOI: 10.1177/1179546820977196] [Cited by in Crossref: 21] [Cited by in F6Publishing: 26] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 422 |
Dou Q, Wei X, Zhou K, Yang S, Jia P. Cardiovascular Manifestations and Mechanisms in Patients with COVID-19. Trends Endocrinol Metab 2020;31:893-904. [PMID: 33172748 DOI: 10.1016/j.tem.2020.10.001] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 11.3] [Reference Citation Analysis]
|
| 423 |
Roncon L, Zuin M, Barco S, Valerio L, Zuliani G, Zonzin P, Konstantinides SV. Incidence of acute pulmonary embolism in COVID-19 patients: Systematic review and meta-analysis. Eur J Intern Med 2020;82:29-37. [PMID: 32958372 DOI: 10.1016/j.ejim.2020.09.006] [Cited by in Crossref: 83] [Cited by in F6Publishing: 51] [Article Influence: 27.7] [Reference Citation Analysis]
|
| 424 |
Morris G, Athan E, Walder K, Bortolasci CC, O'Neil A, Marx W, Berk M, Carvalho AF, Maes M, Puri BK. Can endolysosomal deacidification and inhibition of autophagy prevent severe COVID-19? Life Sci 2020;262:118541. [PMID: 33035581 DOI: 10.1016/j.lfs.2020.118541] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 425 |
Al-Ghafry M, Aygun B, Appiah-Kubi A, Vlachos A, Ostovar G, Capone C, Sweberg T, Palumbo N, Goenka P, Wolfe LW, Lipton JM, Acharya SS. Are children with SARS-CoV-2 infection at high risk for thrombosis? Viscoelastic testing and coagulation profiles in a case series of pediatric patients. Pediatr Blood Cancer 2020;67:e28737. [PMID: 33098753 DOI: 10.1002/pbc.28737] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 7.3] [Reference Citation Analysis]
|
| 426 |
Diaz T, Trachtenberg BH, Abraham SJK, KosagiSharaf R, Durant-Archibold AA. Aspirin Bioactivity for Prevention of Cardiovascular Injury in COVID-19. Front Cardiovasc Med 2020;7:562708. [PMID: 33330639 DOI: 10.3389/fcvm.2020.562708] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 427 |
Altuwaijri F, Alotaibi O. Sudden Cardiac Arrest at the Triage of Emergency Medicine Department in a Patient With COVID-19. Cureus 2020. [DOI: 10.7759/cureus.11795] [Reference Citation Analysis]
|
| 428 |
Chalela R, Caguana O, Zuccarino F, Khilzi K, Rodríguez-Chiaradía DA. Case Report on a Patient with Steinert Disease Complicated by COVID-19. Vasc Health Risk Manag 2020;16:463-6. [PMID: 33244235 DOI: 10.2147/VHRM.S266659] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 429 |
Kow CS, Mustafa ZU, Hasan SS. The use of combined hormonal contraceptives amid the COVID-19 pandemic. Eur J Contracept Reprod Health Care 2021;26:85-6. [PMID: 33245006 DOI: 10.1080/13625187.2020.1849618] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 430 |
Franchini M, Marano G, Cruciani M, Mengoli C, Pati I, Masiello F, Veropalumbo E, Pupella S, Vaglio S, Liumbruno GM. COVID-19-associated coagulopathy. Diagnosis (Berl) 2020;7:357-63. [PMID: 32683333 DOI: 10.1515/dx-2020-0078] [Cited by in Crossref: 31] [Cited by in F6Publishing: 36] [Article Influence: 10.3] [Reference Citation Analysis]
|
| 431 |
Zhang X, Yang X, Jiao H, Liu X. Coagulopathy in patients with COVID-19: a systematic review and meta-analysis. Aging (Albany NY) 2020;12:24535-51. [PMID: 33229625 DOI: 10.18632/aging.104138] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 432 |
Sagarra-Romero L, Viñas-Barros A. COVID-19: Short and Long-Term Effects of Hospitalization on Muscular Weakness in the Elderly. Int J Environ Res Public Health 2020;17:E8715. [PMID: 33255233 DOI: 10.3390/ijerph17238715] [Cited by in Crossref: 18] [Cited by in F6Publishing: 22] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 433 |
Dai W, Rao R, Sher A, Tania N, Musante CJ, Allen R. A Prototype QSP Model of the Immune Response to SARS-CoV-2 for Community Development. CPT Pharmacometrics Syst Pharmacol 2021;10:18-29. [PMID: 33217169 DOI: 10.1002/psp4.12574] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 434 |
Valchanov K, Krishnan U, Hoole SP, Davies WR, Pettit S, Jones N, Parmar J, Catarino P, Osman M, Berman M. COVID-19 patient with coronary thrombosis supported with ECMO and Impella 5.0 ventricular assist device: a case report. Eur Heart J Case Rep 2020;4:1-6. [PMID: 33442588 DOI: 10.1093/ehjcr/ytaa342] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 435 |
Streng AS, Delnoij TSR, Mulder MMG, Sels JWEM, Wetzels RJH, Verhezen PWM, Olie RH, Kooman JP, van Kuijk SMJ, Brandts L, Ten Cate H, Lorusso R, van der Horst ICC, van Bussel BCT, Henskens YMC. Monitoring of Unfractionated Heparin in Severe COVID-19: An Observational Study of Patients on CRRT and ECMO. TH Open 2020;4:e365-75. [PMID: 33235946 DOI: 10.1055/s-0040-1719083] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 436 |
Borcherding N, Jethava Y, Vikas P. Repurposing Anti-Cancer Drugs for COVID-19 Treatment. Drug Des Devel Ther 2020;14:5045-58. [PMID: 33239864 DOI: 10.2147/DDDT.S282252] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 6.3] [Reference Citation Analysis]
|
| 437 |
Wang KC, Xiao R, Cheung ZB, Barbera JP, Forsh DA. Early mortality after hip fracture surgery in COVID-19 patients: A systematic review and meta-analysis. J Orthop 2020;22:584-91. [PMID: 33223732 DOI: 10.1016/j.jor.2020.11.012] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 9.0] [Reference Citation Analysis]
|
| 438 |
Eljilany I, Elzouki AN. D-Dimer, Fibrinogen, and IL-6 in COVID-19 Patients with Suspected Venous Thromboembolism: A Narrative Review. Vasc Health Risk Manag 2020;16:455-62. [PMID: 33223833 DOI: 10.2147/VHRM.S280962] [Cited by in Crossref: 42] [Cited by in F6Publishing: 48] [Article Influence: 14.0] [Reference Citation Analysis]
|
| 439 |
Luglio M, Tannuri U, de Carvalho WB, Bastos KLM, Rodriguez IS, Johnston C, Delgado AF. COVID-19 and Liver Damage: Narrative Review and Proposed Clinical Protocol for Critically ill Pediatric Patients. Clinics (Sao Paulo) 2020;75:e2250. [PMID: 33206767 DOI: 10.6061/clinics/2020/e2250] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 440 |
Arigondam AK, Hakeem AR, Reddy MS, Rela M. An Evidence-based Protocol for Minimizing Thromboembolic Events in SARS-CoV-2 Infection. Arch Med Res 2021;52:252-60. [PMID: 33423804 DOI: 10.1016/j.arcmed.2020.11.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 441 |
Piazza G, Campia U, Hurwitz S, Snyder JE, Rizzo SM, Pfeferman MB, Morrison RB, Leiva O, Fanikos J, Nauffal V, Almarzooq Z, Goldhaber SZ. Registry of Arterial and Venous Thromboembolic Complications in Patients With COVID-19. J Am Coll Cardiol 2020;76:2060-72. [PMID: 33121712 DOI: 10.1016/j.jacc.2020.08.070] [Cited by in Crossref: 152] [Cited by in F6Publishing: 158] [Article Influence: 50.7] [Reference Citation Analysis]
|
| 442 |
Al-Subaie AM. Coagulopathies in novel coronavirus (SARS-CoV-2) pandemic: Emerging evidence for hematologists. Saudi J Biol Sci 2021;28:956-61. [PMID: 33169062 DOI: 10.1016/j.sjbs.2020.11.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 443 |
Ionescu F, Jaiyesimi I, Petrescu I, Lawler PR, Castillo E, Munoz-Maldonado Y, Imam Z, Narasimhan M, Abbas AE, Konde A, Nair GB. Association of anticoagulation dose and survival in hospitalized COVID-19 patients: A retrospective propensity score-weighted analysis. Eur J Haematol 2021;106:165-74. [PMID: 33043484 DOI: 10.1111/ejh.13533] [Cited by in Crossref: 40] [Cited by in F6Publishing: 43] [Article Influence: 13.3] [Reference Citation Analysis]
|
| 444 |
Bagate F, Tuffet S, Masi P, Perier F, Razazi K, de Prost N, Carteaux G, Payen D, Mekontso Dessap A. Rescue therapy with inhaled nitric oxide and almitrine in COVID-19 patients with severe acute respiratory distress syndrome. Ann Intensive Care 2020;10:151. [PMID: 33150525 DOI: 10.1186/s13613-020-00769-2] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 6.3] [Reference Citation Analysis]
|
| 445 |
Dobesh PP, Trujillo TC. Coagulopathy, Venous Thromboembolism, and Anticoagulation in Patients with COVID-19. Pharmacotherapy 2020;40:1130-51. [PMID: 33006163 DOI: 10.1002/phar.2465] [Cited by in Crossref: 41] [Cited by in F6Publishing: 43] [Article Influence: 13.7] [Reference Citation Analysis]
|
| 446 |
Michelson EA, Cripps MW, Ray B, Winegar DA, Viola F. Initial clinical experience with the Quantra QStat System in adult trauma patients. Trauma Surg Acute Care Open 2020;5:e000581. [PMID: 33178896 DOI: 10.1136/tsaco-2020-000581] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 447 |
Al-Mufti F, Becker C, Kamal H, Alshammari H, Dodson V, Nuoman R, Dakay K, Cooper J, Gulko E, Kaur G, Sahni R, Scurlock C, Mayer SA, Gandhi CD. Acute Cerebrovascular Disorders and Vasculopathies Associated with Significant Mortality in SARS-CoV-2 Patients Admitted to The Intensive Care Unit in The New York Epicenter. J Stroke Cerebrovasc Dis 2021;30:105429. [PMID: 33276301 DOI: 10.1016/j.jstrokecerebrovasdis.2020.105429] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 448 |
Ranucci M. In Response. Anesth Analg 2020;131:e119-20. [PMID: 33031685 DOI: 10.1213/ANE.0000000000004950] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 449 |
Rauch A, Labreuche J, Lassalle F, Goutay J, Caplan M, Charbonnier L, Rohn A, Jeanpierre E, Dupont A, Duhamel A, Faure K, Lambert M, Kipnis E, Garrigue D, Lenting PJ, Poissy J, Susen S. Coagulation biomarkers are independent predictors of increased oxygen requirements in COVID-19. J Thromb Haemost 2020;18:2942-53. [PMID: 32881304 DOI: 10.1111/jth.15067] [Cited by in Crossref: 64] [Cited by in F6Publishing: 65] [Article Influence: 21.3] [Reference Citation Analysis]
|
| 450 |
Kirksey MA, Yang EI, Kuvadia M, Miller AO. Management Considerations for the COVID-19 Patient with Severe Disease: a Case Scenario and Literature Review. HSS J 2020;16:153-9. [PMID: 33020700 DOI: 10.1007/s11420-020-09789-x] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 451 |
Goodarzi P, Mahdavi F, Mirzaei R, Hasanvand H, Sholeh M, Zamani F, Sohrabi M, Tabibzadeh A, Jeda AS, Niya MHK, Keyvani H, Karampoor S. Coronavirus disease 2019 (COVID-19): Immunological approaches and emerging pharmacologic treatments. Int Immunopharmacol 2020;88:106885. [PMID: 32795893 DOI: 10.1016/j.intimp.2020.106885] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 9.3] [Reference Citation Analysis]
|
| 452 |
Kadir RA, Kobayashi T, Iba T, Erez O, Thachil J, Kazi S, Malinowski AK, Othman M. COVID-19 coagulopathy in pregnancy: Critical review, preliminary recommendations, and ISTH registry-Communication from the ISTH SSC for Women's Health. J Thromb Haemost 2020;18:3086-98. [PMID: 32846051 DOI: 10.1111/jth.15072] [Cited by in Crossref: 42] [Cited by in F6Publishing: 41] [Article Influence: 14.0] [Reference Citation Analysis]
|
| 453 |
Kamel MH, Yin W, Zavaro C, Francis JM, Chitalia VC. Hyperthrombotic Milieu in COVID-19 Patients. Cells 2020;9:E2392. [PMID: 33142844 DOI: 10.3390/cells9112392] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 454 |
Ghafouri S, Rettig M, Kahlon KS. An 89-Year-Old Man with COVID-19-Associated Coagulopathy Presenting with a Prolonged Partial Thromboplastin Time, Lupus Anticoagulant, and a High Titer of Factor VIII Inhibitor. Am J Case Rep 2020;21:e926728. [PMID: 33122620 DOI: 10.12659/AJCR.926728] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 455 |
Fajnzylber J, Regan J, Coxen K, Corry H, Wong C, Rosenthal A, Worrall D, Giguel F, Piechocka-Trocha A, Atyeo C, Fischinger S, Chan A, Flaherty KT, Hall K, Dougan M, Ryan ET, Gillespie E, Chishti R, Li Y, Jilg N, Hanidziar D, Baron RM, Baden L, Tsibris AM, Armstrong KA, Kuritzkes DR, Alter G, Walker BD, Yu X, Li JZ; Massachusetts Consortium for Pathogen Readiness. SARS-CoV-2 viral load is associated with increased disease severity and mortality. Nat Commun. 2020;11:5493. [PMID: 33127906 DOI: 10.1038/s41467-020-19057-5] [Cited by in Crossref: 474] [Cited by in F6Publishing: 490] [Article Influence: 158.0] [Reference Citation Analysis]
|
| 456 |
Kichloo A, Dettloff K, Aljadah M, Albosta M, Jamal S, Singh J, Wani F, Kumar A, Vallabhaneni S, Khan MZ. COVID-19 and Hypercoagulability: A Review. Clin Appl Thromb Hemost 2020;26:1076029620962853. [PMID: 33074732 DOI: 10.1177/1076029620962853] [Cited by in Crossref: 54] [Cited by in F6Publishing: 56] [Article Influence: 18.0] [Reference Citation Analysis]
|
| 457 |
Levy JH, Iba T, Connors JM. Editorial commentary: Vascular injury in acute infections and COVID-19: everything old is new again. Trends Cardiovasc Med 2021;31:6-7. [PMID: 33129973 DOI: 10.1016/j.tcm.2020.10.011] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 458 |
Görlinger K, Dirkmann D, Gandhi A, Simioni P. COVID-19-Associated Coagulopathy and Inflammatory Response: What Do We Know Already and What Are the Knowledge Gaps? Anesth Analg 2020;131:1324-33. [PMID: 33079850 DOI: 10.1213/ANE.0000000000005147] [Cited by in Crossref: 41] [Cited by in F6Publishing: 43] [Article Influence: 13.7] [Reference Citation Analysis]
|
| 459 |
Hasan SS, Radford S, Kow CS, Zaidi STR. Venous thromboembolism in critically ill COVID-19 patients receiving prophylactic or therapeutic anticoagulation: a systematic review and meta-analysis. J Thromb Thrombolysis 2020;50:814-21. [PMID: 32748122 DOI: 10.1007/s11239-020-02235-z] [Cited by in Crossref: 64] [Cited by in F6Publishing: 50] [Article Influence: 21.3] [Reference Citation Analysis]
|
| 460 |
Ranucci M, Sitzia C, Baryshnikova E, Di Dedda U, Cardani R, Martelli F, Corsi Romanelli M. Covid-19-Associated Coagulopathy: Biomarkers of Thrombin Generation and Fibrinolysis Leading the Outcome. J Clin Med 2020;9:E3487. [PMID: 33126772 DOI: 10.3390/jcm9113487] [Cited by in Crossref: 39] [Cited by in F6Publishing: 44] [Article Influence: 13.0] [Reference Citation Analysis]
|
| 461 |
Roberts KA, Colley L, Agbaedeng TA, Ellison-Hughes GM, Ross MD. Vascular Manifestations of COVID-19 - Thromboembolism and Microvascular Dysfunction. Front Cardiovasc Med 2020;7:598400. [PMID: 33195487 DOI: 10.3389/fcvm.2020.598400] [Cited by in Crossref: 40] [Cited by in F6Publishing: 43] [Article Influence: 13.3] [Reference Citation Analysis]
|
| 462 |
Elbeddini A, Gerochi R, Elshahawi A. Evaluation of the prophylaxis and treatment of COVID-associated coagulopathy. J Pharm Policy Pract 2020;13:73. [PMID: 33117545 DOI: 10.1186/s40545-020-00274-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 463 |
Galstyan GM. Coagulopathy in COVID-19. Pulʹmonologiâ (Mosk ) 2020;30:645-657. [DOI: 10.18093/0869-0189-2020-30-5-645-657] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 5.3] [Reference Citation Analysis]
|
| 464 |
Schulman S, Hu Y, Konstantinides S. Venous Thromboembolism in COVID-19. Thromb Haemost 2020;120:1642-53. [PMID: 33099284 DOI: 10.1055/s-0040-1718532] [Cited by in Crossref: 32] [Cited by in F6Publishing: 25] [Article Influence: 10.7] [Reference Citation Analysis]
|
| 465 |
Raimann FJ, Piekarski F, Adam EH, Zacharowski K, Neef V. Safety considerations for the use of Point-Of-Care diagnostics during SARS-CoV-2 pandemic. J Clin Lab Anal 2021;35:e23631. [PMID: 33089548 DOI: 10.1002/jcla.23631] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 466 |
Shu T, Ning W, Wu D, Xu J, Han Q, Huang M, Zou X, Yang Q, Yuan Y, Bie Y, Pan S, Mu J, Han Y, Yang X, Zhou H, Li R, Ren Y, Chen X, Yao S, Qiu Y, Zhang DY, Xue Y, Shang Y, Zhou X. Plasma Proteomics Identify Biomarkers and Pathogenesis of COVID-19. Immunity 2020;53:1108-1122.e5. [PMID: 33128875 DOI: 10.1016/j.immuni.2020.10.008] [Cited by in Crossref: 124] [Cited by in F6Publishing: 140] [Article Influence: 41.3] [Reference Citation Analysis]
|
| 467 |
Morris G, Bortolasci CC, Puri BK, Olive L, Marx W, O'Neil A, Athan E, Carvalho A, Maes M, Walder K, Berk M. Preventing the development of severe COVID-19 by modifying immunothrombosis. Life Sci 2021;264:118617. [PMID: 33096114 DOI: 10.1016/j.lfs.2020.118617] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 9.0] [Reference Citation Analysis]
|
| 468 |
Luo HC, You CY, Lu SW, Fu YQ. Characteristics of coagulation alteration in patients with COVID-19. Ann Hematol 2021;100:45-52. [PMID: 33079220 DOI: 10.1007/s00277-020-04305-x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 9.7] [Reference Citation Analysis]
|
| 469 |
Gąsecka A, Borovac JA, Guerreiro RA, Giustozzi M, Parker W, Caldeira D, Chiva-Blanch G. Thrombotic Complications in Patients with COVID-19: Pathophysiological Mechanisms, Diagnosis, and Treatment. Cardiovasc Drugs Ther 2021;35:215-29. [PMID: 33074525 DOI: 10.1007/s10557-020-07084-9] [Cited by in Crossref: 60] [Cited by in F6Publishing: 69] [Article Influence: 20.0] [Reference Citation Analysis]
|
| 470 |
Negri EM, Piloto BM, Morinaga LK, Jardim CVP, Lamy SAE, Ferreira MA, D'Amico EA, Deheinzelin D. Heparin Therapy Improving Hypoxia in COVID-19 Patients - A Case Series. Front Physiol 2020;11:573044. [PMID: 33192569 DOI: 10.3389/fphys.2020.573044] [Cited by in Crossref: 21] [Cited by in F6Publishing: 32] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 471 |
Essa RA, Ahmed SK. Case Report: Acute lower limb ischemia in a recovered COVID-19 patient. F1000Res 2020;9:1253. [DOI: 10.12688/f1000research.26603.1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 472 |
Revzin MV, Raza S, Warshawsky R, D'Agostino C, Srivastava NC, Bader AS, Malhotra A, Patel RD, Chen K, Kyriakakos C, Pellerito JS. Multisystem Imaging Manifestations of COVID-19, Part 1: Viral Pathogenesis and Pulmonary and Vascular System Complications. Radiographics 2020;40:1574-99. [PMID: 33001783 DOI: 10.1148/rg.2020200149] [Cited by in Crossref: 50] [Cited by in F6Publishing: 52] [Article Influence: 16.7] [Reference Citation Analysis]
|
| 473 |
Siepmann T, Sedghi A, Simon E, Winzer S, Barlinn J, de With K, Mirow L, Wolz M, Gruenewald T, Schroettner P, von Bonin S, Pallesen LP, Rosengarten B, Schubert J, Lohmann T, Machetanz J, Spieth P, Koch T, Bornstein S, Reichmann H, Puetz V, Barlinn K. Increased risk of acute stroke among patients with severe COVID-19: a multicenter study and meta-analysis. Eur J Neurol. 2021;28:238-247. [PMID: 32920964 DOI: 10.1111/ene.14535] [Cited by in Crossref: 39] [Cited by in F6Publishing: 41] [Article Influence: 13.0] [Reference Citation Analysis]
|
| 474 |
Salam S, Mallat J, Elkambergy H. Acute high-risk pulmonary embolism requiring thrombolytic therapy in a COVID-19 pneumonia patient despite intermediate dosing deep vein thromboprophylaxis. Respir Med Case Rep 2020;31:101263. [PMID: 33083223 DOI: 10.1016/j.rmcr.2020.101263] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 475 |
Sharifian-Dorche M, Huot P, Osherov M, Wen D, Saveriano A, Giacomini PS, Antel JP, Mowla A. Neurological complications of coronavirus infection; a comparative review and lessons learned during the COVID-19 pandemic. J Neurol Sci 2020;417:117085. [PMID: 32871412 DOI: 10.1016/j.jns.2020.117085] [Cited by in Crossref: 123] [Cited by in F6Publishing: 129] [Article Influence: 41.0] [Reference Citation Analysis]
|
| 476 |
Cherneva Z, Cherneva R. COVID-19 Associated Coagulopathy and Implications for its Treatment. Acta Medica Bulgarica 2020;47:48-52. [DOI: 10.2478/amb-2020-0035] [Reference Citation Analysis]
|
| 477 |
Tsantes AE, Tsantes AG, Kokoris SI, Bonovas S, Frantzeskaki F, Tsangaris I, Kopterides P. COVID-19 Infection-Related Coagulopathy and Viscoelastic Methods: A Paradigm for Their Clinical Utility in Critical Illness. Diagnostics (Basel) 2020;10:E817. [PMID: 33066390 DOI: 10.3390/diagnostics10100817] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 478 |
Hajra A, Mathai SV, Ball S, Bandyopadhyay D, Veyseh M, Chakraborty S, Lavie CJ, Aronow WS. Management of Thrombotic Complications in COVID-19: An Update. Drugs 2020;80:1553-62. [PMID: 32803670 DOI: 10.1007/s40265-020-01377-x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 33] [Article Influence: 10.0] [Reference Citation Analysis]
|
| 479 |
Kaddoura R, Salam AM. Thrombosis Management and Challenges in COVID-19 Patients Presenting with Acute Coronary Syndromes. Heart Views 2020;21:195-208. [PMID: 33688412 DOI: 10.4103/HEARTVIEWS.HEARTVIEWS_143_20] [Reference Citation Analysis]
|
| 480 |
Wijeratne T, Crewther S. Post-COVID 19 Neurological Syndrome (PCNS); a novel syndrome with challenges for the global neurology community. J Neurol Sci 2020;419:117179. [PMID: 33070003 DOI: 10.1016/j.jns.2020.117179] [Cited by in Crossref: 64] [Cited by in F6Publishing: 39] [Article Influence: 21.3] [Reference Citation Analysis]
|
| 481 |
Rostami M, Mansouritorghabeh H. D-dimer level in COVID-19 infection: a systematic review. Expert Rev Hematol 2020;13:1265-75. [PMID: 32997543 DOI: 10.1080/17474086.2020.1831383] [Cited by in Crossref: 113] [Cited by in F6Publishing: 69] [Article Influence: 37.7] [Reference Citation Analysis]
|
| 482 |
Ari S, Can V, Demir ÖF, Ari H, Ağca FV, Melek M, Çamci S, Dikiş ÖŞ, Huysal K, Türk T. Elevated eosinophil count is related with lower anti-factor Xa activity in COVID-19 patients. J Hematop 2020;:1-10. [PMID: 33046998 DOI: 10.1007/s12308-020-00419-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 483 |
Hadid T, Kafri Z, Al-Katib A. Coagulation and anticoagulation in COVID-19. Blood Rev 2021;47:100761. [PMID: 33067035 DOI: 10.1016/j.blre.2020.100761] [Cited by in Crossref: 56] [Cited by in F6Publishing: 64] [Article Influence: 18.7] [Reference Citation Analysis]
|
| 484 |
Wooding DJ, Bach H. 'Treatment of COVID-19 with convalescent plasma' - Author's reply. Clin Microbiol Infect 2021;27:639-40. [PMID: 33007474 DOI: 10.1016/j.cmi.2020.09.039] [Reference Citation Analysis]
|
| 485 |
Stanworth SJ, New HV, Apelseth TO, Brunskill S, Cardigan R, Doree C, Germain M, Goldman M, Massey E, Prati D, Shehata N, So-Osman C, Thachil J. Effects of the COVID-19 pandemic on supply and use of blood for transfusion. Lancet Haematol 2020;7:e756-64. [PMID: 32628911 DOI: 10.1016/S2352-3026(20)30186-1] [Cited by in Crossref: 150] [Cited by in F6Publishing: 149] [Article Influence: 50.0] [Reference Citation Analysis]
|
| 486 |
Spiezia L, Campello E, Cola M, Poletto F, Cerruti L, Poretto A, Simion C, Cattelan A, Vettor R, Simioni P. More Severe Hypercoagulable State in Acute COVID-19 Pneumonia as Compared With Other Pneumonia. Mayo Clin Proc Innov Qual Outcomes 2020;4:696-702. [PMID: 33024937 DOI: 10.1016/j.mayocpiqo.2020.09.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 487 |
Morris G, Bortolasci CC, Puri BK, Olive L, Marx W, O'Neil A, Athan E, Carvalho AF, Maes M, Walder K, Berk M. The pathophysiology of SARS-CoV-2: A suggested model and therapeutic approach. Life Sci 2020;258:118166. [PMID: 32739471 DOI: 10.1016/j.lfs.2020.118166] [Cited by in Crossref: 60] [Cited by in F6Publishing: 61] [Article Influence: 20.0] [Reference Citation Analysis]
|
| 488 |
Frazer JS, Tyrynis Everden AJ. Emerging patterns of hypercoagulability associated with critical COVID-19: A review. Trends in Anaesthesia and Critical Care 2020;34:4-13. [DOI: 10.1016/j.tacc.2020.07.004] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 489 |
Sokolowska M, Lukasik ZM, Agache I, Akdis CA, Akdis D, Akdis M, Barcik W, Brough HA, Eiwegger T, Eljaszewicz A, Eyerich S, Feleszko W, Gomez-Casado C, Hoffmann-Sommergruber K, Janda J, Jiménez-Saiz R, Jutel M, Knol EF, Kortekaas Krohn I, Kothari A, Makowska J, Moniuszko M, Morita H, O'Mahony L, Nadeau K, Ozdemir C, Pali-Schöll I, Palomares O, Papaleo F, Prunicki M, Schmidt-Weber CB, Sediva A, Schwarze J, Shamji MH, Tramper-Stranders GA, van de Veen W, Untersmayr E. Immunology of COVID-19: Mechanisms, clinical outcome, diagnostics, and perspectives-A report of the European Academy of Allergy and Clinical Immunology (EAACI). Allergy 2020;75:2445-76. [PMID: 32584441 DOI: 10.1111/all.14462] [Cited by in Crossref: 95] [Cited by in F6Publishing: 98] [Article Influence: 31.7] [Reference Citation Analysis]
|
| 490 |
Singhania N, Bansal S, Nimmatoori DP, Ejaz AA, McCullough PA, Singhania G. Current Overview on Hypercoagulability in COVID-19. Am J Cardiovasc Drugs 2020;20:393-403. [PMID: 32748336 DOI: 10.1007/s40256-020-00431-z] [Cited by in Crossref: 108] [Cited by in F6Publishing: 98] [Article Influence: 36.0] [Reference Citation Analysis]
|
| 491 |
Blasi A, von Meijenfeldt FA, Adelmeijer J, Calvo A, Ibañez C, Perdomo J, Reverter JC, Lisman T. In vitro hypercoagulability and ongoing in vivo activation of coagulation and fibrinolysis in COVID-19 patients on anticoagulation. J Thromb Haemost 2020;18:2646-53. [PMID: 32762118 DOI: 10.1111/jth.15043] [Cited by in Crossref: 84] [Cited by in F6Publishing: 87] [Article Influence: 28.0] [Reference Citation Analysis]
|
| 492 |
Sparks MA, South AM, Badley AD, Baker-Smith CM, Batlle D, Bozkurt B, Cattaneo R, Crowley SD, Dell'Italia LJ, Ford AL, Griendling K, Gurley SB, Kasner SE, Murray JA, Nath KA, Pfeffer MA, Rangaswami J, Taylor WR, Garovic VD. Severe Acute Respiratory Syndrome Coronavirus 2, COVID-19, and the Renin-Angiotensin System: Pressing Needs and Best Research Practices. Hypertension 2020;76:1350-67. [PMID: 32981369 DOI: 10.1161/HYPERTENSIONAHA.120.15948] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 12.0] [Reference Citation Analysis]
|
| 493 |
Goette A, Patscheke M, Henschke F, Hammwöhner M. COVID-19-Induced Cytokine Release Syndrome Associated with Pulmonary Vein Thromboses, Atrial Cardiomyopathy, and Arterial Intima Inflammation. TH Open 2020;4:e271-9. [PMID: 32995705 DOI: 10.1055/s-0040-1716717] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 494 |
Ionescu F, Grasso-Knight G, Castillo E, Naeem E, Petrescu I, Imam Z, Patel VK, Narasimhan M, Nair GB. Therapeutic Anticoagulation Delays Death in COVID-19 Patients: Cross-Sectional Analysis of a Prospective Cohort. TH Open 2020;4:e263-70. [PMID: 32995704 DOI: 10.1055/s-0040-1716721] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 495 |
Ferrari E, Sartre B, Squara F, Contenti J, Occelli C, Lemoel F, Levraut J, Doyen D, Dellamonica J, Mondain V, Chirio D, Risso K, Cua E, Orban JC, Ichai C, Labbaoui M, Mossaz B, Moceri P, Appert-Flory A, Fischer F, Toulon P. High Prevalence of Acquired Thrombophilia Without Prognosis Value in Patients With Coronavirus Disease 2019. J Am Heart Assoc 2020;9:e017773. [PMID: 32972320 DOI: 10.1161/JAHA.120.017773] [Cited by in Crossref: 24] [Cited by in F6Publishing: 29] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 496 |
Villa Palacio MI, López Henao E. Alteraciones hematológicas en COVID-19. nova 2020;18:75-9. [DOI: 10.22490/24629448.4189] [Reference Citation Analysis]
|
| 497 |
Osuchowski MF, Aletti F, Cavaillon JM, Flohé SB, Giamarellos-Bourboulis EJ, Huber-Lang M, Relja B, Skirecki T, Szabó A, Maegele M. SARS-CoV-2/COVID-19: Evolving Reality, Global Response, Knowledge Gaps, and Opportunities. Shock 2020;54:416-37. [PMID: 32433217 DOI: 10.1097/SHK.0000000000001565] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 9.0] [Reference Citation Analysis]
|
| 498 |
Kow CS, Hasan SS. [The use of antiplatelet agents for arterial thromboprophylaxis in COVID-19]. Rev Esp Cardiol 2021;74:114-5. [PMID: 32989336 DOI: 10.1016/j.recesp.2020.08.007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 499 |
Shah A, Donovan K, McHugh A, Pandey M, Aaron L, Bradbury CA, Stanworth SJ, Alikhan R, Von Kier S, Maher K, Curry N, Shapiro S, Rowland MJ, Thomas M, Mason R, Holland M, Holmes T, Ware M, Gurney S, McKechnie SR. Thrombotic and haemorrhagic complications in critically ill patients with COVID-19: a multicentre observational study. Crit Care 2020;24:561. [PMID: 32948243 DOI: 10.1186/s13054-020-03260-3] [Cited by in Crossref: 74] [Cited by in F6Publishing: 80] [Article Influence: 24.7] [Reference Citation Analysis]
|
| 500 |
Ramage AE. Potential for Cognitive Communication Impairment in COVID-19 Survivors: A Call to Action for Speech-Language Pathologists. Am J Speech Lang Pathol 2020;29:1821-32. [PMID: 32946270 DOI: 10.1044/2020_AJSLP-20-00147] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 5.7] [Reference Citation Analysis]
|
| 501 |
Oppenheimer BW, Bakker J, Goldring RM, Teter K, Green DL, Berger KI. Increased Dead Space Ventilation and Refractory Hypercapnia in Patients With Coronavirus Disease 2019: A Potential Marker of Thrombosis in the Pulmonary Vasculature. Crit Care Explor 2020;2:e0208. [PMID: 33063042 DOI: 10.1097/CCE.0000000000000208] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 502 |
Garatti A, Castelvecchio S, Daprati A, Molfetta R, Volpe M, De Vincentiis C, Parolari A, Menicanti L. Clinical Course of COVID-19 Infection in Patients Urgently Operated of Cardiac Surgical Procedures. Ann Surg 2020;272:e275-9. [PMID: 32932327 DOI: 10.1097/SLA.0000000000004393] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 503 |
Héctor C, Roberto H, Eugenia FM. Safety and Efficacy of the combined use of ivermectin, dexamethasone, enoxaparin and aspirin against COVID 19.. [DOI: 10.1101/2020.09.10.20191619] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 4.7] [Reference Citation Analysis]
|
| 504 |
Soumya RS, Unni TG, Raghu KG. Impact of COVID-19 on the Cardiovascular System: A Review of Available Reports. Cardiovasc Drugs Ther 2021;35:411-25. [PMID: 32926272 DOI: 10.1007/s10557-020-07073-y] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 6.7] [Reference Citation Analysis]
|
| 505 |
Gerotziafas GT, Catalano M, Colgan MP, Pecsvarady Z, Wautrecht JC, Fazeli B, Olinic DM, Farkas K, Elalamy I, Falanga A, Fareed J, Papageorgiou C, Arellano RS, Agathagelou P, Antic D, Auad L, Banfic L, Bartolomew JR, Benczur B, Bernardo MB, Boccardo F, Cifkova R, Cosmi B, De Marchi S, Dimakakos E, Dimopoulos MA, Dimitrov G, Durand-Zaleski I, Edmonds M, El Nazar EA, Erer D, Esponda OL, Gresele P, Gschwandtner M, Gu Y, Heinzmann M, Hamburg NM, Hamadé A, Jatoi NA, Karahan O, Karetova D, Karplus T, Klein-Weigel P, Kolossvary E, Kozak M, Lefkou E, Lessiani G, Liew A, Marcoccia A, Marshang P, Marakomichelakis G, Matuska J, Moraglia L, Pillon S, Poredos P, Prior M, Salvador DRK, Schlager O, Schernthaner G, Sieron A, Spaak J, Spyropoulos A, Sprynger M, Suput D, Stanek A, Stvrtinova V, Szuba A, Tafur A, Vandreden P, Vardas PE, Vasic D, Vikkula M, Wennberg P, Zhai Z; Scientific Reviewer Committee. Guidance for the Management of Patients with Vascular Disease or Cardiovascular Risk Factors and COVID-19: Position Paper from VAS-European Independent Foundation in Angiology/Vascular Medicine. Thromb Haemost 2020;120:1597-628. [PMID: 32920811 DOI: 10.1055/s-0040-1715798] [Cited by in Crossref: 86] [Cited by in F6Publishing: 68] [Article Influence: 28.7] [Reference Citation Analysis]
|
| 506 |
Pavoni V, Gianesello L, Pazzi M, Stera C, Meconi T, Frigieri FC. Venous thromboembolism and bleeding in critically ill COVID-19 patients treated with higher than standard low molecular weight heparin doses and aspirin: A call to action. Thromb Res 2020;196:313-7. [PMID: 32977129 DOI: 10.1016/j.thromres.2020.09.013] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 10.7] [Reference Citation Analysis]
|
| 507 |
Iba T, Connors JM, Levy JH. The coagulopathy, endotheliopathy, and vasculitis of COVID-19. Inflamm Res 2020;69:1181-9. [PMID: 32918567 DOI: 10.1007/s00011-020-01401-6] [Cited by in Crossref: 202] [Cited by in F6Publishing: 164] [Article Influence: 67.3] [Reference Citation Analysis]
|
| 508 |
Ji HJ, Su Z, Zhao R, Komissarov AA, Yi G, Liu SL, Idell S, Matthay MA. Insufficient hyperfibrinolysis in COVID-19: a systematic review of thrombolysis based on meta-analysis and meta-regression. medRxiv 2020:2020. [PMID: 32935113 DOI: 10.1101/2020.09.07.20190165] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 509 |
Ayan M, Kovelamudi S, Al-Hawwas M. Subacute stent thrombosis in a patient with COVID-19 pneumonia. Proc (Bayl Univ Med Cent) 2020;34:175-7. [PMID: 33456191 DOI: 10.1080/08998280.2020.1812792] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 510 |
Hardy M, Lecompte T, Douxfils J, Lessire S, Dogné JM, Chatelain B, Testa S, Gouin-Thibault I, Gruel Y, Medcalf RL, Ten Cate H, Lippi G, Mullier F. Management of the thrombotic risk associated with COVID-19: guidance for the hemostasis laboratory. Thromb J 2020;18:17. [PMID: 32922211 DOI: 10.1186/s12959-020-00230-1] [Cited by in Crossref: 36] [Cited by in F6Publishing: 40] [Article Influence: 12.0] [Reference Citation Analysis]
|
| 511 |
White D, MacDonald S, Edwards T, Bridgeman C, Hayman M, Sharp M, Cox-Morton S, Duff E, Mahajan S, Moore C, Kirk M, Williams R, Besser M, Thomas W. Evaluation of COVID-19 coagulopathy; laboratory characterization using thrombin generation and nonconventional haemostasis assays. Int J Lab Hematol 2021;43:123-30. [PMID: 32892505 DOI: 10.1111/ijlh.13329] [Cited by in Crossref: 38] [Cited by in F6Publishing: 42] [Article Influence: 12.7] [Reference Citation Analysis]
|
| 512 |
Sebuhyan M, Mirailles R, Crichi B, Frere C, Bonnin P, Bergeron-Lafaurie A, Denis B, Liegeon G, Peyrony O, Farge D; Saint-Louis CORE (COVID-19 RESEARCH) group. How to screen and diagnose deep venous thrombosis (DVT) in patients hospitalized for or suspected of COVID-19 infection, outside the intensive care units. J Med Vasc 2020;45:334-43. [PMID: 33248536 DOI: 10.1016/j.jdmv.2020.08.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 513 |
Qasim Agha O, Berryman R. Acute Splenic Artery Thrombosis and Infarction Associated with COVID-19 Disease. Case Rep Crit Care 2020;2020:8880143. [PMID: 32934849 DOI: 10.1155/2020/8880143] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 4.7] [Reference Citation Analysis]
|
| 514 |
Stattin K, Lipcsey M, Andersson H, Pontén E, Bülow Anderberg S, Gradin A, Larsson A, Lubenow N, von Seth M, Rubertsson S, Hultström M, Frithiof R. Inadequate prophylactic effect of low-molecular weight heparin in critically ill COVID-19 patients. J Crit Care 2020;60:249-52. [PMID: 32920503 DOI: 10.1016/j.jcrc.2020.08.026] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 515 |
Meleveedu KS, Miskovsky J, Meharg J, Abdelrahman A, Tandon R, Moody AE, Dasilva P, Masse G, LaPorte J, Saied Calvino A, Allen G, El-Bizri R, Roberts T, Armenio V, Katz SC. Tocilizumab for severe COVID-19 related illness - A community academic medical center experience. Cytokine X 2020;2:100035. [PMID: 32895645 DOI: 10.1016/j.cytox.2020.100035] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 516 |
Iba T, Levy JH, Levi M, Connors JM, Thachil J. Coagulopathy of Coronavirus Disease 2019. Crit Care Med 2020;48:1358-64. [PMID: 32467443 DOI: 10.1097/CCM.0000000000004458] [Cited by in Crossref: 264] [Cited by in F6Publishing: 303] [Article Influence: 88.0] [Reference Citation Analysis]
|
| 517 |
Loi M, Branchford B, Kim J, Self C, Nuss R. COVID-19 anticoagulation recommendations in children. Pediatr Blood Cancer 2020;67:e28485. [PMID: 32558124 DOI: 10.1002/pbc.28485] [Cited by in Crossref: 37] [Cited by in F6Publishing: 42] [Article Influence: 12.3] [Reference Citation Analysis]
|
| 518 |
Maldonado E, Tao D, Mackey K. Antithrombotic Therapies in COVID-19 Disease: a Systematic Review. J Gen Intern Med 2020;35:2698-706. [PMID: 32556875 DOI: 10.1007/s11606-020-05906-y] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 7.7] [Reference Citation Analysis]
|
| 519 |
Thachil J, Juffermans NP, Ranucci M, Connors JM, Warkentin TE, Ortel TL, Levi M, Iba T, Levy JH. ISTH DIC subcommittee communication on anticoagulation in COVID-19. J Thromb Haemost 2020;18:2138-44. [PMID: 32881336 DOI: 10.1111/jth.15004] [Cited by in Crossref: 48] [Cited by in F6Publishing: 54] [Article Influence: 16.0] [Reference Citation Analysis]
|
| 520 |
Thachil J, Longstaff C, Favaloro EJ, Lippi G, Urano T, Kim PY; SSC Subcommittee on Fibrinolysis of the International Society on Thrombosis and Haemostasis. The need for accurate D-dimer reporting in COVID-19: Communication from the ISTH SSC on fibrinolysis. J Thromb Haemost 2020;18:2408-11. [PMID: 32881272 DOI: 10.1111/jth.14956] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 10.3] [Reference Citation Analysis]
|
| 521 |
Birkeland K, Zimmer R, Kimchi A, Kedan I. Venous Thromboembolism in Hospitalized COVID-19 Patients: Systematic Review. Interact J Med Res 2020;9:e22768. [PMID: 32805702 DOI: 10.2196/22768] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 522 |
Zerwes S, Steinbauer M, Gosslau Y, Warm T, Hyhlik-Dürr A. [COVID-19 infection-Risk of thromboembolic complications]. Gefasschirurgie 2020;:1-6. [PMID: 32905019 DOI: 10.1007/s00772-020-00687-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 523 |
Chhabra ST, Goyal P. Venous Thromboembolism in COVID-19: Are Women Different? Indian Journal of Cardiovascular Disease in Women WINCARS 2020;5:200-208. [DOI: 10.1055/s-0040-1716925] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 524 |
Busetto L, Bettini S, Fabris R, Serra R, Dal Pra C, Maffei P, Rossato M, Fioretto P, Vettor R. Obesity and COVID-19: An Italian Snapshot. Obesity (Silver Spring) 2020;28:1600-5. [PMID: 32463545 DOI: 10.1002/oby.22918] [Cited by in Crossref: 114] [Cited by in F6Publishing: 110] [Article Influence: 38.0] [Reference Citation Analysis]
|
| 525 |
Takkar S, Jyotsna M, Goyal P, Chaudhary A, Vipperla S, Hemalatha Y, Midha V, John M, Kakollu A, Tandon P, Puri S, Anupama H, Priya G, Pinto B, Reddy VP, Irukulla MM, Takkar A, Kaur M, Karak S, Vegesna R, Chhina DK, Kapoor PM, Adapa S. Consensus Scientific Statement on Advisory Working Guidelines and Recommendations for the Female Population in COVID-19 Era by WINCARS. Indian Journal of Cardiovascular Disease in Women WINCARS 2020;5:175-194. [DOI: 10.1055/s-0040-1718607] [Reference Citation Analysis]
|
| 526 |
Acevedo-peña J, Yomayusa-gonzález N, Cantor-cruz F, Pinzón-flórez C, Barrero-garzón L, De-la-hoz-siegler I, Low-padilla E, Ramírez-cerón C, Combariza-vallejo F, Arias-barrera C, Moreno-cortés J, Rozo-vanstrahlen J, Correa-pérez L, Rojas-gambasica J, González-gonzález C, La-rotta-caballero E, Ruíz-talero P, Contreras-páez R, Lineros-montañez A, Ordoñez-cardales J, Escobar-olaya M, Izaguirre-ávila R, Campos-guerra J, Accini-mendoza J, Pizarro-gómez C, Patiño-pérez A, Flores-rodríguez J, Valencia-moreno A, Londoño-villegas A, Saavedra-rodríguez A, Madera-rojas A, Caballero-arteaga A, Díaz-campos A, Correa-rivera F, Mantilla-reinaud A, Becerra-torres Á, Peña-castellanos Á, Reina-soler A, Escobar-suarez B, Patiño-escobar B, Rodríguez-cortés C, Rebolledo-maldonado C, Ocampo-botero C, Rivera-ordoñez C, Saavedra-trujillo C, Figueroa-restrepo C, Agudelo-lópez C, Jaramillo-villegas C, Villaquirán-torres C, Rodríguez-ariza D, Rincón-valenzuela D, Lemus-rojas M, Pinto-pinzón D, Garzón-díaz D, Cubillos-apolinar D, Beltrán-linares E, Kondo-rodríguez E, Yama-mosquera E, Polania-fierro E, Real-urbina E, Rosas-romero A, Mendoza-beltrán F, Guevara-pulido F, Celia-márquez G, Ramos-ramos G, Prada-martínez G, León-basantes G, Liévano-sánchez G, Ortíz-ruíz G, Barreto-garcía G, Ibagón-nieto H, Idrobo-quintero H, Martínez-ramírez I, Solarte-rodríguez I, Quintero-barrios J, Arenas-gamboa J, Pérez-cely J, Castellanos-parada J, Garzón-martínez F, Luna-ríos J, Lara-terán J, Vargas-rodríguez J, Dueñas-villamil R, Bohórquez-reyes V, Martínez-acosta C, Gómez-mesa E, Gaitán-rozo J, Cortes-colorado J, Coral-casas J, Horlandy-gómez L, Bautista-toloza L, Palacios LP, Fajardo-latorre L, Pino-villarreal L, Rojas-puentes L, Rodríguez-sánchez P, Herrera-méndez M, Orozco-levi M, Sosa-briceño M, Moreno-ruíz N, Sáenz-morales O, Amaya-gonzález P, Ramírez-garcía S, Nieto-estrada V, Carballo-zárate V, Abello-polo V. Consenso colombiano para la prevención, el diagnóstico y el tratamiento de condiciones trombóticas en adultos con COVID-19: aplicando el Marco de la Evidencia a la Decisión (EtD) GRADE. Revista Colombiana de Cardiología 2020;27:446-460. [DOI: 10.1016/j.rccar.2020.08.003] [Reference Citation Analysis]
|
| 527 |
van Veenendaal N, Scheeren TWL, Meijer K, van der Voort PHJ. Rotational thromboelastometry to assess hypercoagulability in COVID-19 patients. Thromb Res 2020;196:379-81. [PMID: 32980621 DOI: 10.1016/j.thromres.2020.08.046] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
|
| 528 |
Medcalf RL, Keragala CB, Myles PS. Fibrinolysis and COVID-19: A plasmin paradox. J Thromb Haemost 2020;18:2118-22. [PMID: 32543119 DOI: 10.1111/jth.14960] [Cited by in Crossref: 63] [Cited by in F6Publishing: 66] [Article Influence: 21.0] [Reference Citation Analysis]
|
| 529 |
Chen EC, Zon RL, Battinelli EM, Connors JM. Approach to the Patient with COVID-19-Associated Thrombosis: A Case-Based Review. Oncologist 2020;25:e1500-8. [PMID: 32881209 DOI: 10.1634/theoncologist.2020-0682] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 530 |
Malone RW, Tisdall P, Fremont-Smith P, Liu Y, Huang XP, White KM, Miorin L, Del Olmo EM, Alon A, Delaforge E, Hennecker CD, Wang G, Pottel J, Smith N, Hall JM, Shapiro G, Mittermaier A, Kruse AC, García-Sastre A, Roth BL, Glasspool-Malone J, Ricke DO. COVID-19: Famotidine, Histamine, Mast Cells, and Mechanisms. Res Sq 2020:rs. [PMID: 32702719 DOI: 10.21203/rs.3.rs-30934/v2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 531 |
Marchandot B, Trimaille A, Curtiaud A, Carmona A, Matsushita K, Sato C, Leonard-Lorant I, Sattler L, Grunebaum L, Ohana M, Ohlmann P, Jesel L, Morel O. Staging Severity of COVID-19 according to Hemostatic Abnormalities (CAHA Score). Thromb Haemost 2020;120:1716-9. [PMID: 32862411 DOI: 10.1055/s-0040-1715836] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 532 |
Luo L, Xu M, Du M, Kou H, Liao D, Cheng Z, Mei H, Hu Y. Early coagulation tests predict risk stratification and prognosis of COVID-19. Aging (Albany NY) 2020;12:15918-37. [PMID: 32860672 DOI: 10.18632/aging.103581] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 533 |
Lim SL, Chan KH, Slim J, Guron G, Shaaban HS. COVID-19 Associated Coagulopathy in the Setting of Underlying Malignancy. Cureus 2020. [DOI: 10.7759/cureus.10095] [Reference Citation Analysis]
|
| 534 |
Vitiello A, Pelliccia C, Ferrara F. COVID-19 Patients with Pulmonary Fibrotic Tissue: Clinical Pharmacological Rational of Antifibrotic Therapy.SN Compr Clin Med. 2020;1-4. [PMID: 32875276 DOI: 10.1007/s42399-020-00487-7] [Cited by in Crossref: 25] [Cited by in F6Publishing: 17] [Article Influence: 8.3] [Reference Citation Analysis]
|
| 535 |
Kordzadeh-Kermani E, Khalili H, Karimzadeh I. Pathogenesis, clinical manifestations and complications of coronavirus disease 2019 (COVID-19). Future Microbiol 2020;15:1287-305. [PMID: 32851877 DOI: 10.2217/fmb-2020-0110] [Cited by in Crossref: 56] [Cited by in F6Publishing: 61] [Article Influence: 18.7] [Reference Citation Analysis]
|
| 536 |
Bohn MK, Hall A, Sepiashvili L, Jung B, Steele S, Adeli K. Pathophysiology of COVID-19: Mechanisms Underlying Disease Severity and Progression. Physiology (Bethesda). 2020;35:288-301. [PMID: 32783610 DOI: 10.1152/physiol.00019.2020] [Cited by in Crossref: 88] [Cited by in F6Publishing: 105] [Article Influence: 29.3] [Reference Citation Analysis]
|
| 537 |
Luigetti M, Iorio R, Bentivoglio AR, Tricoli L, Riso V, Marotta J, Piano C, Primiano G, Zileri Del Verme L, Lo Monaco MR, Calabresi P; GEMELLI AGAINST COVID-19 group. Assessment of neurological manifestations in hospitalized patients with COVID-19. Eur J Neurol 2020;27:2322-8. [PMID: 32681611 DOI: 10.1111/ene.14444] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 10.0] [Reference Citation Analysis]
|
| 538 |
Mezalek ZT, Khibri H, Ammouri W, Bouaouad M, Haidour S, Harmouche H, Maamar M, Adnaoui M. COVID-19 Associated Coagulopathy and Thrombotic Complications. Clin Appl Thromb Hemost. 2020;26:1076029620948137. [PMID: 32795186 DOI: 10.1177/1076029620948137] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 539 |
Katneni UK, Alexaki A, Hunt RC, Schiller T, DiCuccio M, Buehler PW, Ibla JC, Kimchi-Sarfaty C. Coagulopathy and Thrombosis as a Result of Severe COVID-19 Infection: A Microvascular Focus. Thromb Haemost 2020;120:1668-79. [PMID: 32838472 DOI: 10.1055/s-0040-1715841] [Cited by in Crossref: 47] [Cited by in F6Publishing: 38] [Article Influence: 15.7] [Reference Citation Analysis]
|
| 540 |
Soleimanian S, Yaghobi R. Harnessing Memory NK Cell to Protect Against COVID-19. Front Pharmacol 2020;11:1309. [PMID: 32973527 DOI: 10.3389/fphar.2020.01309] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 5.7] [Reference Citation Analysis]
|
| 541 |
Martín-Rojas RM, Pérez-Rus G, Delgado-Pinos VE, Domingo-González A, Regalado-Artamendi I, Alba-Urdiales N, Demelo-Rodríguez P, Monsalvo S, Rodríguez-Macías G, Ballesteros M, Osorio-Prendes S, Díez-Martín JL, Pascual Izquierdo C. COVID-19 coagulopathy: An in-depth analysis of the coagulation system. Eur J Haematol 2020;105:741-50. [PMID: 32749010 DOI: 10.1111/ejh.13501] [Cited by in Crossref: 74] [Cited by in F6Publishing: 75] [Article Influence: 24.7] [Reference Citation Analysis]
|
| 542 |
Chatterjee S, Sengupta T, Majumder S, Majumder R. COVID-19: a probable role of the anticoagulant Protein S in managing COVID-19-associated coagulopathy. Aging (Albany NY) 2020;12:15954-61. [PMID: 32826388 DOI: 10.18632/aging.103869] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 5.3] [Reference Citation Analysis]
|
| 543 |
Szelenberger R, Saluk-Bijak J, Bijak M. Ischemic Stroke among the Symptoms Caused by the COVID-19 Infection. J Clin Med 2020;9:E2688. [PMID: 32825182 DOI: 10.3390/jcm9092688] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 544 |
Shahjouei S, Naderi S, Li J, Khan A, Chaudhary D, Farahmand G, Male S, Griessenauer C, Sabra M, Mondello S, Cernigliaro A, Khodadadi F, Dev A, Goyal N, Ranji-Burachaloo S, Olulana O, Avula V, Ebrahimzadeh SA, Alizada O, Hancı MM, Ghorbani A, Vaghefi Far A, Ranta A, Punter M, Ramezani M, Ostadrahimi N, Tsivgoulis G, Fragkou PC, Nowrouzi-Sohrabi P, Karofylakis E, Tsiodras S, Neshin Aghayari Sheikh S, Saberi A, Niemelä M, Rezai Jahromi B, Mowla A, Mashayekhi M, Bavarsad Shahripour R, Sajedi SA, Ghorbani M, Kia A, Rahimian N, Abedi V, Zand R. Risk of stroke in hospitalized SARS-CoV-2 infected patients: A multinational study. EBioMedicine 2020;59:102939. [PMID: 32818804 DOI: 10.1016/j.ebiom.2020.102939] [Cited by in Crossref: 59] [Cited by in F6Publishing: 62] [Article Influence: 19.7] [Reference Citation Analysis]
|
| 545 |
Theoharides TC, Antonopoulou S, Demopoulos CA. Coronavirus 2019, Microthromboses, and Platelet Activating Factor. Clin Ther 2020;42:1850-2. [PMID: 32883529 DOI: 10.1016/j.clinthera.2020.08.006] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
|
| 546 |
Godoy LC, Goligher EC, Lawler PR, Slutsky AS, Zarychanski R. Anticipating and managing coagulopathy and thrombotic manifestations of severe COVID-19. CMAJ 2020;192:E1156-61. [PMID: 32816822 DOI: 10.1503/cmaj.201240] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 547 |
Erdinc B, Raina JS. Spontaneous Retroperitoneal Bleed Coincided With Massive Acute Deep Vein Thrombosis as Initial Presentation of COVID-19. Cureus. 2020;12:e9772. [PMID: 32953290 DOI: 10.7759/cureus.9772] [Cited by in Crossref: 9] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 548 |
Shimonov D, Srivatana V. Peritoneal Dialysis for Acute Kidney Injury during the COVID-19 Pandemic. Clin J Am Soc Nephrol 2020;15:1829-31. [PMID: 32801119 DOI: 10.2215/CJN.09240620] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 549 |
Mohanty SK, Satapathy A, Naidu MM, Mukhopadhyay S, Sharma S, Barton LM, Stroberg E, Duval EJ, Pradhan D, Tzankov A, Parwani AV. Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and coronavirus disease 19 (COVID-19) - anatomic pathology perspective on current knowledge. Diagn Pathol 2020;15:103. [PMID: 32799894 DOI: 10.1186/s13000-020-01017-8] [Cited by in Crossref: 70] [Cited by in F6Publishing: 79] [Article Influence: 23.3] [Reference Citation Analysis]
|
| 550 |
Curran CS, Rivera DR, Kopp JB. COVID-19 Usurps Host Regulatory Networks. Front Pharmacol 2020;11:1278. [PMID: 32922297 DOI: 10.3389/fphar.2020.01278] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 6.3] [Reference Citation Analysis]
|
| 551 |
Suzuki E, Sakai T, Hoshino C, Hirao M, Yamaguchi R, Nakahara R. Assessment of the Need for Early Initiation of Rehabilitation Treatments in Patients with Coronavirus Disease 2019. Prog Rehabil Med 2020;5:20200018. [PMID: 32844131 DOI: 10.2490/prm.20200018] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 552 |
Vyas V, Kanagalingam G, Yadava S, Gambhir HS, Costanza M, Chaudhuri D. Bilateral pulmonary artery thrombectomy with saddle embolism and COVID-19 infection. Proc (Bayl Univ Med Cent) 2020;33:666-7. [PMID: 33100564 DOI: 10.1080/08998280.2020.1799133] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 553 |
Aggarwal M, Dass J, Mahapatra M. Hemostatic Abnormalities in COVID-19: An Update. Indian J Hematol Blood Transfus 2020;:1-11. [PMID: 32837053 DOI: 10.1007/s12288-020-01328-2] [Cited by in Crossref: 18] [Cited by in F6Publishing: 22] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 554 |
Thakkar S, Arora S, Kumar A, Jaswaney R, Faisaluddin M, Ammad Ud Din M, Shariff M, Barssoum K, Patel HP, Nirav A, Jani C, Savani S, Desimone C, Mulpuru S, Deshmukh A. A Systematic Review of the Cardiovascular Manifestations and Outcomes in the Setting of Coronavirus-19 Disease.. [DOI: 10.1101/2020.08.09.20171330] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 555 |
Zhang C, Shen L, Le KJ, Pan MM, Kong LC, Gu ZC, Xu H, Zhang Z, Ge WH, Lin HW. Incidence of Venous Thromboembolism in Hospitalized Coronavirus Disease 2019 Patients: A Systematic Review and Meta-Analysis. Front Cardiovasc Med. 2020;7:151. [PMID: 32850990 DOI: 10.3389/fcvm.2020.00151] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 9.7] [Reference Citation Analysis]
|
| 556 |
Knowlton KU. Pathogenesis of SARS-CoV-2 induced cardiac injury from the perspective of the virus. J Mol Cell Cardiol 2020;147:12-7. [PMID: 32771409 DOI: 10.1016/j.yjmcc.2020.08.002] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 6.7] [Reference Citation Analysis]
|
| 557 |
Java A, Apicelli AJ, Liszewski MK, Coler-Reilly A, Atkinson JP, Kim AH, Kulkarni HS. The complement system in COVID-19: friend and foe? JCI Insight 2020;5:140711. [PMID: 32554923 DOI: 10.1172/jci.insight.140711] [Cited by in Crossref: 199] [Cited by in F6Publishing: 211] [Article Influence: 66.3] [Reference Citation Analysis]
|
| 558 |
Weenink RP, Preckel B, Hulst AH, Hermanides J, de Jong MD, Schlack WS, Stevens MF, Sperna Weiland NH, Hollmann MW. Second Update for Anaesthetists on Clinical Features of COVID-19 Patients and Relevant Management. J Clin Med 2020;9:E2542. [PMID: 32781614 DOI: 10.3390/jcm9082542] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 559 |
D'Souza R, Malhamé I, Teshler L, Acharya G, Hunt BJ, McLintock C. A critical review of the pathophysiology of thrombotic complications and clinical practice recommendations for thromboprophylaxis in pregnant patients with COVID-19. Acta Obstet Gynecol Scand 2020;99:1110-20. [PMID: 32678949 DOI: 10.1111/aogs.13962] [Cited by in Crossref: 38] [Cited by in F6Publishing: 45] [Article Influence: 12.7] [Reference Citation Analysis]
|
| 560 |
Kaur S, Tripathi DM, Yadav A. The Enigma of Endothelium in COVID-19. Front Physiol 2020;11:989. [PMID: 32848893 DOI: 10.3389/fphys.2020.00989] [Cited by in Crossref: 51] [Cited by in F6Publishing: 56] [Article Influence: 17.0] [Reference Citation Analysis]
|
| 561 |
Vernuccio F, Lombardo FP, Cannella R, Panzuto F, Giambelluca D, Arzanauskaite M, Midiri M, Cabassa P. Thromboembolic complications of COVID-19: the combined effect of a pro-coagulant pattern and an endothelial thrombo-inflammatory syndrome. Clin Radiol 2020;75:804-10. [PMID: 32829885 DOI: 10.1016/j.crad.2020.07.019] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
|
| 562 |
Minen F, Hands C, Mustafa MR, Pienaar A, Lillie J. Thrombophilia in Pediatric Patients with Multisystem Inflammatory Syndrome in Children Secondary to Coronavirus Disease 2019 Supported on Extracorporeal Membrane Oxygenation. ASAIO Journal 2021;67:7-11. [DOI: 10.1097/mat.0000000000001270] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 563 |
Ferguson K, Quail N, Kewin P, Blyth KG. COVID-19 associated with extensive pulmonary arterial, intracardiac and peripheral arterial thrombosis. BMJ Case Rep 2020;13:e237460. [PMID: 32747597 DOI: 10.1136/bcr-2020-237460] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 564 |
Thachil J, Tang N, Gando S, Falanga A, Levi M, Clark C, Iba T. Laboratory haemostasis monitoring in COVID-19. J Thromb Haemost 2020;18:2058-60. [PMID: 32324960 DOI: 10.1111/jth.14866] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 565 |
Mazo J, Singh S, Khan Z, Foster A, Komarnitsky E, Nagaraj A, Patel S, Kikkeri V. More than Just Pneumonia: Acute Pulmonary Embolism in Two Middle-Aged Patients with COVID-19. Case Rep Med 2020;2020:4812036. [PMID: 32774385 DOI: 10.1155/2020/4812036] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 566 |
Pasquarelli-do-Nascimento G, Braz-de-Melo HA, Faria SS, Santos IO, Kobinger GP, Magalhães KG. Hypercoagulopathy and Adipose Tissue Exacerbated Inflammation May Explain Higher Mortality in COVID-19 Patients With Obesity. Front Endocrinol (Lausanne) 2020;11:530. [PMID: 32849309 DOI: 10.3389/fendo.2020.00530] [Cited by in Crossref: 52] [Cited by in F6Publishing: 58] [Article Influence: 17.3] [Reference Citation Analysis]
|
| 567 |
Gazzaruso C, Paolozzi E, Valenti C, Brocchetta M, Naldani D, Grignani C, Salvucci F, Marino F, Coppola A, Gallotti P. Association between antithrombin and mortality in patients with COVID-19. A possible link with obesity. Nutr Metab Cardiovasc Dis 2020;30:1914-9. [PMID: 32907762 DOI: 10.1016/j.numecd.2020.07.040] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 11.7] [Reference Citation Analysis]
|
| 568 |
Gürlek D, Özbek NY. Covid 19 Enfeksiyonu Olan Hastalarda Koagülasyon Sistem Anormallikleri. Turkish Journal of Pediatric Disease 2020. [DOI: 10.12956/tchd.757753] [Reference Citation Analysis]
|
| 569 |
South K, McCulloch L, McColl BW, Elkind MS, Allan SM, Smith CJ. Preceding infection and risk of stroke: An old concept revived by the COVID-19 pandemic. Int J Stroke 2020;15:722-32. [PMID: 32618498 DOI: 10.1177/1747493020943815] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 7.7] [Reference Citation Analysis]
|
| 570 |
Kho J, Ioannou A, Van den Abbeele K, Mandal AKJ, Missouris CG. Pulmonary embolism in COVID-19: Clinical characteristics and cardiac implications. Am J Emerg Med 2020;38:2142-6. [PMID: 33046316 DOI: 10.1016/j.ajem.2020.07.054] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 5.3] [Reference Citation Analysis]
|
| 571 |
Boscolo A, Spiezia L, Correale C, Sella N, Pesenti E, Beghetto L, Campello E, Poletto F, Cerruti L, Cola M, De Cassai A, Pasin L, Eugenio S, Vettor R, Cattelan AM, Simioni P, Navalesi P. Different Hypercoagulable Profiles in Patients with COVID-19 Admitted to the Internal Medicine Ward and the Intensive Care Unit. Thromb Haemost 2020;120:1474-7. [DOI: 10.1055/s-0040-1714350] [Cited by in Crossref: 192] [Cited by in F6Publishing: 89] [Article Influence: 64.0] [Reference Citation Analysis]
|
| 572 |
Al-Horani RA, Kar S, Aliter KF. Potential Anti-COVID-19 Therapeutics that Block the Early Stage of the Viral Life Cycle: Structures, Mechanisms, and Clinical Trials. Int J Mol Sci 2020;21:E5224. [PMID: 32718020 DOI: 10.3390/ijms21155224] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 9.3] [Reference Citation Analysis]
|
| 573 |
Gosling AF, Bose S, Gomez E, Parikh M, Cook C, Sarge T, Shaefi S, Leibowitz A. Perioperative Considerations for Tracheostomies in the Era of COVID-19. Anesth Analg 2020;131:378-86. [PMID: 32459668 DOI: 10.1213/ANE.0000000000005009] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 6.3] [Reference Citation Analysis]
|
| 574 |
Sultan S, Acharya Y. Antimalarial and cytotoxic drugs on COVID-19 and the cardiovascular burden: Literature review and lessons to be learned. Vascular 2021;29:220-7. [PMID: 32691699 DOI: 10.1177/1708538120941635] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 575 |
Collett LW, Gluck S, Strickland RM, Reddi BJ. Evaluation of coagulation status using viscoelastic testing in intensive care patients with coronavirus disease 2019 (COVID-19): An observational point prevalence cohort study. Aust Crit Care 2021;34:155-9. [PMID: 32773357 DOI: 10.1016/j.aucc.2020.07.003] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 576 |
Nishiga M, Wang DW, Han Y, Lewis DB, Wu JC. COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives. Nat Rev Cardiol. 2020;17:543-558. [PMID: 32690910 DOI: 10.1038/s41569-020-0413-9] [Cited by in Crossref: 653] [Cited by in F6Publishing: 700] [Article Influence: 217.7] [Reference Citation Analysis]
|
| 577 |
Fajnzylber J, Regan J, Coxen K, Corry H, Wong C, Rosenthal A, Worrall D, Giguel F, Piechocka-trocha A, Atyeo C, Fischinger S, Chan A, Flaherty KT, Hall K, Dougan M, Ryan ET, Gillespie E, Chishti R, Li Y, Jilg N, Hanidziar D, Baron RM, Baden L, Tsibris AM, Armstrong KA, Kuritzkes DR, Alter G, Walker BD, Yu X, Li JZ, for the Massachusetts Consortium for Pathogen Readiness. SARS-CoV-2 Viral Load is Associated with Increased Disease Severity and Mortality.. [DOI: 10.1101/2020.07.15.20131789] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 578 |
Allegra A, Innao V, Allegra AG, Musolino C. Coagulopathy and thromboembolic events in patients with SARS-CoV-2 infection: pathogenesis and management strategies. Ann Hematol 2020;99:1953-65. [PMID: 32671455 DOI: 10.1007/s00277-020-04182-4] [Cited by in Crossref: 32] [Cited by in F6Publishing: 22] [Article Influence: 10.7] [Reference Citation Analysis]
|
| 579 |
Mackman N, Antoniak S, Wolberg AS, Kasthuri R, Key NS. Coagulation Abnormalities and Thrombosis in Patients Infected With SARS-CoV-2 and Other Pandemic Viruses. Arterioscler Thromb Vasc Biol 2020;40:2033-44. [PMID: 32657623 DOI: 10.1161/ATVBAHA.120.314514] [Cited by in Crossref: 106] [Cited by in F6Publishing: 108] [Article Influence: 35.3] [Reference Citation Analysis]
|
| 580 |
Dicker D, Bettini S, Farpour-Lambert N, Frühbeck G, Golan R, Goossens G, Halford J, O'Malley G, Mullerova D, Ramos Salas X, Hassapiou MN, Sagen J, Woodward E, Yumuk V, Busetto L. Obesity and COVID-19: The Two Sides of the Coin. Obes Facts 2020;13:430-8. [PMID: 32659766 DOI: 10.1159/000510005] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 11.7] [Reference Citation Analysis]
|
| 581 |
Marietta M, Coluccio V, Luppi M. COVID-19, coagulopathy and venous thromboembolism: more questions than answers. Intern Emerg Med 2020;15:1375-87. [PMID: 32653981 DOI: 10.1007/s11739-020-02432-x] [Cited by in Crossref: 56] [Cited by in F6Publishing: 45] [Article Influence: 18.7] [Reference Citation Analysis]
|
| 582 |
Ahmed S, Zimba O, Gasparyan AY. Thrombosis in Coronavirus disease 2019 (COVID-19) through the prism of Virchow's triad. Clin Rheumatol. 2020;39:2529-2543. [PMID: 32654082 DOI: 10.1007/s10067-020-05275-1] [Cited by in Crossref: 122] [Cited by in F6Publishing: 95] [Article Influence: 40.7] [Reference Citation Analysis]
|
| 583 |
Cavagna E, Muratore F, Ferrari F. Pulmonary Thromboembolism in COVID-19: Venous Thromboembolism or Arterial Thrombosis? Radiol Cardiothorac Imaging 2020;2:e200289. [PMID: 33778609 DOI: 10.1148/ryct.2020200289] [Cited by in Crossref: 28] [Cited by in F6Publishing: 31] [Article Influence: 9.3] [Reference Citation Analysis]
|
| 584 |
Zerwes S, Hernandez Cancino F, Liebetrau D, Gosslau Y, Warm T, Märkl B, Hyhlik-Dürr A. [Increased risk of deep vein thrombosis in intensive care unit patients with CoViD-19 infections?-Preliminary data]. Chirurg 2020;91:588-94. [PMID: 32504106 DOI: 10.1007/s00104-020-01222-7] [Cited by in Crossref: 15] [Cited by in F6Publishing: 19] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 585 |
Baker SA, Kwok S, Berry GJ, Montine TJ. Angiotensin-converting enzyme 2 (ACE2) expression increases with age in patients requiring mechanical ventilation.. [DOI: 10.1101/2020.07.05.20140467] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 586 |
FitzGerald ES, Jamieson AM. Unique transcriptional changes in coagulation cascade genes in SARS-CoV-2-infected lung epithelial cells: A potential factor in COVID-19 coagulopathies. bioRxiv 2020:2020. [PMID: 32676594 DOI: 10.1101/2020.07.06.182972] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 587 |
Thachil J, Cushman M, Srivastava A. A proposal for staging COVID-19 coagulopathy. Res Pract Thromb Haemost 2020;4:731-6. [PMID: 32685880 DOI: 10.1002/rth2.12372] [Cited by in Crossref: 63] [Cited by in F6Publishing: 66] [Article Influence: 21.0] [Reference Citation Analysis]
|
| 588 |
Galanis N, Stavraka C, Agathangelidis F, Petsatodis E, Giankoulof C, Givissis P. Coagulopathy in COVID-19 infection: a case of acute upper limb ischemia. J Surg Case Rep. 2020;2020:rjaa204. [PMID: 32661487 DOI: 10.1093/jscr/rjaa204] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 5.7] [Reference Citation Analysis]
|
| 589 |
Connors JM, Levy JH. Thromboinflammation and the hypercoagulability of COVID-19. J Thromb Haemost 2020;18:1559-61. [PMID: 32302453 DOI: 10.1111/jth.14849] [Cited by in Crossref: 412] [Cited by in F6Publishing: 429] [Article Influence: 137.3] [Reference Citation Analysis]
|
| 590 |
Bourgonje AR, Abdulle AE, Timens W, Hillebrands JL, Navis GJ, Gordijn SJ, Bolling MC, Dijkstra G, Voors AA, Osterhaus AD, van der Voort PH, Mulder DJ, van Goor H. Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19). J Pathol 2020;251:228-48. [PMID: 32418199 DOI: 10.1002/path.5471] [Cited by in Crossref: 566] [Cited by in F6Publishing: 581] [Article Influence: 188.7] [Reference Citation Analysis]
|
| 591 |
Almazeedi S, Al-Youha S, Jamal MH, Al-Haddad M, Al-Muhaini A, Al-Ghimlas F, Al-Sabah S. Characteristics, risk factors and outcomes among the first consecutive 1096 patients diagnosed with COVID-19 in Kuwait. EClinicalMedicine 2020;24:100448. [PMID: 32766546 DOI: 10.1016/j.eclinm.2020.100448] [Cited by in Crossref: 97] [Cited by in F6Publishing: 96] [Article Influence: 32.3] [Reference Citation Analysis]
|
| 592 |
Lüke F, Orsó E, Kirsten J, Poeck H, Grube M, Wolff D, Burkhardt R, Lunz D, Lubnow M, Schmidt B, Hitzenbichler F, Hanses F, Salzberger B, Evert M, Herr W, Brochhausen C, Pukrop T, Reichle A, Heudobler D. Coronavirus disease 2019 induces multi-lineage, morphologic changes in peripheral blood cells. EJHaem 2020. [PMID: 32838398 DOI: 10.1002/jha2.44] [Cited by in Crossref: 15] [Cited by in F6Publishing: 21] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 593 |
Lobastov KV, Schastlivtsev IV, Porembskaya OY, Dzenina OV, Bargandzhiya AB, Tsaplin SN. COVID-19-associated coagulopathy: review of current recommendations for diagnosis, treatment and prevention. Ambulatornaya khirurgiya 2020. [DOI: 10.21518/1995-1477-2020-3-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 594 |
Polidoro RB, Hagan RS, de Santis Santiago R, Schmidt NW. Overview: Systemic Inflammatory Response Derived From Lung Injury Caused by SARS-CoV-2 Infection Explains Severe Outcomes in COVID-19. Front Immunol 2020;11:1626. [PMID: 32714336 DOI: 10.3389/fimmu.2020.01626] [Cited by in Crossref: 87] [Cited by in F6Publishing: 91] [Article Influence: 29.0] [Reference Citation Analysis]
|
| 595 |
Nasonov EL. IMMUNOPATHOLOGY AND IMMUNOPHARMACOTHERAPY OF CORONAVIRUS DISEASE 2019 (COVID-19): FOCUS ON INTERLEUKIN 6. Naučno-praktičeskaâ revmatologiâ 2020;58:245-61. [DOI: 10.14412/1995-4484-2020-245-261] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 596 |
Tralongo AC, Extermann M. Older patients with cancer and febrile neutropenia in the COVID-19 era: A new concern. J Geriatr Oncol 2020;11:1329-30. [PMID: 32571666 DOI: 10.1016/j.jgo.2020.06.021] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 597 |
Savioli F, Rocha LL. Coagulation profile in severe COVID-19 patients: what do we know so far? Rev Bras Ter Intensiva 2020;32:197-9. [PMID: 32667446 DOI: 10.5935/0103-507x.20200031] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 598 |
Fiore A, de Roux Q, Daami N, Clariot S, Folliguet T, Taccone FS, Mongardon N. Clinical feedback from experience with COVID-19: Specific considerations for extracorporeal membrane oxygenation. J Infect 2020;81:e59-60. [PMID: 32579990 DOI: 10.1016/j.jinf.2020.06.050] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 599 |
Abou-Ismail MY, Diamond A, Kapoor S, Arafah Y, Nayak L. The hypercoagulable state in COVID-19: Incidence, pathophysiology, and management. Thromb Res 2020;194:101-15. [PMID: 32788101 DOI: 10.1016/j.thromres.2020.06.029] [Cited by in Crossref: 283] [Cited by in F6Publishing: 218] [Article Influence: 94.3] [Reference Citation Analysis]
|
| 600 |
Ghannam M, Alshaer Q, Al-Chalabi M, Zakarna L, Robertson J, Manousakis G. Neurological involvement of coronavirus disease 2019: a systematic review. J Neurol 2020;267:3135-53. [PMID: 32561990 DOI: 10.1007/s00415-020-09990-2] [Cited by in Crossref: 60] [Cited by in F6Publishing: 75] [Article Influence: 20.0] [Reference Citation Analysis]
|
| 601 |
Lechowicz K, Drożdżal S, Machaj F, Rosik J, Szostak B, Zegan-Barańska M, Biernawska J, Dabrowski W, Rotter I, Kotfis K. COVID-19: The Potential Treatment of Pulmonary Fibrosis Associated with SARS-CoV-2 Infection. J Clin Med 2020;9:E1917. [PMID: 32575380 DOI: 10.3390/jcm9061917] [Cited by in Crossref: 89] [Cited by in F6Publishing: 94] [Article Influence: 29.7] [Reference Citation Analysis]
|
| 602 |
Polat V, Bostancı Gİ. Sudden death due to acute pulmonary embolism in a young woman with COVID-19. J Thromb Thrombolysis 2020;50:239-41. [PMID: 32394237 DOI: 10.1007/s11239-020-02132-5] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 603 |
Naidich JJ, Boltyenkov A, Wang JJ, Chusid J, Hughes D, Sanelli PC. Coronavirus Disease 2019 (COVID-19) Pandemic Shifts Inpatient Imaging Utilization. J Am Coll Radiol 2020;17:1289-98. [PMID: 32622817 DOI: 10.1016/j.jacr.2020.06.011] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 604 |
Kow CS, Hasan SS. Use of low-molecular-weight heparin in COVID-19 patients. J Vasc Surg Venous Lymphat Disord 2020;8:900-1. [PMID: 32561464 DOI: 10.1016/j.jvsv.2020.06.006] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 605 |
Ribes A, Vardon-Bounes F, Mémier V, Poette M, Au-Duong J, Garcia C, Minville V, Sié P, Bura-Rivière A, Voisin S, Payrastre B. Thromboembolic events and Covid-19. Adv Biol Regul 2020;77:100735. [PMID: 32773098 DOI: 10.1016/j.jbior.2020.100735] [Cited by in Crossref: 39] [Cited by in F6Publishing: 44] [Article Influence: 13.0] [Reference Citation Analysis]
|
| 606 |
Costa A, Weinstein ES, Sahoo DR, Thompson SC, Faccincani R, Ragazzoni L. How to Build the Plane While Flying: VTE/PE Thromboprophylaxis Clinical Guidelines for COVID-19 Patients. Disaster Med Public Health Prep 2020;14:391-405. [PMID: 32613929 DOI: 10.1017/dmp.2020.195] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 607 |
Thachil J, Agarwal S. Understanding the COVID-19 coagulopathy spectrum. Anaesthesia 2020;75:1432-6. [PMID: 32437586 DOI: 10.1111/anae.15141] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 10.3] [Reference Citation Analysis]
|
| 608 |
Gravell RJ, Theodoreson MD, Buonsenso D, Curtis J. Radiological manifestations of COVID-19: key points for the physician. Br J Hosp Med (Lond). 2020;81:1-11. [PMID: 32589534 DOI: 10.12968/hmed.2020.0231] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 609 |
Orsucci D, Ienco EC, Nocita G, Napolitano A, Vista M. Neurological features of COVID-19 and their treatment: a review. Drugs Context 2020;9:2020-5-1. [PMID: 32587625 DOI: 10.7573/dic.2020-5-1] [Cited by in Crossref: 46] [Cited by in F6Publishing: 53] [Article Influence: 15.3] [Reference Citation Analysis]
|
| 610 |
Pal A, Pawar A, Goswami K, Sharma P, Prasad R. Hydroxychloroquine and Covid-19: A Cellular and Molecular Biology Based Update. Indian J Clin Biochem 2020;35:274-84. [PMID: 32641874 DOI: 10.1007/s12291-020-00900-x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
|
| 611 |
Radke RM, Frenzel T, Baumgartner H, Diller GP. Adult congenital heart disease and the COVID-19 pandemic. Heart 2020;106:1302-9. [PMID: 32522822 DOI: 10.1136/heartjnl-2020-317258] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 12.3] [Reference Citation Analysis]
|
| 612 |
Gervaise A, Bouzad C, Peroux E, Helissey C. Acute pulmonary embolism in non-hospitalized COVID-19 patients referred to CTPA by emergency department. Eur Radiol 2020;30:6170-7. [PMID: 32518989 DOI: 10.1007/s00330-020-06977-5] [Cited by in Crossref: 66] [Cited by in F6Publishing: 71] [Article Influence: 22.0] [Reference Citation Analysis]
|
| 613 |
Petrak RM, Skorodin NC, Van Hise NW, Fliegelman RM, Pinsky J, Didwania V, Anderson M, Diaz M, Shah K, Chundi VV, Hines DW, Harting BP, Sidwha K, Yu B, Brune P, Owaisi A, Beezhold D, Kent J, Vais D, Han A, Gowda N, Sahgal N, Silverman J, Stake J, Nepomuceno J, Heddurshetti R. Tocilizumab as a Therapeutic Agent for Critically Ill Patients Infected with SARS-CoV-2.. [DOI: 10.1101/2020.06.05.20122622] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 614 |
Whisenant JG, Trama A, Torri V, De Toma A, Viscardi G, Cortellini A, Michielin O, Barlesi F, Dingemans AC, Van Meerbeeck J, Pancaldi V, Soo RA, Leighl NB, Peters S, Wakelee H, Garassino MC, Horn L. TERAVOLT: Thoracic Cancers International COVID-19 Collaboration. Cancer Cell 2020;37:742-5. [PMID: 32425702 DOI: 10.1016/j.ccell.2020.05.008] [Cited by in Crossref: 38] [Cited by in F6Publishing: 32] [Article Influence: 12.7] [Reference Citation Analysis]
|
| 615 |
van Dam LF, Kroft LJM, van der Wal LI, Cannegieter SC, Eikenboom J, de Jonge E, Huisman MV, Klok FA. Clinical and computed tomography characteristics of COVID-19 associated acute pulmonary embolism: A different phenotype of thrombotic disease? Thromb Res 2020;193:86-9. [PMID: 32531548 DOI: 10.1016/j.thromres.2020.06.010] [Cited by in Crossref: 110] [Cited by in F6Publishing: 122] [Article Influence: 36.7] [Reference Citation Analysis]
|
| 616 |
Maier CL, Truong AD, Auld SC, Polly DM, Tanksley CL, Duncan A. COVID-19-associated hyperviscosity: a link between inflammation and thrombophilia? Lancet 2020;395:1758-9. [PMID: 32464112 DOI: 10.1016/S0140-6736(20)31209-5] [Cited by in Crossref: 153] [Cited by in F6Publishing: 145] [Article Influence: 51.0] [Reference Citation Analysis]
|
| 617 |
Langer F, Kluge S, Klamroth R, Oldenburg J. Coagulopathy in COVID-19 and Its Implication for Safe and Efficacious Thromboprophylaxis. Hamostaseologie 2020;40:264-9. [PMID: 32498097 DOI: 10.1055/a-1178-3551] [Cited by in Crossref: 58] [Cited by in F6Publishing: 47] [Article Influence: 19.3] [Reference Citation Analysis]
|
| 618 |
Moores LK, Tritschler T, Brosnahan S, Carrier M, Collen JF, Doerschug K, Holley AB, Jimenez D, Le Gal G, Rali P, Wells P. Prevention, Diagnosis, and Treatment of VTE in Patients With Coronavirus Disease 2019: CHEST Guideline and Expert Panel Report. Chest 2020;158:1143-63. [PMID: 32502594 DOI: 10.1016/j.chest.2020.05.559] [Cited by in Crossref: 402] [Cited by in F6Publishing: 435] [Article Influence: 134.0] [Reference Citation Analysis]
|
| 619 |
Spagnolo P, Cozzi A, Foà RA, Spinazzola A, Monfardini L, Bnà C, Alì M, Schiaffino S, Sardanelli F. CT-derived pulmonary vascular metrics and clinical outcome in COVID-19 patients. Quant Imaging Med Surg 2020;10:1325-33. [PMID: 32550141 DOI: 10.21037/qims-20-546] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 620 |
Marchandot B, Sattler L, Jesel L, Matsushita K, Schini-Kerth V, Grunebaum L, Morel O. COVID-19 Related Coagulopathy: A Distinct Entity? J Clin Med 2020;9:E1651. [PMID: 32486469 DOI: 10.3390/jcm9061651] [Cited by in Crossref: 67] [Cited by in F6Publishing: 71] [Article Influence: 22.3] [Reference Citation Analysis]
|
| 621 |
Morgan K, Samuel K, Vandeputte M, Hayes PC, Plevris JN. SARS-CoV-2 Infection and the Liver. Pathogens. 2020;9. [PMID: 32486188 DOI: 10.3390/pathogens9060430] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 9.7] [Reference Citation Analysis]
|
| 622 |
Al-Ani F, Chehade S, Lazo-Langner A. Thrombosis risk associated with COVID-19 infection. A scoping review. Thromb Res 2020;192:152-60. [PMID: 32485418 DOI: 10.1016/j.thromres.2020.05.039] [Cited by in Crossref: 218] [Cited by in F6Publishing: 172] [Article Influence: 72.7] [Reference Citation Analysis]
|
| 623 |
Bonny V, Maillard A, Mousseaux C, Plaçais L, Richier Q. [COVID-19: Pathogenesis of a multi-faceted disease]. Rev Med Interne 2020;41:375-89. [PMID: 32507520 DOI: 10.1016/j.revmed.2020.05.003] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 624 |
Sakka M, Connors JM, Hékimian G, Martin-Toutain I, Crichi B, Colmegna I, Bonnefont-Rousselot D, Farge D, Frere C. Association between D-Dimer levels and mortality in patients with coronavirus disease 2019 (COVID-19): a systematic review and pooled analysis. J Med Vasc 2020;45:268-74. [PMID: 32862984 DOI: 10.1016/j.jdmv.2020.05.003] [Cited by in Crossref: 21] [Cited by in F6Publishing: 29] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 625 |
Duroi I, Van Durme F, Bruyns T, Louage S, Heyse A. Fatal Ischaemic Stroke During COVID-19 and Acute Lung Injury. Eur J Case Rep Intern Med 2020;7:001732. [PMID: 32523931 DOI: 10.12890/2020_001732] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 626 |
Prieto-Lobato A, Ramos-Martínez R, Vallejo-Calcerrada N, Corbí-Pascual M, Córdoba-Soriano JG. A Case Series of Stent Thrombosis During the COVID-19 Pandemic. JACC Case Rep 2020;2:1291-6. [PMID: 32835270 DOI: 10.1016/j.jaccas.2020.05.024] [Cited by in Crossref: 34] [Cited by in F6Publishing: 39] [Article Influence: 11.3] [Reference Citation Analysis]
|
| 627 |
Moore HB, Barrett CD, Moore EE, Jhunjhnuwala R, McIntyre RC, Moore PK, Wang J, Hajizadeh N, Talmor DS, Sauaia A, Yaffe MB. STudy of Alteplase for Respiratory failure in SARS-Cov2/COVID-19: Study Design of the Phase IIa STARS Trial. Res Pract Thromb Haemost 2020. [PMID: 32838109 DOI: 10.1002/rth2.12395] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 628 |
Shaw R, Tighe N, Odegard KC, Alexander P, Emani S, Yuki K. Intubation precautions in a pediatric patient with severe COVID-19. J Pediatr Surg Case Rep 2020;58:101495. [PMID: 32455111 DOI: 10.1016/j.epsc.2020.101495] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 629 |
Woolsey C, Borisevich V, Prasad AN, Agans KN, Deer DJ, Dobias NS, Heymann JC, Foster SL, Levine CB, Medina L, Melody K, Geisbert JB, Fenton KA, Geisbert TW, Cross RW. Establishment of an African green monkey model for COVID-19. bioRxiv 2020:2020. [PMID: 32511377 DOI: 10.1101/2020.05.17.100289] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 12.0] [Reference Citation Analysis]
|
| 630 |
Kazi S, Malinowski AK, Othman M. The delights and perils of publishing, knowledge-sharing and critique during a pandemic: Observations from COVID-19 coagulopathies. Thromb Res 2020;192:37-9. [PMID: 32425263 DOI: 10.1016/j.thromres.2020.05.023] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 631 |
Puzzitiello RN, Pagani NR, Moverman MA, Moon AS, Menendez ME, Ryan SP. Inflammatory and Coagulative Considerations for the Management of Orthopaedic Trauma Patients With COVID-19: A Review of the Current Evidence and Our Surgical Experience. J Orthop Trauma 2020;34:389-94. [PMID: 32427809 DOI: 10.1097/BOT.0000000000001842] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 632 |
Raucci F, Mansour AA, Casillo GM, Saviano A, Caso F, Scarpa R, Mascolo N, Iqbal AJ, Maione F. Interleukin-17A (IL-17A), a key molecule of innate and adaptive immunity, and its potential involvement in COVID-19-related thrombotic and vascular mechanisms. Autoimmun Rev 2020;19:102572. [PMID: 32376393 DOI: 10.1016/j.autrev.2020.102572] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 12.3] [Reference Citation Analysis]
|
| 633 |
Cordero A, Escribano D, Bertomeu-gonzález V. Complicaciones cardiovasculares y pronóstico en pacientes con COVID-19. Revista Española de Cardiología Suplementos 2020;20:9-13. [DOI: 10.1016/s1131-3587(20)30029-7] [Reference Citation Analysis]
|
| 634 |
Bulanov A, Bulanova E, Simarova I, Bovt E, Eliseeva O, Panteleev M, Rumyantsev A, Ataullakhanov F, Karamzin S. Hemostasis system in COVID-19 patients with heparin therapy. Profil med 2020;23:85. [DOI: 10.17116/profmed20202306185] [Reference Citation Analysis]
|
| 635 |
Nitsure M, Sarangi B, Shankar GH, Reddy VS, Walimbe A, Sharma V, Prayag S. Mechanisms of Hypoxia in COVID-19 Patients: A Pathophysiologic Reflection. Indian J Crit Care Med 2020;24:967-70. [PMID: 33281323 DOI: 10.5005/jp-journals-10071-23547] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 4.7] [Reference Citation Analysis]
|
| 636 |
Venkataraman R. Thromboelastogram to Detect Hypercoagulability in Critically Ill COVID-19 Patients: Has Its Time Come? Indian J Crit Care Med 2020;24:1154-5. [PMID: 33446961 DOI: 10.5005/jp-journals-10071-23678] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 637 |
Mehta N, Qiao R. Medical management of COVID-19 clinic. J Biomed Res 2020;34:416-21. [PMID: 33100274 DOI: 10.7555/JBR.34.20200118] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 638 |
Valle C, Bonaffini PA, Dal Corso M, Mercanzin E, Franco PN, Sonzogni A, Vacca G, Gianatti A, Sironi S. Pulmonary Embolism and COVID-19, an Unexpected Association: Experience from Two Centers in the Core of the Infection Italian Peak. SSRN Journal. [DOI: 10.2139/ssrn.3588533] [Reference Citation Analysis]
|
| 639 |
Juneja D, Savio RD, Srinivasan S, Pandit RA, Ramasubban S, Reddy PK, Singh MK, Gopal PB, Chaudhry D, Govil D, Dixit SB, Samavedam S. Basic Critical Care for Management of COVID-19 Patients: Position Paper of the Indian Society of Critical Care Medicine, Part II. Indian J Crit Care Med 2020;24:S254-62. [PMID: 33354049 DOI: 10.5005/jp-journals-10071-23593] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 640 |
Kaur S, Hussain S, Kolhe K, Kumar G, Tripathi DM, Tomar A, Kale P, Narayanan A, Bihari C, Bajpai M, Maiwall R, Gupta E, Sarin SK. Elevated Plasma Levels of ICAM1 Predict Mortality in COVID-19 and Sepsis Patients with Liver Cirrhosis. SSRN Journal. [DOI: 10.2139/ssrn.3741508] [Reference Citation Analysis]
|
| 641 |
Benito N, Filella D, Mateo J, Fortuna AM, Gutierrez-Alliende JE, Hernandez N, Gimenez AM, Pomar V, Castellvi I, Corominas H, Casademont J, Domingo P. Pulmonary Thrombosis or Embolism in a Large Cohort of Hospitalized Patients With Covid-19. Front Med (Lausanne) 2020;7:557. [PMID: 32984388 DOI: 10.3389/fmed.2020.00557] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 8.3] [Reference Citation Analysis]
|
| 642 |
Bulanov A, Simarova I, Bulanova E, Siniavkin D, Feklistov A, Rabotinsky S, Katrish S. New coronavirus infection COVID-19: clinical and prognostic significance of plasma fibrinogen level. Annals of critical care 2020. [DOI: 10.21320/1818-474x-2020-4-42-47] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 643 |
[DOI: 10.1101/2020.08.23.20177824] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
|
| 644 |
[DOI: 10.1101/2020.08.30.274464] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
|
| 645 |
[DOI: 10.1101/2020.05.30.20117929] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Reference Citation Analysis]
|
